[{"title":"Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia","googleId":"ujnvDqo_VpQJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/1/7/6611","googleCitationCount":624,"googleAuthor":"K Pratz","doi":"10.1182/blood-2018-08-868752","elsevierAuthor":"Cerrano M.","publicationName":"Current Oncology Reports","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"1 February 2019","elsevierCitationCount":"15","altmetricAuthors":["Courtney D. DiNardo","Keith Pratz","Vinod Pullarkat","Brian A. Jonas","Martha Arellano","Pamela S. Becker","Olga Frankfurt","Marina Konopleva","Andrew H. Wei","Hagop M. Kantarjian","Tu Xu","Wan-Jen Hong","Brenda Chyla","Jalaja Potluri","Daniel A. Pollyea","Anthony Letai"],"twitterCount":129,"altmetricId":50303142},{"title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","googleId":"rkKJHiGs1AEJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/25/2745/37141","googleCitationCount":515,"googleAuthor":"M Hallek","doi":"10.1182/blood-2017-09-806398","elsevierAuthor":"Schuh A.H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"8","altmetricAuthors":["Michael Hallek","Bruce D. Cheson","Daniel Catovsky","Federico Caligaris-Cappio","Guillermo Dighiero","Hartmut Döhner","Peter Hillmen","Michael Keating","Emili Montserrat","Nicholas Chiorazzi","Stephan Stilgenbauer","Kanti R. Rai","John C. Byrd","Barbara Eichhorst","Susan O’Brien","Tadeusz Robak","John F. Seymour","Thomas J. Kipps"],"twitterCount":92,"altmetricId":34338182},{"title":"Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party","googleId":"z589FarS5lMJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/12/1275/36625","googleCitationCount":432,"googleAuthor":"","doi":"10.1182/blood-2017-09-801498","elsevierAuthor":"Schuurhuis G.J.","publicationName":"Blood","elsevierCoverDate":"2018-03-22","elsevierCoverDisplayDate":"22 March 2018","elsevierCitationCount":"278","altmetricAuthors":["Gerrit J. Schuurhuis","Michael Heuser","Sylvie Freeman","Marie-Christine Béné","Francesco Buccisano","Jacqueline Cloos","David Grimwade","Torsten Haferlach","Robert K. Hills","Christopher S. Hourigan","Jeffrey L. Jorgensen","Wolfgang Kern","Francis Lacombe","Luca Maurillo","Claude Preudhomme","Bert A. van der Reijden","Christian Thiede","Adriano Venditti","Paresh Vyas","Brent L. Wood","Roland B. Walter","Konstanze Döhner","Gail J. Roboz","Gert J. Ossenkoppele"],"twitterCount":94,"altmetricId":31602945},{"title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome","googleId":"usyL4ZQfnBoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/13/1365/105711","googleCitationCount":298,"googleAuthor":"V Pengo","doi":"10.1182/blood-2018-04-848333","elsevierAuthor":"Pengo V.","publicationName":"Blood","elsevierCoverDate":"2018-09-27","elsevierCoverDisplayDate":"27 September 2018","elsevierCitationCount":"223","altmetricAuthors":["Vittorio Pengo","Gentian Denas","Giacomo Zoppellaro","Seena Padayattil Jose","Ariela Hoxha","Amelia Ruffatti","Laura Andreoli","Angela Tincani","Caterina Cenci","Domenico Prisco","Tiziana Fierro","Paolo Gresele","Arturo Cafolla","Valeria De Micheli","Angelo Ghirarduzzi","Alberto Tosetto","Anna Falanga","Ida Martinelli","Sophie Testa","Doris Barcellona","Maria Gerosa","Alessandra Banzato"],"twitterCount":685,"altmetricId":44947070},{"title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","googleId":"eKU-2zGgD6YJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/23/2465/273833","googleCitationCount":203,"googleAuthor":"AC Horne","doi":"10.1182/blood.2018894618","elsevierAuthor":"Rosée P.L.","publicationName":"Blood","elsevierCoverDate":"2019-06-06","elsevierCoverDisplayDate":"6 June 2019","elsevierCitationCount":"128","altmetricAuthors":["Paul La Rosée","AnnaCarin Horne","Melissa Hines","Tatiana von Bahr Greenwood","Rafal Machowicz","Nancy Berliner","Sebastian Birndt","Juana Gil-Herrera","Michael Girschikofsky","Michael B. Jordan","Ashish Kumar","Jan A. M. van Laar","Gunnar Lachmann","Kim E. Nichols","Athimalaipet V. Ramanan","Yini Wang","Zhao Wang","Gritta Janka","Jan-Inge Henter"],"twitterCount":108,"altmetricId":59206208},{"title":"Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia","googleId":"X4IYF3gmtwoJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/14/1522/36655","googleCitationCount":301,"googleAuthor":"","doi":"10.1182/blood-2017-08-798322","elsevierAuthor":"Paul S.","publicationName":"Acta Haematologica","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"19","altmetricAuthors":["Nicola Gökbuget","Hervé Dombret","Massimiliano Bonifacio","Albrecht Reichle","Carlos Graux","Christoph Faul","Helmut Diedrich","Max S. Topp","Monika Brüggemann","Heinz-August Horst","Violaine Havelange","Julia Stieglmaier","Hendrik Wessels","Vincent Haddad","Jonathan E. Benjamin","Gerhard Zugmaier","Dirk Nagorsen","Ralf C. Bargou"],"twitterCount":21,"altmetricId":32227957},{"title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","googleId":"2e7MbCysLswJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/16/1703/260505","googleCitationCount":263,"googleAuthor":"L Cerroni","doi":"10.1182/blood-2018-11-881268","elsevierAuthor":"Rongioletti F.","publicationName":"Journal of the European Academy of Dermatology and Venereology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"0","altmetricAuthors":["Rein Willemze","Lorenzo Cerroni","Werner Kempf","Emilio Berti","Fabio Facchetti","Steven H. Swerdlow","Elaine S. Jaffe"],"twitterCount":106,"altmetricId":53825289},{"title":"Anemia of inflammation","googleId":"NRz1oUNwWFMJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/1/40/6617","googleCitationCount":178,"googleAuthor":"G Weiss","doi":"10.1182/blood-2018-06-856500","elsevierAuthor":"Weiss G.","publicationName":"Blood","elsevierCoverDate":"2019-01-03","elsevierCoverDisplayDate":"3 January 2019","elsevierCitationCount":"122","altmetricAuthors":["Guenter Weiss","Tomas Ganz","Lawrence T. Goodnough"],"twitterCount":18,"altmetricId":50965774},{"title":"Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms","googleId":"H9-2bm4iCgIJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/9/906/260659","googleCitationCount":158,"googleAuthor":"SP Jackson","doi":"10.1182/blood-2018-11-882993","elsevierAuthor":"Jackson S.P.","publicationName":"Blood","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"97","altmetricAuthors":["Shaun P. Jackson","Roxane Darbousset","Simone M. Schoenwaelder"],"twitterCount":22,"altmetricId":53976360},{"title":"Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience","googleId":"7lP1ZQaRlWcJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/17/1910/36756","googleCitationCount":248,"googleAuthor":"JA Burger","doi":"10.1182/blood-2017-10-810044","elsevierAuthor":"O’Brien S.","publicationName":"Blood","elsevierCoverDate":"2018-04-26","elsevierCoverDisplayDate":"26 April 2018","elsevierCitationCount":"184","altmetricAuthors":["Susan O’Brien","Richard R. Furman","Steven Coutre","Ian W. Flinn","Jan A. Burger","Kristie Blum","Jeff Sharman","William Wierda","Jeffrey Jones","Weiqiang Zhao","Nyla A. Heerema","Amy J. Johnson","Ying Luan","Danelle F. James","Alvina D. Chu","John C. Byrd"],"twitterCount":62,"altmetricId":32894845},{"title":"Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet","googleId":"MuUQMktihvAJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/15/1630/273295","googleCitationCount":130,"googleAuthor":"MA Sanz","doi":"10.1182/blood-2019-01-894980","elsevierAuthor":"Sanz M.A.","publicationName":"Blood","elsevierCoverDate":"2019-04-11","elsevierCoverDisplayDate":"11 April 2019","elsevierCitationCount":"95","altmetricAuthors":["Miguel A. Sanz","Pierre Fenaux","Martin S. Tallman","Elihu H. Estey","Bob Löwenberg","Tomoki Naoe","Eva Lengfelder","Hartmut Döhner","Alan K. Burnett","Sai-Juan Chen","Vikram Mathews","Harry Iland","Eduardo Rego","Hagop Kantarjian","Lionel Adès","Giuseppe Avvisati","Pau Montesinos","Uwe Platzbecker","Farhad Ravandi","Nigel H. Russell","Francesco Lo-Coco"],"twitterCount":92,"altmetricId":56043378},{"title":"Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib","googleId":"szO9S1l0TyoJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/7/676/260566","googleCitationCount":140,"googleAuthor":"AT Fathi","doi":"10.1182/blood-2018-08-869008","elsevierAuthor":"Stein E.M.","publicationName":"Blood","elsevierCoverDate":"2019-02-14","elsevierCoverDisplayDate":"14 February 2019","elsevierCitationCount":"101","altmetricAuthors":["Eytan M. Stein","Courtney D. DiNardo","Amir T. Fathi","Daniel A. Pollyea","Richard M. Stone","Jessica K. Altman","Gail J. Roboz","Manish R. Patel","Robert Collins","Ian W. Flinn","Mikkael A. Sekeres","Anthony S. Stein","Hagop M. Kantarjian","Ross L. Levine","Paresh Vyas","Kyle J. MacBeth","Alessandra Tosolini","Jason VanOostendorp","Qiang Xu","Ira Gupta","Thomas Lila","Alberto Risueno","Katharine E. Yen","Bin Wu","Eyal C. Attar","Martin S. Tallman","Stéphane de Botton"],"twitterCount":19,"altmetricId":52264109},{"title":"Iron deficiency","googleId":"Fdzfj-QmfzgJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/1/30/6613","googleCitationCount":131,"googleAuthor":"","doi":"10.1182/blood-2018-05-815944","elsevierAuthor":"Camaschella C.","publicationName":"Blood","elsevierCoverDate":"2019-01-03","elsevierCoverDisplayDate":"3 January 2019","elsevierCitationCount":"68","altmetricAuthors":["Clara Camaschella"],"twitterCount":55,"altmetricId":53424160},{"title":"The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL","googleId":"4X4ex8QcoFgJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/23/2446/40003","googleCitationCount":137,"googleAuthor":"P Hillmen","doi":"10.1182/blood-2018-05-850461","elsevierAuthor":"Flinn I.W.","publicationName":"Blood","elsevierCoverDate":"2018-12-06","elsevierCoverDisplayDate":"6 December 2018","elsevierCitationCount":"91","altmetricAuthors":["Ian W. Flinn","Peter Hillmen","Marco Montillo","Zsolt Nagy","Árpád Illés","Gabriel Etienne","Julio Delgado","Bryone J. Kuss","Constantine S. Tam","Zoltán Gasztonyi","Fritz Offner","Scott Lunin","Francesco Bosch","Matthew S. Davids","Nicole Lamanna","Ulrich Jaeger","Paolo Ghia","Florence Cymbalista","Craig A. Portell","Alan P. Skarbnik","Amanda F. Cashen","David T. Weaver","Virginia M. Kelly","Barry Turnbull","Stephan Stilgenbauer"],"twitterCount":46,"altmetricId":49219661},{"title":"A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403","googleId":"bXf9Z7n2IDEJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/14/1548/260519","googleCitationCount":118,"googleAuthor":"J Yin","doi":"10.1182/blood-2018-10-881961","elsevierAuthor":"Aladag E.","publicationName":"Clinical Lymphoma, Myeloma and Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0","altmetricAuthors":["Wendy Stock","Selina M. Luger","Anjali S. Advani","Jun Yin","Richard C. Harvey","Charles G. Mullighan","Cheryl L. Willman","Noreen Fulton","Kristina M. Laumann","Greg Malnassy","Elisabeth Paietta","Edy Parker","Susan Geyer","Krzysztof Mrózek","Clara D. Bloomfield","Ben Sanford","Guido Marcucci","Michaela Liedtke","David F. Claxton","Matthew C. Foster","Jeffrey A. Bogart","John C. Grecula","Frederick R. Appelbaum","Harry Erba","Mark R. Litzow","Martin S. Tallman","Richard M. Stone","Richard A. Larson"],"twitterCount":84,"altmetricId":54131941},{"title":"Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma","googleId":"KXKLSsanZgsJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/6/587/39419","googleCitationCount":155,"googleAuthor":"BA Walker","doi":"10.1182/blood-2018-03-840132","elsevierAuthor":"Manni S.","publicationName":"Frontiers in Oncology","elsevierCoverDate":"2020-05-15","elsevierCoverDisplayDate":"15 May 2020","elsevierCitationCount":"0","altmetricAuthors":["Brian A. Walker","Konstantinos Mavrommatis","Christopher P. Wardell","T. Cody Ashby","Michael Bauer","Faith E. Davies","Adam Rosenthal","Hongwei Wang","Pingping Qu","Antje Hoering","Mehmet Samur","Fadi Towfic","Maria Ortiz","Erin Flynt","Zhinuan Yu","Zhihong Yang","Dan Rozelle","John Obenauer","Matthew Trotter","Daniel Auclair","Jonathan Keats","Niccolo Bolli","Mariateresa Fulciniti","Raphael Szalat","Philippe Moreau","Brian Durie","A. Keith Stewart","Hartmut Goldschmidt","Marc S. Raab","Hermann Einsele","Pieter Sonneveld","Jesus San Miguel","Sagar Lonial","Graham H. Jackson","Kenneth C. Anderson","Herve Avet-Loiseau","Nikhil Munshi","Anjan Thakurta","Gareth J. Morgan"],"twitterCount":47,"altmetricId":43568290},{"title":"Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trial","googleId":"ywR-oRml3z8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/4/393/103899","googleCitationCount":166,"googleAuthor":"PD le Coutre","doi":"10.1182/blood-2016-09-739086","elsevierAuthor":"Cortes J.E.","publicationName":"Blood","elsevierCoverDate":"2018-07-26","elsevierCoverDisplayDate":"26 July 2018","elsevierCitationCount":"113","altmetricAuthors":["Jorge E. Cortes","Dong-Wook Kim","Javier Pinilla-Ibarz","Philipp D. le Coutre","Ronald Paquette","Charles Chuah","Franck E. Nicolini","Jane F. Apperley","H. Jean Khoury","Moshe Talpaz","Daniel J. DeAngelo","Elisabetta Abruzzese","Delphine Rea","Michele Baccarani","Martin C. Müller","Carlo Gambacorti-Passerini","Stephanie Lustgarten","Victor M. Rivera","Frank G. Haluska","François Guilhot","Michael W. Deininger","Andreas Hochhaus","Timothy P. Hughes","Neil P. Shah","Hagop M. Kantarjian"],"twitterCount":52,"altmetricId":34731373},{"title":"Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma","googleId":"nC2fjARYPcgJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/11/1183/36457","googleCitationCount":180,"googleAuthor":"AF Herrera","doi":"10.1182/blood-2017-10-811224","elsevierAuthor":"Herrera A.","publicationName":"Blood","elsevierCoverDate":"2018-03-15","elsevierCoverDisplayDate":"15 March 2018","elsevierCitationCount":"130","altmetricAuthors":["Alex F. Herrera","Alison J. Moskowitz","Nancy L. Bartlett","Julie M. Vose","Radhakrishnan Ramchandren","Tatyana A. Feldman","Ann S. LaCasce","Stephen M. Ansell","Craig H. Moskowitz","Keenan Fenton","Carol Anne Ogden","David Taft","Qu Zhang","Kazunobu Kato","Mary Campbell","Ranjana H. Advani"],"twitterCount":95,"altmetricId":30334244},{"title":"Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma","googleId":"fN5I4Kls-a8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/23/2456/40023","googleCitationCount":137,"googleAuthor":"A Perrot","doi":"10.1182/blood-2018-06-858613","elsevierAuthor":"Perrot A.","publicationName":"Blood","elsevierCoverDate":"2018-12-06","elsevierCoverDisplayDate":"6 December 2018","elsevierCitationCount":"105","altmetricAuthors":["Aurore Perrot","Valerie Lauwers-Cances","Jill Corre","Nelly Robillard","Cyrille Hulin","Marie-Lorraine Chretien","Thomas Dejoie","Sabrina Maheo","Anne-Marie Stoppa","Brigitte Pegourie","Lionel Karlin","Laurent Garderet","Bertrand Arnulf","Chantal Doyen","Nathalie Meuleman","Bruno Royer","Jean-Richard Eveillard","Lotfi Benboubker","Mamoun Dib","Olivier Decaux","Arnaud Jaccard","Karim Belhadj","Sabine Brechignac","Brigitte Kolb","Cecile Fohrer","Mohamad Mohty","Margaret Macro","Paul G. Richardson","Victoria Carlton","Martin Moorhead","Tom Willis","Malek Faham","Kenneth C. Anderson","Jean-Luc Harousseau","Xavier Leleu","Thierry Facon","Philippe Moreau","Michel Attal","Hervé Avet-Loiseau","Nikhil Munshi"],"twitterCount":125,"altmetricId":48850775},{"title":"The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia","googleId":"Tg67Np0BHccJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/24/2661/37193","googleCitationCount":148,"googleAuthor":"G Garcia-Manero","doi":"10.1182/blood-2017-12-818948","elsevierAuthor":"Stein E.M.","publicationName":"Blood","elsevierCoverDate":"2018-06-14","elsevierCoverDisplayDate":"14 June 2018","elsevierCitationCount":"104","altmetricAuthors":["Eytan M. Stein","Guillermo Garcia-Manero","David A. Rizzieri","Raoul Tibes","Jesus G. Berdeja","Michael R. Savona","Mojca Jongen-Lavrenic","Jessica K. Altman","Blythe Thomson","Stephen J. Blakemore","Scott R. Daigle","Nigel J. Waters","A. Benjamin Suttle","Alicia Clawson","Roy Pollock","Andrei Krivtsov","Scott A. Armstrong","Jorge DiMartino","Eric Hedrick","Bob Löwenberg","Martin S. Tallman"],"twitterCount":8,"altmetricId":40683853},{"title":"Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease","googleId":"Ttb1RV90FW0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/26/2877/39185","googleCitationCount":127,"googleAuthor":"J Picarsic","doi":"10.1182/blood-2018-03-839753","elsevierAuthor":"Abla O.","publicationName":"Blood","elsevierCoverDate":"2018-06-28","elsevierCoverDisplayDate":"28 June 2018","elsevierCitationCount":"83","altmetricAuthors":["Oussama Abla","Eric Jacobsen","Jennifer Picarsic","Zdenka Krenova","Ronald Jaffe","Jean-Francois Emile","Benjamin H. Durham","Jorge Braier","Frédéric Charlotte","Jean Donadieu","Fleur Cohen-Aubart","Carlos Rodriguez-Galindo","Carl Allen","James A. Whitlock","Sheila Weitzman","Kenneth L. McClain","Julien Haroche","Eli L. Diamond"],"twitterCount":84,"altmetricId":42375764},{"title":"Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies","googleId":"Phcv2JDVDXsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120325842","googleCitationCount":156,"googleAuthor":"C Chester","doi":"10.1182/blood-2017-06-741041","elsevierAuthor":"Chester C.","publicationName":"Blood","elsevierCoverDate":"2018-01-04","elsevierCoverDisplayDate":"4 January 2018","elsevierCitationCount":"129","altmetricAuthors":["Cariad Chester","Miguel F. Sanmamed","Jun Wang","Ignacio Melero"],"twitterCount":12,"altmetricId":28715122},{"title":"First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation","googleId":"zvWVUyEev8MJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/23/2515/36958","googleCitationCount":138,"googleAuthor":"R Romee","doi":"10.1182/blood-2017-12-823757","elsevierAuthor":"Romee R.","publicationName":"Blood","elsevierCoverDate":"2018-06-07","elsevierCoverDisplayDate":"7 June 2018","elsevierCitationCount":"113","altmetricAuthors":["Rizwan Romee","Sarah Cooley","Melissa M. Berrien-Elliott","Peter Westervelt","Michael R. Verneris","John E. Wagner","Daniel J. Weisdorf","Bruce R. Blazar","Celalettin Ustun","Todd E. DeFor","Sithara Vivek","Lindsey Peck","John F. DiPersio","Amanda F. Cashen","Rachel Kyllo","Amy Musiek","András Schaffer","Milan J. Anadkat","Ilana Rosman","Daniel Miller","Jack O. Egan","Emily K. Jeng","Amy Rock","Hing C. Wong","Todd A. Fehniger","Jeffrey S. Miller"],"twitterCount":79,"altmetricId":33443441},{"title":"Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD","googleId":"duBf_-f88okJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/8/840/260612","googleCitationCount":104,"googleAuthor":"RF Schlenk"},{"title":"Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B","googleId":"SlZWOYuoJ98J","googleLink":"https://ashpublications.org/blood/article-abstract/131/9/1022/39176","googleCitationCount":150,"googleAuthor":""},{"title":"CD38 antibodies in multiple myeloma: back to the future","googleId":"555YzaDWP9QJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/1/13/107710","googleCitationCount":152,"googleAuthor":"NWCJ van de Donk"},{"title":"Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML","googleId":"ZxyXPy_haXIJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/16/1703/39364","googleCitationCount":112,"googleAuthor":"R Gabdoulline"},{"title":"Neutrophils and NETs in modulating acute and chronic inflammation","googleId":"7iU0N_1supQJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/20/2178/273824","googleCitationCount":84,"googleAuthor":""},{"title":"Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy","googleId":"7v8VC-sQAN8J","googleLink":"https://ashpublications.org/blood/article-abstract/131/1/121/107692","googleCitationCount":151,"googleAuthor":"JA Hill"},{"title":"Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma","googleId":"1jcoMEnGQXgJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/3/301/38303","googleCitationCount":141,"googleAuthor":"MA Dimopoulos"},{"title":"Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib","googleId":"AcBE25t2gEMJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/17/1955/36746","googleCitationCount":132,"googleAuthor":"MP Ledoux"},{"title":"Neutrophil plasticity in the tumor microenvironment","googleId":"zD70Pb6L31AJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/20/2159/273823","googleCitationCount":79,"googleAuthor":"LE Hind"},{"title":"Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy","googleId":"6socCXSvchkJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/15/1652/273303","googleCitationCount":90,"googleAuthor":"J Gauthier"},{"title":"Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab","googleId":"ID8ZSqpvWAUJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/19/2031/273817","googleCitationCount":88,"googleAuthor":"JC Byrd"},{"title":"International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease","googleId":"LB_7YQffihsJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/20/2115/39506","googleCitationCount":97,"googleAuthor":"A Dispenzieri"},{"title":"Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study","googleId":"SmoobG3QLqgJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/6/530/260550","googleCitationCount":93,"googleAuthor":""},{"title":"Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL","googleId":"rROBLyuddiwJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/11/851/273871","googleCitationCount":74,"googleAuthor":"CS Tam"},{"title":"Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study","googleId":"Ex6BVKRSq6oJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/6/540/260562","googleCitationCount":94,"googleAuthor":"AG Kulasekararaj"},{"title":"Anemia at older age: etiologies, clinical implications, and management","googleId":"v6yqyf2nro8J","googleLink":"https://ashpublications.org/blood/article-abstract/131/5/505/104393","googleCitationCount":130,"googleAuthor":""},{"title":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome","googleId":"rGEf5YiIIasJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/13/1442/36639","googleCitationCount":133,"googleAuthor":""},{"title":"Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia","googleId":"coP_EJ64uHsJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/10/1011/272728","googleCitationCount":89,"googleAuthor":"JA Burger"},{"title":"Age-related clonal hematopoiesis","googleId":"KLfSQtHm2rAJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/5/496/104398","googleCitationCount":121,"googleAuthor":"LI Shlush"},{"title":"A randomized phase III study of ibrutinib (PCI-32765)-based therapy vs. standard fludarabine, cyclophosphamide, and rituximab (FCR) chemoimmunotherapy in …","googleId":"zPEWyi_8HAMJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/LBA-4/375111","googleCitationCount":96,"googleAuthor":"TD Shanafelt"},{"title":"Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study","googleId":"cLUZkQ77jzYJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/21/2357/37110","googleCitationCount":112,"googleAuthor":"IE Ahn"},{"title":"Sorafenib as maintenance therapy post allogeneic stem cell transplantation for FLT3-ITD positive AML: results from the randomized, double-blind, placebo-controlled …","googleId":"cmlnwS8dVUoJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/661/266168","googleCitationCount":89,"googleAuthor":""},{"title":"Erythroferrone inhibits the induction of hepcidin by BMP6","googleId":"yIDQiSybwBcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/14/1473/39343","googleCitationCount":89,"googleAuthor":"J Arezes"},{"title":"Mosunetuzumab induces complete remissions in poor prognosis non-Hodgkin lymphoma patients, including those who are resistant to or relapsing after …","googleId":"KQ_0Tiph888J","googleLink":"https://profiles.wustl.edu/en/publications/mosunetuzumab-induces-complete-remissions-in-poor-prognosis-non-h","googleCitationCount":63,"googleAuthor":"S Assouline","doi":"10.1182/blood-2019-123742","elsevierAuthor":"Schuster S.J.","publicationName":"Blood","elsevierCoverDate":"2019-11-13","elsevierCoverDisplayDate":"13 November 2019","elsevierCitationCount":"41","altmetricAuthors":["Schuster, Stephen J","Bartlett, Nancy L","Assouline, Sarit","Yoon, Sung-Soo","Bosch, Francesc","Sehn, Laurie H","Cheah, Chan Y.","Shadman, Mazyar","Gregory, Gareth P","Ku, Matthew","Wei, Michael C","Yin, Shen","Kwan, Antonia","Yousefi, Kasra","Hernandez, Genevive","Li, Chi-Chung","O'Hear, Carol","Budde, Lihua E"],"twitterCount":4,"altmetricId":70481089},{"title":"Axicabtagene ciloleucel (Axi-cel) CD19 chimeric antigen receptor (CAR) T-cell therapy for relapsed/refractory large B-cell lymphoma: real world experience","googleId":"N3gMHvb-I6UJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/91/265997","googleCitationCount":91,"googleAuthor":""},{"title":"How I treat disseminated intravascular coagulation","googleId":"TJc-EMAiLfUJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/8/845/104418","googleCitationCount":119,"googleAuthor":"M Levi"},{"title":"Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma","googleId":"S1SSL8qPru4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/1/40/39282","googleCitationCount":100,"googleAuthor":"P Caimi"},{"title":"Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR","googleId":"rFMfmIzYvpAJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/12/924/374909","googleCitationCount":65,"googleAuthor":"BE Shaw"},{"title":"Aging of hematopoietic stem cells","googleId":"JXCbrFQT-U4J","googleLink":"https://ashpublications.org/blood/article-abstract/131/5/479/104419","googleCitationCount":108,"googleAuthor":"SS Lazare"},{"title":"Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma","googleId":"uQkRoWC0CPgJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/22/2413/37097","googleCitationCount":99,"googleAuthor":"V Spina"},{"title":"Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells","googleId":"_i5dqI6g210J","googleLink":"https://ashpublications.org/blood/article-abstract/133/20/2212/273855","googleCitationCount":73,"googleAuthor":"JT Jordan"},{"title":"The multifaceted role of fibrinogen in tissue injury and inflammation","googleId":"WTa0jSDfbMYJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/6/511/260540","googleCitationCount":65,"googleAuthor":"JG Schoenecker"},{"title":"Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML","googleId":"H_-Y8SuLmrEJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/13/1415/36624","googleCitationCount":97,"googleAuthor":"JF Zeidner"},{"title":"The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells","googleId":"j2TUStN2sXUJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/17/1876/275916","googleCitationCount":67,"googleAuthor":"J Gauthier"},{"title":"Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents","googleId":"wey0myfSgUoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120322941","googleCitationCount":91,"googleAuthor":"XR Xu","doi":"10.1182/blood-2017-05-743187","elsevierAuthor":"Xu X.R.","publicationName":"Blood","elsevierCoverDate":"2018-04-19","elsevierCoverDisplayDate":"19 April 2018","elsevierCitationCount":"72","altmetricAuthors":["Xiaohong Ruby Xu","George M. Yousef","Heyu Ni"],"twitterCount":23,"altmetricId":38331592},{"title":"Chimeric antigen receptor–modified T cells: CD19 and the road beyond","googleId":"JqIEvAwb2DEJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/24/2621/37176","googleCitationCount":83,"googleAuthor":"AI Salter"},{"title":"Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications","googleId":"r_gtEplH82gJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/14/1478/39337","googleCitationCount":82,"googleAuthor":"A Dispenzieri"},{"title":"Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma","googleId":"E3zwf0Tiu_UJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/11/860/273869","googleCitationCount":62,"googleAuthor":"MJ Frigault"},{"title":"TIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myeloma","googleId":"fWVlNvs7JqcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/16/1689/39360","googleCitationCount":88,"googleAuthor":"C Guillerey"},{"title":"Emapalumab for the treatment of relapsed/refractory hemophagocytic lymphohistiocytosis","googleId":"3wypXXeePXUJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/21/1783/374991","googleCitationCount":55,"googleAuthor":"N Berliner"},{"title":"Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT","googleId":"eBA0UDxCufkJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/26/2978/39137","googleCitationCount":88,"googleAuthor":"BW Haak"},{"title":"TNF-α–driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging","googleId":"wmyDZT_hRoIJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/9/727/260784","googleCitationCount":50,"googleAuthor":"P Davizon-Castillo"},{"title":"JCARH125, anti-BCMA CAR T-cell therapy for relapsed/refractory multiple myeloma: initial proof of concept results from a phase 1/2 multicenter study (EVOLVE)","googleId":"BvedO4ZYwksJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/957/266016","googleCitationCount":71,"googleAuthor":"S Mailankody"},{"title":"Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma","googleId":"AYdnzZFCR84J","googleLink":"https://ashpublications.org/blood/article-abstract/132/24/2546/39526","googleCitationCount":66,"googleAuthor":"NJ Bahlis"},{"title":"Transfusion-associated circulatory overload and transfusion-related acute lung injury","googleId":"64bPPxAdvMgJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/17/1840/275907","googleCitationCount":63,"googleAuthor":"JW Semple"},{"title":"Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus","googleId":"LzqpIAygEYkJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/17/1960/36763","googleCitationCount":94,"googleAuthor":"A Lattanzi"},{"title":"Daratumumab plus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma","googleId":"FRRIttgL5gUJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/5/421/273899","googleCitationCount":55,"googleAuthor":"J Martinez-Lopez"},{"title":"Prevention of transfusion-transmitted infections","googleId":"iLkBh_lbjN8J","googleLink":"https://ashpublications.org/blood/article-abstract/133/17/1854/275902","googleCitationCount":61,"googleAuthor":"MP Busch"},{"title":"High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology","googleId":"O7nL5Yhl7dAJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/18/2060/36718","googleCitationCount":87,"googleAuthor":"RL King"},{"title":"Genetics of MDS","googleId":"Et4dUxhNkQ4J","googleLink":"https://ashpublications.org/blood/article-abstract/133/10/1049/272730","googleCitationCount":67,"googleAuthor":""},{"title":"CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells","googleId":"O8T4qdxuI5AJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/3/311/38326","googleCitationCount":92,"googleAuthor":"AK Sewell"},{"title":"Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations","googleId":"I8vVW1leuNcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/12/1225/39628","googleCitationCount":74,"googleAuthor":"E Sharma"},{"title":"Coagulation factor XII in thrombosis and inflammation","googleId":"VnujRBMUezYJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/17/1903/36747","googleCitationCount":78,"googleAuthor":"C Maas"},{"title":"Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma","googleId":"-KMk9rKIvZQJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/12/1313/260486","googleCitationCount":56,"googleAuthor":"BM Grande"},{"title":"Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse","googleId":"9pXXCiHMCHgJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/25/2639/39577","googleCitationCount":78,"googleAuthor":""},{"title":"Immune regulatory cell infusion for graft-versus-host disease prevention and therapy","googleId":"gZnCmbwA9CYJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/24/2651/37155","googleCitationCount":75,"googleAuthor":"BR Blazar"},{"title":"Phase 2b study of 2 dosing regimens of quizartinib monotherapy in FLT3-ITD–mutated, relapsed or refractory AML","googleId":"UUmN-mj-7WsJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/6/598/39411","googleCitationCount":75,"googleAuthor":""},{"title":"High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy","googleId":"dbQYD6X7VUcJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/7/636/260715","googleCitationCount":54,"googleAuthor":"J Gauthier"},{"title":"Axicabtagene ciloleucel in the real world: outcomes and predictors of response, resistance and toxicity","googleId":"3mLEDeWxv7EJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/92/266121","googleCitationCount":64,"googleAuthor":"J Ritz"},{"title":"Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type","googleId":"j4-S_OhYCI4J","googleLink":"https://ashpublications.org/blood/article-abstract/131/23/2528/36945","googleCitationCount":79,"googleAuthor":""},{"title":"Liver iron sensing and body iron homeostasis","googleId":"0xEZm7kA8RoJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/1/18/6615","googleCitationCount":60,"googleAuthor":"CY Wang"},{"title":"Phase 1b study of obinutuzumab, ibrutinib, and venetoclax in relapsed and refractory chronic lymphocytic leukemia","googleId":"PqfArGry4TYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/15/1568/39320","googleCitationCount":70,"googleAuthor":"FT Awan"},{"title":"PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells","googleId":"cxA89f1TdOwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/11/1095/39390","googleCitationCount":74,"googleAuthor":"AJ Silver"},{"title":"Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignancies","googleId":"_f11Qx0fikUJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/4/374/260685","googleCitationCount":49,"googleAuthor":"MA Liu"},{"title":"Biology and treatment of Richter syndrome","googleId":"n62INAq8hboJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/25/2761/37138","googleCitationCount":69,"googleAuthor":"D Rossi"},{"title":"Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma","googleId":"XQB7BY9H-m0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/22/2454/37093","googleCitationCount":73,"googleAuthor":"E Ladewig"},{"title":"Venetoclax plus R-or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial","googleId":"xKanOH7c8iQJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/18/1964/260455","googleCitationCount":53,"googleAuthor":"G Salles"},{"title":"Genetics of diffuse large B-cell lymphoma","googleId":"XCAQhp-8WZEJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/21/2307/37115","googleCitationCount":72,"googleAuthor":"L Pasqualucci"},{"title":"Mechanisms of platelet clearance and translation to improve platelet storage","googleId":"tTXYey4l7NMJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/14/1512/36658","googleCitationCount":74,"googleAuthor":"ME Quach"},{"title":"SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery","googleId":"EgIMzMtOdogJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/17/1737/39507","googleCitationCount":67,"googleAuthor":"E Haddad"},{"title":"Hepcidin agonists as therapeutic tools","googleId":"1jxdJ4rHkEYJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/16/1790/36820","googleCitationCount":68,"googleAuthor":"C Casu"},{"title":"Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma","googleId":"D6Sw2tiUZp8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/8/777/39453","googleCitationCount":68,"googleAuthor":""},{"title":"circMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression","googleId":"vN-hQnA_JfoJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/18/1533/374934","googleCitationCount":37,"googleAuthor":""},{"title":"Subcutaneous delivery of daratumumab in relapsed or refractory multiple myeloma","googleId":"4bvoiVEXYuMJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/8/668/260752","googleCitationCount":53,"googleAuthor":"SZ Usmani"},{"title":"Phase 3 randomized study of daratumumab plus lenalidomide and dexamethasone (D-Rd) versus lenalidomide and dexamethasone (Rd) in patients with newly …","googleId":"mvR9xDUoV18J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/LBA-2/375112","googleCitationCount":66,"googleAuthor":"T Plesner"},{"title":"Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables","googleId":"XC88TfjUjwYJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/2/111/260687","googleCitationCount":51,"googleAuthor":"AW Roberts"},{"title":"The Medalist trial: results of a phase 3, randomized, double-blind, placebo-controlled study of luspatercept to treat anemia in patients with very low-, low-, or …","googleId":"jido8SlaCjoJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1/262479","googleCitationCount":62,"googleAuthor":"GJ Mufti"},{"title":"Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy","googleId":"T5lLpIaJkgwJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/1/44/260662","googleCitationCount":42,"googleAuthor":"JA Fraietta"},{"title":"Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with β-thalassemia","googleId":"uyObWrHZCkQJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/12/1279/260489","googleCitationCount":55,"googleAuthor":"A Piga"},{"title":"Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma","googleId":"-btW1FWZ5-QJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/16/1337/374961","googleCitationCount":41,"googleAuthor":"A Oriol"},{"title":"Arterial thromboembolic events preceding the diagnosis of cancer in older persons","googleId":"vacBPW5IYGUJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/8/781/260596","googleCitationCount":54,"googleAuthor":"BB Navi"},{"title":"Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia","googleId":"cW6MbPVcwSEJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/9/995/39172","googleCitationCount":75,"googleAuthor":"R Aplenc"},{"title":"New therapies for hemophilia","googleId":"O0aDfW0cCAkJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/5/389/272947","googleCitationCount":55,"googleAuthor":"AC Weyand"},{"title":"Splenectomy for immune thrombocytopenia: down but not out","googleId":"S3Cvy7ruGEMJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/11/1172/36453","googleCitationCount":75,"googleAuthor":"S Chaturvedi"},{"title":"MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD","googleId":"kZ6Byc6aM-gJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/25/2846/37158","googleCitationCount":69,"googleAuthor":"AS Renteria"},{"title":"Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis","googleId":"jRbN5WW2f1gJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/1/89/39281","googleCitationCount":79,"googleAuthor":"OS Eckstein"},{"title":"Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3","googleId":"Yg3xKgWaHpYJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/19/2013/273820","googleCitationCount":45,"googleAuthor":"RA Campbell"},{"title":"Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma","googleId":"5PBXDZZd3ZoJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/5/436/273091","googleCitationCount":55,"googleAuthor":""},{"title":"Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation","googleId":"LQgEGWij3XkJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/11/892/273868","googleCitationCount":41,"googleAuthor":"M Labopin"},{"title":"Inflammation, von Willebrand factor, and ADAMTS13","googleId":"ommquQR-iZAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120320796","googleCitationCount":59,"googleAuthor":"","doi":"10.1182/blood-2018-02-769000","elsevierAuthor":"Chen J.","publicationName":"Blood","elsevierCoverDate":"2018-07-12","elsevierCoverDisplayDate":"12 July 2018","elsevierCitationCount":"47","altmetricAuthors":["Junmei Chen","Dominic W. Chung"],"twitterCount":13,"altmetricId":43500568},{"title":"Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087","googleId":"tU7okVe3_ssJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/14/1144/374896","googleCitationCount":77,"googleAuthor":"PL Zinzani"},{"title":"Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study","googleId":"A8jyJboyg2YJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/20/2183/6537","googleCitationCount":71,"googleAuthor":"EJ van Beers"},{"title":"Clinical responses and pharmacokinetics of MCARH171, a human-derived Bcma targeted CAR T cell therapy in relapsed/refractory multiple myeloma: final results of a …","googleId":"5hpGuIy02UsJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/959/266042","googleCitationCount":55,"googleAuthor":"S Mailankody"},{"title":"Five-year follow-up of lenalidomide plus rituximab as initial treatment of mantle cell lymphoma","googleId":"IDTlT-s1iDMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/19/2016/39480","googleCitationCount":55,"googleAuthor":"L Cerchietti"},{"title":"A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia","googleId":"arE2_PKMvkAJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/4/387/38494","googleCitationCount":72,"googleAuthor":"AT Fathi"},{"title":"PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation","googleId":"MizdDWlUCq0J","googleLink":"https://ashpublications.org/blood/article-abstract/134/1/22/260653","googleCitationCount":49,"googleAuthor":"YB Chen"},{"title":"A single-cell hematopoietic landscape resolves 8 lineage trajectories and defects in Kit mutant mice","googleId":"wiGjepcqZqoJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/21/e1/37145","googleCitationCount":69,"googleAuthor":"JS Dahlin"},{"title":"Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura","googleId":"TF80EpG6xzUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/20/2143/39510","googleCitationCount":60,"googleAuthor":""},{"title":"Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions","googleId":"ujbScnkP0nsJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/21/2283/37126","googleCitationCount":58,"googleAuthor":""},{"title":"Resolvin D4 attenuates the severity of pathological thrombosis in mice","googleId":"i-Vs9COiyUoJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/17/1458/374930","googleCitationCount":29,"googleAuthor":"D Cherpokova"},{"title":"Genomic landscape and clonal evolution of acute myeloid leukemia with t (8; 21): an international study on 331 patients","googleId":"RUMinJRBnjkJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/10/1140/272750","googleCitationCount":47,"googleAuthor":"K Yoshida"},{"title":"Chronic immune response dysregulation in MDS pathogenesis","googleId":"XjiJpFqKXRoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/15/1553/39326","googleCitationCount":58,"googleAuthor":"L Barreyro"},{"title":"How I manage ibrutinib intolerance and complications in patients with chronic lymphocytic leukemia","googleId":"kvR4L-Vr_VIJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/12/1298/260463","googleCitationCount":46,"googleAuthor":"JC Byrd"},{"title":"Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease","googleId":"N5--ku4I-FcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/9/948/39426","googleCitationCount":55,"googleAuthor":"DT Yeung"},{"title":"Neutrophils: back in the thrombosis spotlight","googleId":"iSaAHNaFTqUJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/20/2186/273843","googleCitationCount":43,"googleAuthor":"DF Noubouossie"},{"title":"Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies","googleId":"7_me1GrDGL0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/3/328/38363","googleCitationCount":72,"googleAuthor":"S Kurtenbach"},{"title":"BCL-2 inhibition in AML: an unexpected bonus?","googleId":"d-qm0buyEHAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/10/1007/39300","googleCitationCount":58,"googleAuthor":"A Letai"},{"title":"Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea","googleId":"hdwdRVVdYnkJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/18/1498/374977","googleCitationCount":43,"googleAuthor":"JT Prchal"},{"title":"The rise of apoptosis: targeting apoptosis in hematologic malignancies","googleId":"EmLsgQSGCDkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/12/1248/39612","googleCitationCount":51,"googleAuthor":""},{"title":"Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients","googleId":"hvIaHk9ZdQUJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/13/1457/261475","googleCitationCount":49,"googleAuthor":""},{"title":"A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease","googleId":"YKX7pvK9DDEJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/17/1865/275910","googleCitationCount":46,"googleAuthor":""},{"title":"An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma","googleId":"5KiIvmIKHrIJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/7/746/39305","googleCitationCount":67,"googleAuthor":""},{"title":"Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma","googleId":"KN5pvRaPXOkJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/13/1072/374935","googleCitationCount":36,"googleAuthor":"A Willerslev-Olsen"},{"title":"Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders","googleId":"3Qx1QmzEpYcJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/23/2082/374932","googleCitationCount":42,"googleAuthor":""},{"title":"Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact","googleId":"RLmfOtF0qfoJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/11/1205/260491","googleCitationCount":65,"googleAuthor":"P Baliakas"},{"title":"Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study","googleId":"ufMfGoU7czsJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/17/1395/374967","googleCitationCount":37,"googleAuthor":"L Falchi"},{"title":"Efficacy and updated safety analysis of a safety Run-in cohort from Griffin, a phase 2 randomized study of Daratumumab (DarA), bortezomib (V), lenalidomide (R), and …","googleId":"ZH75Pkbn6WcJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/151/272998","googleCitationCount":50,"googleAuthor":""},{"title":"Ivosidenib or enasidenib combined with induction and consolidation chemotherapy in patients with newly diagnosed AML with an IDH1 or IDH2 mutation is safe …","googleId":"xO7cZs-egXkJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/560/263325","googleCitationCount":52,"googleAuthor":"AT Fathi"},{"title":"DNA damage responses and p53 in the aging process","googleId":"F6sZVUf9x_8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120325064","googleCitationCount":72,"googleAuthor":"B Schumacher","doi":"10.1182/blood-2017-07-746396","elsevierAuthor":"Ou H.","publicationName":"Blood","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"41","altmetricAuthors":["Hui-Ling Ou","Björn Schumacher"],"twitterCount":14,"altmetricId":28989813},{"title":"How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions","googleId":"--i6pGVeK68J","googleLink":"https://ashpublications.org/blood/article-abstract/131/25/2773/37156","googleCitationCount":59,"googleAuthor":"K Yazdanbakhsh"},{"title":"Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress","googleId":"YAHnz6RLLmIJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/17/1415/374980","googleCitationCount":32,"googleAuthor":""},{"title":"Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial","googleId":"sUuFNeXqR1YJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/9/893/260641","googleCitationCount":45,"googleAuthor":"U Jäger"},{"title":"Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma","googleId":"02d2ndeRITEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/21/2305/39525","googleCitationCount":50,"googleAuthor":"F Lemonnier"},{"title":"The MYC oncogene is a global regulator of the immune response","googleId":"oPV94PRqKt4J","googleLink":"https://ashpublications.org/blood/article-abstract/131/18/2007/36721","googleCitationCount":61,"googleAuthor":"V Baylot"},{"title":"Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia","googleId":"qY3rs9fONO4J","googleLink":"https://ashpublications.org/blood/article-abstract/131/8/855/104417","googleCitationCount":66,"googleAuthor":"D Siegel"},{"title":"A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemia","googleId":"4LOBGToPCkcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/21/2249/39554","googleCitationCount":49,"googleAuthor":""},{"title":"Initial results from a phase 1 clinical study of bb21217, a next-generation anti Bcma CAR T therapy","googleId":"P1qDII-0hKAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/488/262309","googleCitationCount":55,"googleAuthor":"DS Siegel"},{"title":"A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy","googleId":"gtwqc_ytA6EJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/1/49/39283","googleCitationCount":60,"googleAuthor":"E Bachy"},{"title":"R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma","googleId":"0vKIyZ7BFA0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/2/174/37014","googleCitationCount":66,"googleAuthor":"P Soubeyran"},{"title":"Ferritin is secreted via 2 distinct nonclassical vesicular pathways","googleId":"xUJ4nPwYt8AJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/3/342/38393","googleCitationCount":64,"googleAuthor":"M Truman-Rosentsvit"},{"title":"APR-246 combined with azacitidine (AZA) in TP53 mutated myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). A phase 2 study by the …","googleId":"1aIWKBfs_UoJ","googleLink":"https://www.aprea.com/wp-content/uploads/2020/10/EHA_2020_Cluzeau_APR-246-AZA-in-MDS-AML.pdf","googleCitationCount":38,"googleAuthor":""},{"title":"Updated analysis of the efficacy and safety of tisagenlecleucel in pediatric and young adult patients with relapsed/refractory (r/r) acute lymphoblastic leukemia","googleId":"_ri9Xp1qMvAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/895/266293","googleCitationCount":52,"googleAuthor":"SA Grupp"},{"title":"Apixaban, dalteparin, in active cancer associated venous thromboembolism, the ADAM VTE trial","googleId":"jjuVZLuxupEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/421/275722","googleCitationCount":55,"googleAuthor":""},{"title":"Update on clinical gene therapy for hemophilia","googleId":"ZivijzsbRgoJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/5/407/272786","googleCitationCount":45,"googleAuthor":""},{"title":"Activated protein C, protease activated receptor 1, and neuroprotection","googleId":"6dJ8Uy-5SFAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/2/159/39239","googleCitationCount":49,"googleAuthor":"JH Griffin"},{"title":"Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis","googleId":"br9IdzXbTD4J","googleLink":"https://ashpublications.org/blood/article-abstract/133/3/215/261440","googleCitationCount":49,"googleAuthor":""},{"title":"Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism","googleId":"Jm_LnJxq4kYJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/19/1645/374956","googleCitationCount":30,"googleAuthor":"S Lindström"},{"title":"Sepsis alters the transcriptional and translational landscape of human and murine platelets","googleId":"fFMClDDMvHwJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/12/911/374913","googleCitationCount":31,"googleAuthor":"RA Campbell"},{"title":"Ibrutinib blocks Btk-dependent NF-ĸB and NFAT responses in human macrophages during Aspergillus fumigatus phagocytosis","googleId":"Gkm_C7Jg-EAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/18/1985/39605","googleCitationCount":50,"googleAuthor":"T Colley"},{"title":"Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma","googleId":"pp6SpLIBB2oJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/15/1664/273305","googleCitationCount":58,"googleAuthor":"W Lone"},{"title":"von Willebrand factor regulation of blood vessel formation","googleId":"tbNZu4TdwGkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/2/132/39222","googleCitationCount":53,"googleAuthor":""},{"title":"Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group","googleId":"mcoWZ4HCsXcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/8/815/39461","googleCitationCount":46,"googleAuthor":""},{"title":"How I treat CLL patients with ibrutinib","googleId":"t877E0PQEGwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120325234","googleCitationCount":63,"googleAuthor":"","doi":"10.1182/blood-2017-08-764712","elsevierAuthor":"Brown J.R.","publicationName":"Blood","elsevierCoverDate":"2018-01-25","elsevierCoverDisplayDate":"25 January 2018","elsevierCitationCount":"40","altmetricAuthors":["Jennifer R. Brown"],"twitterCount":73,"altmetricId":30643049},{"title":"Charcot-Leyden crystal formation is closely associated with eosinophil extracellular trap cell death","googleId":"si8_Kjo9a1YJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/20/2183/39501","googleCitationCount":48,"googleAuthor":"T Tokunaga"},{"title":"The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes","googleId":"ihiW_wmzhZcJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/10/1039/272716","googleCitationCount":44,"googleAuthor":""},{"title":"Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG","googleId":"d0_6QzHgCRIJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/3/237/261418","googleCitationCount":46,"googleAuthor":""},{"title":"Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia","googleId":"OTwRwpz5gS4J","googleLink":"https://ashpublications.org/blood/article-abstract/133/26/2765/272768","googleCitationCount":37,"googleAuthor":"JG Gribben"},{"title":"RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice","googleId":"MnSBZ7tDYKMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/9/935/39421","googleCitationCount":46,"googleAuthor":"JC Aster"},{"title":"Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma","googleId":"Rkl0sVt3QiEJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/10/802/260637","googleCitationCount":32,"googleAuthor":""},{"title":"Phase Ib/II combination study of APR-246 and azacitidine (AZA) in patients with TP53 mutant myelodysplastic syndromes (MDS) and acute myeloid leukemia …","googleId":"SZABTb60FXcJ","googleLink":"https://www.sectoral.com/PDF/PE%20News/Aprea_news_2018-12-02-2.pdf","googleCitationCount":54,"googleAuthor":"DP Steensma"},{"title":"How I manage monoclonal gammopathy of undetermined significance","googleId":"nRC6XZPFTEcJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/2/163/37011","googleCitationCount":58,"googleAuthor":"RS Go"},{"title":"Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2","googleId":"k3ceF69Yn3wJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/4/395/260700","googleCitationCount":32,"googleAuthor":""},{"title":"New therapies using nonfactor products for patients with hemophilia and inhibitors","googleId":"OebkXaJr500J","googleLink":"https://ashpublications.org/blood/article-abstract/133/5/399/272778","googleCitationCount":36,"googleAuthor":""},{"title":"Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice","googleId":"B7aoy4S9wDsJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/13/1430/36633","googleCitationCount":56,"googleAuthor":""},{"title":"How I treat chronic myeloid leukemia in children and adolescents","googleId":"Ky6MTujXCRkJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/22/2374/273851","googleCitationCount":34,"googleAuthor":""},{"title":"Platelets kill circulating parasites of all major Plasmodium species in human malaria","googleId":"A1wTz1arp1wJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/12/1332/39622","googleCitationCount":44,"googleAuthor":"S Kho"},{"title":"Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia","googleId":"7Pl-VShWYB8J","googleLink":"https://ashpublications.org/blood/article-abstract/131/14/1617/36676","googleCitationCount":52,"googleAuthor":"A Lequeux"},{"title":"Treatment optimization and genomic outcomes in refractory severe aplastic anemia treated with eltrombopag","googleId":"TAqBMrvE7EAJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/24/2575/261459","googleCitationCount":31,"googleAuthor":"T Winkler"},{"title":"Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy","googleId":"K4MnY62COGsJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/2/137/39566","googleCitationCount":41,"googleAuthor":"S Kusumoto"},{"title":"Mechanisms of immune escape after allogeneic hematopoietic cell transplantation","googleId":"J6eZm1bgGDAJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/12/1290/260469","googleCitationCount":40,"googleAuthor":"R Zeiser"},{"title":"Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma","googleId":"Y7-I1BiLj0UJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/15/1238/374463","googleCitationCount":32,"googleAuthor":""},{"title":"Ibrutinib plus lenalidomide and rituximab has promising activity in relapsed/refractory non–germinal center B-cell–like DLBCL","googleId":"MVFVGDZVkzMJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/13/1024/374922","googleCitationCount":30,"googleAuthor":""},{"title":"Checkpoint inhibitors augment CD19-directed chimeric antigen receptor (CAR) T cell therapy in relapsed B-cell acute lymphoblastic leukemia","googleId":"_kjEX5gTdZUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/556/263334","googleCitationCount":43,"googleAuthor":"AE Seif"},{"title":"Lentiviral and genome-editing strategies for the treatment of β-hemoglobinopathies","googleId":"cuEgftL7L2wJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/15/1203/374450","googleCitationCount":25,"googleAuthor":"A Miccio"},{"title":"Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation","googleId":"feLL-mqSHEUJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/20/2233/273841","googleCitationCount":38,"googleAuthor":""},{"title":"Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease","googleId":"njZF8tP4sZUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/22/2323/107704","googleCitationCount":37,"googleAuthor":"DC Fajgenbaum"},{"title":"Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial","googleId":"noFGATS8fiwJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/13/1456/36613","googleCitationCount":52,"googleAuthor":""},{"title":"Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes","googleId":"QUTJhP8oIEMJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/1/9/260658","googleCitationCount":33,"googleAuthor":""},{"title":"Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results","googleId":"rWAkxD2Y2sQJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/22/1973/374968","googleCitationCount":29,"googleAuthor":"AD Shapiro"},{"title":"Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade","googleId":"r56yA1ldetgJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/17/1406/374970","googleCitationCount":35,"googleAuthor":"M Janakiram"},{"title":"Parsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies","googleId":"oPd457PUXLsJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/16/1742/260507","googleCitationCount":34,"googleAuthor":""},{"title":"Carfilzomib-lenalidomide-dexamethasone (KRd) induction-autologous transplant (ASCT)-Krd consolidation vs KRd 12 cycles vs carfilzomib-cyclophosphamide …","googleId":"5j5CuC1DoGMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/121/262862","googleCitationCount":47,"googleAuthor":""},{"title":"Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy","googleId":"nN9zI39pjPUJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/2/168/39568","googleCitationCount":38,"googleAuthor":"K Klann"},{"title":"Characterization and treatment of congenital thrombotic thrombocytopenic purpura","googleId":"jy_NFFmQ2PMJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/15/1644/273301","googleCitationCount":37,"googleAuthor":"C Vendramin"},{"title":"Toward personalized treatment in multiple myeloma based on molecular characteristics","googleId":"BkdpuDbvcmYJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/7/660/260559","googleCitationCount":38,"googleAuthor":""},{"title":"Germline DDX41 mutations define a significant entity within adult MDS/AML patients","googleId":"frP6XijjEJ8J","googleLink":"https://ashpublications.org/blood/article-abstract/134/17/1441/374965","googleCitationCount":30,"googleAuthor":"E Raffoux"},{"title":"Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years","googleId":"vmSQFnrYEZcJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/22/2475/37076","googleCitationCount":46,"googleAuthor":"CU Rank"},{"title":"Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines","googleId":"MDX3-Jiby-8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/16/1635/39368","googleCitationCount":41,"googleAuthor":"BS Hoppe"},{"title":"Luspatercept for the treatment of anemia in myelodysplastic syndromes and primary myelofibrosis","googleId":"REXoqpgIWYUJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/8/790/260592","googleCitationCount":35,"googleAuthor":""},{"title":"Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network","googleId":"D7un5yyaE1MJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/4/417/38488","googleCitationCount":57,"googleAuthor":""},{"title":"A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with FLT3 mutations","googleId":"axw4OM55jtwJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/4/426/38537","googleCitationCount":48,"googleAuthor":""},{"title":"Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies","googleId":"XRf1Tk9ogcwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/13/1438/105719","googleCitationCount":44,"googleAuthor":"CE Allen"},{"title":"Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma","googleId":"smqPHCui5KEJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/9/761/260762","googleCitationCount":32,"googleAuthor":"R Kridel"},{"title":"Radius: a phase 2 randomized trial investigating standard of care±midostaurin after allogeneic stem cell transplant in FLT3-ITD-mutated AML","googleId":"qm_5oLStC1sJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/662/266179","googleCitationCount":41,"googleAuthor":"MM Patnaik"},{"title":"Updated analysis of a phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B-cell maturation antigen, in …","googleId":"wUlaEowlA1IJ","googleLink":"https://cms.cws.net/content/beta.myelomasociety.org/files/2018ash/Wan-Hong%20Zhao%20-%20ASH%20presentation%20_Abstract%20955.pdf","googleCitationCount":39,"googleAuthor":""},{"title":"T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency","googleId":"WQc23I5TiIUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/22/2362/107711","googleCitationCount":39,"googleAuthor":"I Brigida"},{"title":"Myeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockade","googleId":"HRF1IfVXkFEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/16/1675/39370","googleCitationCount":43,"googleAuthor":"SA Minnie"},{"title":"Acute lymphoblastic leukemia in adolescent and young adults: treat as adults or as children?","googleId":"VkMPmnC5LhsJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/4/351/103892","googleCitationCount":42,"googleAuthor":""},{"title":"Treatment of rare factor deficiencies other than hemophilia","googleId":"oo0ku8AD-m8J","googleLink":"https://ashpublications.org/blood/article-abstract/133/5/415/272776","googleCitationCount":35,"googleAuthor":"F Peyvandi"},{"title":"The potential role of γδ T cells after allogeneic HCT for leukemia","googleId":"JnYPV9ccOSQJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/10/1063/36406","googleCitationCount":47,"googleAuthor":"K Schilbach"},{"title":"Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia","googleId":"xbzOUeYRTgYJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/3/289/38308","googleCitationCount":48,"googleAuthor":"A Petit"},{"title":"How I treat breast implant–associated anaplastic large cell lymphoma","googleId":"YoSwGwY-R_gJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/18/1889/39611","googleCitationCount":37,"googleAuthor":"MW Clemens"},{"title":"A niche-dependent myeloid transcriptome signature defines dormant myeloma cells","googleId":"oVsbD8kjLiQJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/1/30/260664","googleCitationCount":28,"googleAuthor":"WH Khoo"},{"title":"Somatic mutations and clonal hematopoiesis in congenital neutropenia","googleId":"6r6DczkUJ-8J","googleLink":"https://ashpublications.org/blood/article-abstract/131/4/408/38500","googleCitationCount":50,"googleAuthor":"CA Miller"},{"title":"Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutants","googleId":"JR8z0UUqlNUJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/25/2669/273906","googleCitationCount":28,"googleAuthor":"C Pecquet"},{"title":"Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition","googleId":"CFyBTvztbIAJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/15/1639/36848","googleCitationCount":44,"googleAuthor":"P Gallipoli"},{"title":"Phase 1 study of CD19/CD22 bispecific chimeric antigen receptor (CAR) therapy in children and young adults with B cell acute lymphoblastic leukemia (ALL)","googleId":"LueD7KVBV28J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/898/266319","googleCitationCount":39,"googleAuthor":""},{"title":"Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond–like syndrome","googleId":"CcIfZAPzLKYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/12/1318/39626","googleCitationCount":40,"googleAuthor":""},{"title":"Next-generation sequencing–based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse","googleId":"Jb-ASGzxXyoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/15/1604/39340","googleCitationCount":38,"googleAuthor":"TH Kim"},{"title":"Biology of classical Hodgkin lymphoma: implications for prognosis and novel therapies","googleId":"gFLEjuyGWg0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/15/1654/36819","googleCitationCount":43,"googleAuthor":"C Steidl"},{"title":"CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphoma","googleId":"NaZDRV5GxEgJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/9/940/260663","googleCitationCount":32,"googleAuthor":"D Martín-Garcia"},{"title":"Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation","googleId":"wnzWd8U2IFIJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/26/2790/272767","googleCitationCount":31,"googleAuthor":"KS Baker"},{"title":"Dysregulation of the TET family of epigenetic regulators in lymphoid and myeloid malignancies","googleId":"F-_ywtNpPZ0J","googleLink":"https://ashpublications.org/blood/article-abstract/134/18/1487/374973","googleCitationCount":22,"googleAuthor":"CWJ Lio"},{"title":"Apoptosis in megakaryocytes and platelets: the life and death of a lineage","googleId":"BFzxWxTmmmQJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/6/605/39214","googleCitationCount":47,"googleAuthor":"K McArthur"},{"title":"Immunogenicity of emicizumab in people with hemophilia A (PwHA): results from the HAVEN 1-4 studies","googleId":"DRGcpMg2eWwJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/633/266374","googleCitationCount":37,"googleAuthor":"I Paz-Priel"},{"title":"Carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible patients with newly diagnosed multiple myeloma","googleId":"aQpfkaIExKAJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/18/1953/260459","googleCitationCount":34,"googleAuthor":"P Moreau"},{"title":"Biomarkers for posttransplantation outcomes","googleId":"JtXEAoXEfkMJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/20/2193/6540","googleCitationCount":40,"googleAuthor":"S Paczesny"},{"title":"Preliminary data on safety, cellular kinetics and anti-leukemic activity of UCART19, an allogeneic anti-CD19 CAR T-cell product, in a pool of adult and pediatric …","googleId":"LhU-9iwzajgJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/896/266300","googleCitationCount":45,"googleAuthor":"R Benjamin"},{"title":"PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell–inflamed phenotype","googleId":"a7qhDGzVvDsJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/21/2279/272749","googleCitationCount":37,"googleAuthor":"R Bao"},{"title":"Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque–triggered thrombus formation in humans","googleId":"8XCu70CZVPQJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/24/2605/37238","googleCitationCount":41,"googleAuthor":"H Deckmyn"},{"title":"Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib","googleId":"FPNj27_8TrsJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/14/1597/260522","googleCitationCount":30,"googleAuthor":""},{"title":"PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke","googleId":"KQF_AwPlNNoJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/11/1163/36458","googleCitationCount":45,"googleAuthor":"RK Sinha"},{"title":"Genomic landscape of neutrophilic leukemias of ambiguous diagnosis","googleId":"it8k49EhqgUJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/11/867/273877","googleCitationCount":23,"googleAuthor":"D Bottomly"},{"title":"Anti-CD37 chimeric antigen receptor T cells are active against B-and T-cell lymphomas","googleId":"FTWQMkKA28YJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/14/1495/39349","googleCitationCount":35,"googleAuthor":"I Scarfò"},{"title":"The interplay of leukemia cells and the bone marrow microenvironment","googleId":"SUsYnku1d8QJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/14/1507/36671","googleCitationCount":39,"googleAuthor":"D Duarte"},{"title":"Recommendations for managing PD-1 blockade in the context of allogeneic HCT in Hodgkin lymphoma: taming a necessary evil","googleId":"rCEeOQ3YKg0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/1/9/39263","googleCitationCount":39,"googleAuthor":"C Herbaux"},{"title":"Myeloma bone disease: from biology findings to treatment approaches","googleId":"Exa5OxRcbXYJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/14/1534/260513","googleCitationCount":30,"googleAuthor":"E Terpos"},{"title":"Emicizumab prophylaxis provides flexible and effective bleed control in children with hemophilia Α with inhibitors: results from the HAVEN 2 study","googleId":"lIpoBCsboeUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/632/266365","googleCitationCount":40,"googleAuthor":"RF Sidonio"},{"title":"Cooperative PSGL-1 and CXCR2 signaling in neutrophils promotes deep vein thrombosis in mice","googleId":"8FYVg7Szz9wJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/13/1426/105722","googleCitationCount":34,"googleAuthor":"T Yago"},{"title":"Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements","googleId":"jKepa1BxbtIJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/13/1386/105720","googleCitationCount":36,"googleAuthor":"RA Luchtel"},{"title":"α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease","googleId":"yY0gxQ_mWssJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/12/1372/36620","googleCitationCount":40,"googleAuthor":"RJ Soiffer"},{"title":"A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era","googleId":"FzDOzKm_zY0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/5/521/39398","googleCitationCount":36,"googleAuthor":"C Nichols"},{"title":"Sequential anti-CD19 directed chimeric antigen receptor modified T-cell therapy (CART19) and PD-1 blockade with pembrolizumab in patients with relapsed or …","googleId":"vcgao4TmPVoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/4198/275591","googleCitationCount":39,"googleAuthor":"J Svoboda"},{"title":"Posttransplant chimeric antigen receptor therapy","googleId":"HASw_Ici6q0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/10/1045/36415","googleCitationCount":42,"googleAuthor":""},{"title":"How I treat MDS after hypomethylating agent failure","googleId":"Dkw1FlDlNasJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/6/521/260537","googleCitationCount":32,"googleAuthor":""},{"title":"First-in-human CLL1-CD33 compound CAR T cell therapy induces complete remission in patients with refractory acute myeloid leukemia: update on phase 1 clinical …","googleId":"WnRGjeK8-NQJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/901/266370","googleCitationCount":35,"googleAuthor":"K Chen"},{"title":"Phase I experience with a bi-specific CAR targeting CD19 and CD22 in adults with B-cell malignancies","googleId":"Z31dG_pwEJsJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/490/262047","googleCitationCount":35,"googleAuthor":"B Sahaf"},{"title":"Tandom autologous transplantation and combined infusion of CD19 and Bcma-specific chimeric antigen receptor T cells for high risk MM: initial safety and efficacy …","googleId":"cTfz8bFAgCEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1009/262598","googleCitationCount":37,"googleAuthor":""},{"title":"Ibrutinib and rituximab provides superior clinical outcome compared to FCR in younger patients with chronic lymphocytic leukemia (CLL): extended follow-up …","googleId":"CgByRh6fnh8J","googleLink":"https://profiles.wustl.edu/en/publications/ibrutinib-and-rituximab-provides-superior-clinical-outcome-compar","googleCitationCount":25,"googleAuthor":"TD Shanafelt","doi":"10.1182/blood-2019-126824","elsevierAuthor":"Shanafelt T.D.","publicationName":"Blood","elsevierCoverDate":"2019-11-13","elsevierCoverDisplayDate":"13 November 2019","elsevierCitationCount":"11","altmetricAuthors":["Shanafelt, Tait D","Wang, Victoria","Kay, Neil E","Hanson, Curtis A","O'Brien, Susan M","Barrientos, Jacqueline C","Jelinek, Diane F","Braggio, Esteban","Leis, Jose F","Zhang, Cong Christina","Coutre, Steven","Barr, Paul M","Cashen, Amanda F","Mato, Anthony R","Singh, Avina","Mullane, Michael P","Little, Richard F","Erba, Harry P","Stone, Richard M","Litzow, Mark","Tallman, Martin S"],"twitterCount":1,"altmetricId":70440956},{"title":"Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL","googleId":"VvfGPe1CsjUJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/9/919/260644","googleCitationCount":30,"googleAuthor":""},{"title":"A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain","googleId":"orCo5l916YsJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/10/1152/272753","googleCitationCount":28,"googleAuthor":"A Matafonov"},{"title":"Juvenile myelomonocytic leukemia: who's the driver at the wheel?","googleId":"wTNbC1J9qr4J","googleLink":"https://ashpublications.org/blood/article-abstract/133/10/1060/272742","googleCitationCount":32,"googleAuthor":""},{"title":"Azacitidine with or without eltrombopag for first-line treatment of intermediate-or high-risk MDS with thrombocytopenia","googleId":"ThykdeYlS1oJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/25/2629/39573","googleCitationCount":32,"googleAuthor":"M Dickinson"},{"title":"How I treat low von Willebrand factor levels","googleId":"a7YUpX6ADdsJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/8/795/260600","googleCitationCount":27,"googleAuthor":""},{"title":"B-cell receptor–mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma","googleId":"K1rTTR4joRUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/17/1805/39520","googleCitationCount":33,"googleAuthor":"J Zhang"},{"title":"The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH","googleId":"NVCCfZm8QdIJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/18/1528/374992","googleCitationCount":23,"googleAuthor":"LK Hilton"},{"title":"The Gp1ba-Cre transgenic mouse: a new model to delineate platelet and leukocyte functions","googleId":"Zbz-CARWgCgJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/4/331/272780","googleCitationCount":29,"googleAuthor":"Z Nagy"},{"title":"Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial","googleId":"DYtx97ZMFa0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/9/883/39413","googleCitationCount":36,"googleAuthor":"KMJ Heitink-Pollé"},{"title":"How I treat infant leukemia","googleId":"iQxQHxOZ9PMJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/3/205/261427","googleCitationCount":30,"googleAuthor":"P Brown"},{"title":"A phase II study of nivolumab or ipilimumab with or without azacitidine for patients with myelodysplastic syndrome (MDS)","googleId":"iEOltpzFr0UJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/465/262217","googleCitationCount":33,"googleAuthor":"G Garcia-Manero"},{"title":"Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma","googleId":"FQXP5x4BWp4J","googleLink":"https://ashpublications.org/blood/article-abstract/131/23/2552/36954","googleCitationCount":35,"googleAuthor":""},{"title":"Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial","googleId":"anMnUsW8uE8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/2/223/39261","googleCitationCount":37,"googleAuthor":"N van Geloven"},{"title":"l-Glutamine for sickle cell anemia: more questions than answers","googleId":"QVMyKsIomcoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/7/689/39431","googleCitationCount":38,"googleAuthor":"CT Quinn"},{"title":"Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-γ","googleId":"N6lE-cFwSJ8J","googleLink":"https://ashpublications.org/blood/article-abstract/133/19/2043/273818","googleCitationCount":31,"googleAuthor":"LJ Alvarado"},{"title":"Updated results from a phase 1 study of gilteritinib in combination with induction and consolidation chemotherapy in subjects with newly diagnosed acute myeloid …","googleId":"ea8c0UaLyKgJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/564/263255","googleCitationCount":33,"googleAuthor":"KW Pratz"},{"title":"Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark","googleId":"nCrdUPdNppsJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/8/678/260753","googleCitationCount":21,"googleAuthor":"J Taylor"},{"title":"Genome-wide screen identifies cullin-RING ligase machinery required for lenalidomide-dependent CRL4CRBN activity","googleId":"fCBttAdjqpkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/12/1293/39625","googleCitationCount":33,"googleAuthor":"QL Sievers"},{"title":"Molecular genetic investigation, clinical features, and response to treatment in 21 patients with Schnitzler syndrome","googleId":"tuo2mbNEEgIJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/9/974/39169","googleCitationCount":41,"googleAuthor":"JI Arostegui"},{"title":"A novel model of controlling PD-L1 expression in ALK+ anaplastic large cell lymphoma revealed by CRISPR screening","googleId":"awjPAtEPZTIJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/2/171/260699","googleCitationCount":20,"googleAuthor":"JP Zhang"},{"title":"Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms","googleId":"jn3sf1aT6q4J","googleLink":"https://ashpublications.org/blood/article-abstract/134/2/199/260696","googleCitationCount":21,"googleAuthor":"F Schischlik"},{"title":"Venetoclax plus rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) improves outcomes in BCL2-positive first-line diffuse large B-cell …","googleId":"t0Wr4WBO9dIJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/782/266037","googleCitationCount":31,"googleAuthor":"RE Gasiorowski"},{"title":"Integrated molecular profiling of juvenile myelomonocytic leukemia","googleId":"WgHyEvdDhSsJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/14/1576/36685","googleCitationCount":36,"googleAuthor":"Y Okuno"},{"title":"Biology and management of primary effusion lymphoma","googleId":"_mhePIxC_58J","googleLink":"https://ashpublications.org/blood/article-abstract/132/18/1879/39604","googleCitationCount":29,"googleAuthor":"K Shimada"},{"title":"Low dose of human scFv-derived BCMA-targeted CAR-T cells achieved fast response and high complete remission in patients with relapsed/refractory multiple …","googleId":"oNscQ-1PW3UJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/960/266056","googleCitationCount":31,"googleAuthor":"J Jin"},{"title":"The molecular genetics of sideroblastic anemia","googleId":"KgSwY9I5RMAJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/1/59/6612","googleCitationCount":31,"googleAuthor":""},{"title":"Heme-regulated eIF2α kinase in erythropoiesis and hemoglobinopathies","googleId":"RBg4xrHpiGkJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/20/1697/375004","googleCitationCount":16,"googleAuthor":"JJ Chen"},{"title":"Molecular mechanisms of carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of metformin","googleId":"W9MyrQD_J2cJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/7/710/260578","googleCitationCount":28,"googleAuthor":"PE Nikolaou"},{"title":"Presentation and outcome with second-line treatment in AL amyloidosis previously sensitive to nontransplant therapies","googleId":"G4K1W0E18rQJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/5/525/104413","googleCitationCount":39,"googleAuthor":"P Milani"},{"title":"Red cell exchange transfusions lower cerebral blood flow and oxygen extraction fraction in pediatric sickle cell anemia","googleId":"FlCKHjvrwv4J","googleLink":"https://ashpublications.org/blood/article-abstract/131/9/1012/39182","googleCitationCount":38,"googleAuthor":"DK Ragan"},{"title":"How I treat the postthrombotic syndrome","googleId":"il3xEJ3AcawJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/20/2215/6532","googleCitationCount":35,"googleAuthor":"SR Kahn"},{"title":"A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors","googleId":"CpwXj5djHdQJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/24/2127/375128","googleCitationCount":65,"googleAuthor":"R Sidonio"},{"title":"Silent infarcts in sickle cell disease occur in the border zone region and are associated with low cerebral blood flow","googleId":"fijJKbBAG7YJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/16/1714/39362","googleCitationCount":33,"googleAuthor":"DK Ragan"},{"title":"Safety and activity of the investigational Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) in patients with mantle cell lymphoma from a phase 2 trial","googleId":"helsX8t9eG8J","googleLink":"https://www.beigenemedical.com/CongressDocuments/Song%20BGB-3111%20206%20ASH%20Abstract%202018.pdf","googleCitationCount":29,"googleAuthor":""},{"title":"Remodeling of the malaria parasite and host human red cell by vesicle amplification that induces artemisinin resistance","googleId":"AFcw2cVTrJYJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/11/1234/36473","googleCitationCount":55,"googleAuthor":"S Bhattacharjee"},{"title":"BTKCys481Ser drives ibrutinib resistance via ERK1/2 and protects BTKwild-type MYD88-mutated cells by a paracrine mechanism","googleId":"vrwrkUl93IcJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/18/2047/36740","googleCitationCount":35,"googleAuthor":""},{"title":"Novel therapeutics for hemophilia and other bleeding disorders","googleId":"G08sm5TEHCgJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/1/23/39267","googleCitationCount":33,"googleAuthor":"MU Callaghan"},{"title":"Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia","googleId":"TRS9nNjrCwwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/7/717/39444","googleCitationCount":33,"googleAuthor":"TW LeBlanc"},{"title":"Imetelstat is effective treatment for patients with intermediate-2 or high-risk myelofibrosis who have relapsed on or are refractory to Janus kinase inhibitor therapy …","googleId":"mn3x7coI-YIJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/685/266430","googleCitationCount":31,"googleAuthor":"M Cavo"},{"title":"Dual cholinergic signals regulate daily migration of hematopoietic stem cells and leukocytes","googleId":"o78u3I3nOWQJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/3/224/261421","googleCitationCount":26,"googleAuthor":"A García-García"},{"title":"A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL","googleId":"JlZcDyXft8IJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/9/955/39171","googleCitationCount":42,"googleAuthor":""},{"title":"Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia","googleId":"_gurlAE8PoYJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/14/1132/374897","googleCitationCount":21,"googleAuthor":"PB Staber"},{"title":"How I treat polycythemia vera","googleId":"n4Yp7_W4ATkJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/4/341/260695","googleCitationCount":22,"googleAuthor":""},{"title":"The simpler, the better: oral arsenic for acute promyelocytic leukemia","googleId":"RArrpXxPkOgJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/7/597/260708","googleCitationCount":28,"googleAuthor":"F Lo-Coco"},{"title":"ADCT-402, a PBD dimer–containing antibody drug conjugate targeting CD19-expressing malignancies","googleId":"piiTH2hFrAMJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/10/1094/36428","googleCitationCount":36,"googleAuthor":""},{"title":"Mitochondria in the maintenance of hematopoietic stem cells: new perspectives and opportunities","googleId":"EnJhjQ_eNToJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/18/1943/260448","googleCitationCount":24,"googleAuthor":""},{"title":"Ivosidenib (AG-120) induced durable remissions and transfusion independence in patients with iDH1-mutant untreated AML: results from a phase 1 dose escalation …","googleId":"QyQ1vKyBB48J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/561/263448","googleCitationCount":30,"googleAuthor":"S de Botton"},{"title":"New molecular and therapeutic insights into canine diffuse large B cell lymphoma elucidates the role of the dog as a model for human disease","googleId":"owYWPI1NfCgJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/4173/275835","googleCitationCount":27,"googleAuthor":"L Aresu"},{"title":"Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD","googleId":"hLxMIAllN80J","googleLink":"https://ashpublications.org/blood/article-abstract/134/19/1670/375108","googleCitationCount":16,"googleAuthor":"BH Koehn"},{"title":"How I treat cancer-associated venous thromboembolism","googleId":"Ti7w2bI8EtYJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/4/291/272766","googleCitationCount":23,"googleAuthor":""},{"title":"CrbnI391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice","googleId":"_AP84RGfAKUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/14/1535/39346","googleCitationCount":28,"googleAuthor":"EC Fink"},{"title":"Testing and monitoring direct oral anticoagulants","googleId":"NAdzjFqhir4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S000649712043023X","googleCitationCount":28,"googleAuthor":"","doi":"10.1182/blood-2018-04-791541","elsevierAuthor":"Connors J.","publicationName":"Blood","elsevierCoverDate":"2018-11-08","elsevierCoverDisplayDate":"8 November 2018","elsevierCitationCount":"18","altmetricAuthors":["Jean M. Connors"],"twitterCount":41,"altmetricId":48113798},{"title":"Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation","googleId":"OGpp5lgEGOIJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/1/84/107724","googleCitationCount":38,"googleAuthor":"JP Reddy"},{"title":"The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing","googleId":"ofqZ-4fdhwwJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/24/2559/261461","googleCitationCount":20,"googleAuthor":"J Ishihara"},{"title":"Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia","googleId":"dhkVAShhNNAJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/21/2291/272754","googleCitationCount":22,"googleAuthor":"D Sánchez-Martínez"},{"title":"Ibrutinib (Ibr) plus venetoclax (Ven) for first-line treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): results from the MRD …","googleId":"YsRenDSzPA4J","googleLink":"https://research.monash.edu/en/publications/ibrutinib-ibr-plus-venetoclax-ven-for-first-line-treatment-of-chr","googleCitationCount":23,"googleAuthor":"CS Tam","doi":"10.1182/blood-2019-121424","elsevierAuthor":"Tam C.S.","publicationName":"Blood","elsevierCoverDate":"2019-11-13","elsevierCoverDisplayDate":"13 November 2019","elsevierCitationCount":"13","altmetricAuthors":["Tam, Constantine S.","Siddiqi, Tanya","Allan, John N.","Kipps, Thomas J.","Flinn, Ian W.","Kuss, Bryone J.","Opat, Stephen","Barr, Paul M.","Tedeschi, Alessandra","Jacobs, Ryan","Badoux, Xavier C.","Ghia, Paolo","Sukbuntherng, Juthamas","Salem, Ahmed Hamed","Russell, Kristin","Eckert, Karl","Zhou, Cathy","Ninomoto, Joi","James, Danelle F.","Wierda, William G."],"twitterCount":1,"altmetricId":70440947},{"title":"GPIbα is required for platelet-mediated hepatic thrombopoietin generation","googleId":"nA5BgRDW1IUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/6/622/39439","googleCitationCount":32,"googleAuthor":"M Xu"},{"title":"Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects","googleId":"Rijjq4CtHVkJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/18/1977/260465","googleCitationCount":27,"googleAuthor":"AP Hsu"},{"title":"IMiDs prime myeloma cells for daratumumab-mediated cytotoxicity through loss of Ikaros and Aiolos","googleId":"CkbfT8ulTwMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/20/2166/39517","googleCitationCount":27,"googleAuthor":"Y Liao"},{"title":"Coagulopathy induced by traumatic brain injury: systemic manifestation of a localized injury","googleId":"yV8wVT8zox8J","googleLink":"https://ashpublications.org/blood/article-abstract/131/18/2001/36726","googleCitationCount":30,"googleAuthor":"J Zhang"},{"title":"Ferroportin deficiency in erythroid cells causes serum iron deficiency and promotes hemolysis due to oxidative stress","googleId":"JiFKAR-1CIwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/19/2078/39481","googleCitationCount":26,"googleAuthor":"DL Zhang"},{"title":"Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease","googleId":"DNaMjLV68WoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/5/469/39396","googleCitationCount":30,"googleAuthor":""},{"title":"Noninfectious transfusion-associated adverse events and their mitigation strategies","googleId":"zeCftJaisGIJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/17/1831/275901","googleCitationCount":23,"googleAuthor":"R Goel"},{"title":"Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy","googleId":"cuOJt-aqf1YJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/4/353/260691","googleCitationCount":22,"googleAuthor":""},{"title":"Imaging in multiple myeloma: How? When?","googleId":"XeMpTBuYjZ0J","googleLink":"https://ashpublications.org/blood/article-abstract/133/7/644/260542","googleCitationCount":27,"googleAuthor":"M Cavo"},{"title":"MDS overlap disorders and diagnostic boundaries","googleId":"NTkII6hA3pQJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/10/1086/272719","googleCitationCount":21,"googleAuthor":"TN Tanaka"},{"title":"R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma","googleId":"uo4yBGkFVVsJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/3/252/260716","googleCitationCount":19,"googleAuthor":"GM Conte"},{"title":"How I treat myelodysplastic syndromes of childhood","googleId":"R94NofwffiMJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/13/1406/36617","googleCitationCount":32,"googleAuthor":""},{"title":"Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?","googleId":"CfRhjWX1UB4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/18/1871/39601","googleCitationCount":26,"googleAuthor":"D Gratzinger"},{"title":"EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome","googleId":"RqrCFJu0Ld4J","googleLink":"https://ashpublications.org/blood/article-abstract/134/3/277/260721","googleCitationCount":17,"googleAuthor":""},{"title":"A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma","googleId":"KTolUyhKME8J","googleLink":"https://ashpublications.org/blood/article-abstract/133/11/1201/260478","googleCitationCount":26,"googleAuthor":"S Park"},{"title":"Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism","googleId":"BM8yydwQwAgJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/19/2151/36908","googleCitationCount":35,"googleAuthor":"C Kearon"},{"title":"Single-cell RNA-Seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints","googleId":"c2G0p4_xPpcJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/10/1119/272746","googleCitationCount":25,"googleAuthor":"N Andor"},{"title":"How I treat the young patient with multiple myeloma","googleId":"CwMYah8XzpwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/11/1114/39366","googleCitationCount":29,"googleAuthor":""},{"title":"A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL","googleId":"x1KKu6biHrwJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/16/1805/36828","googleCitationCount":33,"googleAuthor":""},{"title":"ETV6-related thrombocytopenia and leukemia predisposition","googleId":"Fjm4-2ZO3DAJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/8/663/260750","googleCitationCount":18,"googleAuthor":"CC Porter"},{"title":"Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks","googleId":"Kx3xsI7wD8oJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120606875","googleCitationCount":60,"googleAuthor":"M Ponzoni","doi":"10.1182/blood-2017-04-737445","elsevierAuthor":"Ponzoni M.","publicationName":"Blood","elsevierCoverDate":"2018-10-11","elsevierCoverDisplayDate":"11 October 2018","elsevierCitationCount":"32","altmetricAuthors":["Maurilio Ponzoni","Elias Campo","Shigeo Nakamura"],"twitterCount":28,"altmetricId":46561391},{"title":"A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis","googleId":"93aU_wpondMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/16/1664/39361","googleCitationCount":30,"googleAuthor":""},{"title":"Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timing","googleId":"icTu_gVgAugJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/7/652/260549","googleCitationCount":23,"googleAuthor":"FK Buadi"},{"title":"A cloning and expression system to probe T-cell receptor specificity and assess functional avidity to neoantigens","googleId":"2vmbki8pkSMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/18/1911/39623","googleCitationCount":26,"googleAuthor":"J Sun"},{"title":"Allogeneic hematopoietic stem cell transplantation for T-cell lymphomas","googleId":"AHOc9XnvIqEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/3/245/39241","googleCitationCount":28,"googleAuthor":""},{"title":"Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma","googleId":"xnuqX9Y_keAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/303/263675","googleCitationCount":32,"googleAuthor":"G Morgan"},{"title":"CD137 deficiency causes immune dysregulation with predisposition to lymphomagenesis","googleId":"FObHu_QNGnYJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/18/1510/374978","googleCitationCount":16,"googleAuthor":""},{"title":"Increased risk of colon cancer and osteogenic sarcoma in Diamond-Blackfan anemia","googleId":"GAQ8U9xH3QIJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/20/2205/39487","googleCitationCount":27,"googleAuthor":"PS Rosenberg"},{"title":"Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted mice","googleId":"O4rb1vX4jfMJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/19/2069/273813","googleCitationCount":23,"googleAuthor":"A Czechowicz"},{"title":"Aged murine hematopoietic stem cells drive aging-associated immune remodeling","googleId":"Ixaoobr1ScgJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/6/565/39425","googleCitationCount":28,"googleAuthor":"M Mulaw"},{"title":"Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92","googleId":"KjCET0i80S4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/10/1050/39327","googleCitationCount":28,"googleAuthor":"N Amodio"},{"title":"Amino acid metabolism in hematologic malignancies and the era of targeted therapy","googleId":"E_X_rYSKUbcJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/13/1014/374923","googleCitationCount":15,"googleAuthor":"PL Lorenzi"},{"title":"Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma","googleId":"-hbfy0AmgEwJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/20/2121/273829","googleCitationCount":23,"googleAuthor":"E Joffe"},{"title":"How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa","googleId":"jggRYiqA4osJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/3/254/39246","googleCitationCount":28,"googleAuthor":""},{"title":"The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy","googleId":"0FAECz8fYx8J","googleLink":"https://ashpublications.org/blood/article-abstract/133/6/550/260571","googleCitationCount":22,"googleAuthor":"T Bilich"},{"title":"Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab","googleId":"ZPNt14qapcwJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/26/2906/39156","googleCitationCount":29,"googleAuthor":""},{"title":"Durable remission achieved from Bcma-directed CAR-T therapy against relapsed or refractory multiple myeloma","googleId":"y2trD9t43E0J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/956/266010","googleCitationCount":27,"googleAuthor":"Y Liu"},{"title":"Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials","googleId":"xWdV_HdJcNYJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/10/1020/272723","googleCitationCount":25,"googleAuthor":""},{"title":"Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis","googleId":"_eK8Fozbr-0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/14/1568/36656","googleCitationCount":31,"googleAuthor":"E Kastritis"},{"title":"The KDM4/JMJD2 histone demethylases are required for hematopoietic stem cell maintenance","googleId":"ormbFSO1wokJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/14/1154/374895","googleCitationCount":17,"googleAuthor":"K Agger"},{"title":"CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment","googleId":"Tjxpz2U3oUEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/7/758/39432","googleCitationCount":29,"googleAuthor":""},{"title":"PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD+ acute myeloid leukemia","googleId":"1BKSnMmsQ2wJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/6/548/260754","googleCitationCount":16,"googleAuthor":"Y Zhu"},{"title":"Neutrophil transendothelial migration: updates and new perspectives","googleId":"RDFdAAeuRRQJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/20/2149/273847","googleCitationCount":22,"googleAuthor":""},{"title":"Long term follow-up after SCRI-CAR19v1 reveals late recurrences as well as a survival advantage to consolidation with HCT after CAR T cell induced remission","googleId":"ZIkjeQkTwVQJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/967/266133","googleCitationCount":26,"googleAuthor":""},{"title":"North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies","googleId":"tSvonoKGcVMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/14/1507/39348","googleCitationCount":26,"googleAuthor":"UA Shah"},{"title":"Availability of FLT3 inhibitors: how do we use them?","googleId":"JbdQcE7ZVKEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120723244","googleCitationCount":15,"googleAuthor":"","doi":"10.1182/blood.2019876821","elsevierAuthor":"Perl A.","publicationName":"Blood","elsevierCoverDate":"2019-08-29","elsevierCoverDisplayDate":"29 August 2019","elsevierCitationCount":"11","altmetricAuthors":["Alexander E. Perl"],"twitterCount":28,"altmetricId":65668039},{"title":"CTCF boundary remodels chromatin domain and drives aberrant HOX gene transcription in acute myeloid leukemia","googleId":"FvFANpsg3iQJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/8/837/39482","googleCitationCount":27,"googleAuthor":"B Yan"},{"title":"Blastoid and pleomorphic mantle cell lymphoma: still a diagnostic and therapeutic challenge!","googleId":"SxOFzLHSqkkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/26/2722/39681","googleCitationCount":27,"googleAuthor":"M Dreyling"},{"title":"B-cell targeting in chronic graft-versus-host disease","googleId":"7TzesTm6Ug0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/13/1399/36612","googleCitationCount":29,"googleAuthor":"R Zeiser"},{"title":"Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk","googleId":"ZPZW-n3EBu4J","googleLink":"https://ashpublications.org/blood/article-abstract/134/12/960/374916","googleCitationCount":21,"googleAuthor":"A Sud"},{"title":"Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma","googleId":"ZMs52WBgwW8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/24/2555/39537","googleCitationCount":25,"googleAuthor":""},{"title":"Epigenetic therapies in acute myeloid leukemia: where to from here?","googleId":"q9wlUiADtZsJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/22/1891/387149","googleCitationCount":10,"googleAuthor":"KA Fennell"},{"title":"Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract","googleId":"Xb6qYiWmEOwJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/20/2262/6534","googleCitationCount":28,"googleAuthor":"N Oishi"},{"title":"The enigma of monosomy 7","googleId":"zqR6-y-6ovcJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/26/2891/39117","googleCitationCount":30,"googleAuthor":"H Honda"},{"title":"Targeting HSP90 dimerization via the C terminus is effective in imatinib-resistant CML and lacks the heat shock response","googleId":"O8UrLJwU0UMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/3/307/39262","googleCitationCount":27,"googleAuthor":"S Bhatia"},{"title":"Resolution of sickle cell disease–associated inflammation and tissue damage with 17R-resolvin D1","googleId":"18It4xUTVxQJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/3/252/261407","googleCitationCount":25,"googleAuthor":"A Matte"},{"title":"Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma","googleId":"Q0d7mUAWxRkJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/14/1572/260532","googleCitationCount":21,"googleAuthor":"F Shirazi"},{"title":"Blood group alters platelet binding kinetics to von Willebrand factor and consequently platelet function","googleId":"Pa_1l_AybWsJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/12/1371/260464","googleCitationCount":19,"googleAuthor":"E Dunne"},{"title":"The identification of fibrosis-driving myofibroblast precursors reveals new therapeutic avenues in myelofibrosis","googleId":"LkdQEGzqDCIJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/19/2111/36909","googleCitationCount":31,"googleAuthor":"R Kramann"},{"title":"Novel insights into the pathogenesis of T-cell lymphomas","googleId":"9nrVvWkYN9EJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/21/2320/37107","googleCitationCount":26,"googleAuthor":""},{"title":"Loss-of-function mutations in PTPRJ cause a new form of inherited thrombocytopenia","googleId":"2Dp-2FRitH0J","googleLink":"https://ashpublications.org/blood/article-abstract/133/12/1346/260482","googleCitationCount":21,"googleAuthor":"C Marconi"},{"title":"Peripheral serotonin causes dengue virus–induced thrombocytopenia through 5HT2 receptors","googleId":"unYtKw9scncJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/21/2325/272751","googleCitationCount":17,"googleAuthor":"CK Mantri"},{"title":"Decreased median survival of adults with sickle cell disease after adjusting for left truncation bias: a pooled analysis","googleId":"zfoet_qz0WMJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/6/615/260539","googleCitationCount":24,"googleAuthor":"MR DeBaun"},{"title":"Monoclonal gammopathy of undetermined significance","googleId":"9SyfqDYMI3AJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/23/2484/273836","googleCitationCount":18,"googleAuthor":"TH Mouhieddine"},{"title":"Self-repopulating recipient bone marrow resident macrophages promote long-term hematopoietic stem cell engraftment","googleId":"qAYTnf9iUssJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/7/735/39451","googleCitationCount":28,"googleAuthor":"S Kaur"},{"title":"Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma","googleId":"Ks7OEX3LevkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/21/2240/39544","googleCitationCount":27,"googleAuthor":"HW Tun"},{"title":"Editing aberrant splice sites efficiently restores β-globin expression in β-thalassemia","googleId":"oDoeCm5SvsYJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/21/2255/272743","googleCitationCount":22,"googleAuthor":"K Luk"},{"title":"Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study","googleId":"xF9ojrGa9OQJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/4/299/272774","googleCitationCount":25,"googleAuthor":"JJ Castillo"},{"title":"Results of the myeloproliferative neoplasms-research consortium (MPN-RC) 112 randomized trial of pegylated interferon alfa-2a (PEG) versus hydroxyurea (HU) …","googleId":"UKPGMAEer3MJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/577/263247","googleCitationCount":26,"googleAuthor":"JT Prchal"},{"title":"Safety and efficacy of emapalumab in pediatric patients with primary hemophagocytic lymphohistiocytosis","googleId":"wxIp7sWsdWMJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/LBA-6/375116","googleCitationCount":24,"googleAuthor":"CE Allen"},{"title":"A global, randomized, placebo-controlled, phase 3 study of ibrutinib plus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (RCHOP) in patients …","googleId":"iXivN_K2OUcJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/784/266057","googleCitationCount":26,"googleAuthor":"P Johnson"},{"title":"Single-cell approaches reveal novel cellular pathways for megakaryocyte and erythroid differentiation","googleId":"76gxswuk0BkJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/13/1427/261456","googleCitationCount":19,"googleAuthor":"AJ Mead"},{"title":"Venetoclax with low-dose cytarabine induces rapid, deep, and durable responses in previously untreated older adults with AML ineligible for intensive chemotherapy","googleId":"-ofe-puQmBAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/284/263513","googleCitationCount":29,"googleAuthor":"A Wei"},{"title":"BAFF and CD4+ T cells are major survival factors for long-lived splenic plasma cells in a B-cell–depletion context","googleId":"HGfH18LebFAJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/14/1545/36669","googleCitationCount":32,"googleAuthor":""},{"title":"Simplifying the diagnosis of inherited platelet disorders? The new tools do not make it any easier","googleId":"AlBcF7rf1toJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/23/2478/273831","googleCitationCount":16,"googleAuthor":"A Greinacher"},{"title":"How I treat refractory chronic graft-versus-host disease","googleId":"ZY3gTBckKM0J","googleLink":"https://ashpublications.org/blood/article-abstract/133/11/1191/260481","googleCitationCount":22,"googleAuthor":"KM Sullivan"},{"title":"How targeted therapy disrupts the treatment paradigm for acquired TTP: the risks, benefits, and unknowns","googleId":"9i-3B0uCTyYJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/5/415/273897","googleCitationCount":16,"googleAuthor":"S Chaturvedi"},{"title":"CXCL1 regulates neutrophil homeostasis in pneumonia-derived sepsis caused by Streptococcus pneumoniae serotype 3","googleId":"5e_74lFm5xwJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/12/1335/260476","googleCitationCount":20,"googleAuthor":"S Paudel"},{"title":"Phase 2 study of combination obinutuzumab, ibrutinib, and venetoclax in treatment-naive and relapsed/refractory chronic lymphocytic leukemia","googleId":"1eOgtV6-GlIJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/693/266034","googleCitationCount":25,"googleAuthor":"FT Awan"},{"title":"Inflammatory consequences of inherited disorders affecting neutrophil function","googleId":"WeWluFV9AiQJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/20/2130/273837","googleCitationCount":16,"googleAuthor":""},{"title":"Genetics and mechanisms of NT5C2-driven chemotherapy resistance in relapsed ALL","googleId":"iASjxRKgB_UJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/21/2263/272740","googleCitationCount":16,"googleAuthor":""},{"title":"Novel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in Hispanics","googleId":"ys66HHoAcKUJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/7/724/260557","googleCitationCount":23,"googleAuthor":"M Qian"},{"title":"Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes","googleId":"Br_H8LcGSkgJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/2/186/260693","googleCitationCount":20,"googleAuthor":"BJ Hayes"},{"title":"Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells","googleId":"VyYFGezvJtkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/3/321/39258","googleCitationCount":27,"googleAuthor":"A Paikari"},{"title":"Iron metabolism under conditions of ineffective erythropoiesis in β-thalassemia","googleId":"NBQeyWPdTDQJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/1/51/6614","googleCitationCount":21,"googleAuthor":""},{"title":"How and when I do allogeneic transplant in CLL","googleId":"eYbaX4vBl6oJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/1/31/39270","googleCitationCount":27,"googleAuthor":"JG Gribben"},{"title":"The von Willebrand factor D′ D3 assembly and structural principles for factor VIII binding and concatemer biogenesis","googleId":"Du7QPmDIQ_MJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/14/1523/260534","googleCitationCount":22,"googleAuthor":"X Dong"},{"title":"Adeno-Associated Mediated Gene Transfer for Hemophilia B: 8 Year Follow up and Impact of Removing Empty Viral Particles on Safety and Efficacy of Gene Transfer","googleId":"QXe-Pye7VMgJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/491/262157","googleCitationCount":23,"googleAuthor":"E Tuddenham"},{"title":"Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma","googleId":"X0vlhY3_GtwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/21/2273/39538","googleCitationCount":25,"googleAuthor":"C Baues"},{"title":"PRM-151 in myelofibrosis: efficacy and safety in an open label extension study","googleId":"LEXJ3YcbZ3AJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/686/266439","googleCitationCount":24,"googleAuthor":"I Veletic"},{"title":"How I treat primary mediastinal B-cell lymphoma","googleId":"QIXcMrtGflkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/8/782/39454","googleCitationCount":25,"googleAuthor":""},{"title":"Critical influences on the pathogenesis of follicular lymphoma","googleId":"-8pS6i17hPwJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/21/2297/37112","googleCitationCount":27,"googleAuthor":"R Küppers"},{"title":"Posttranscriptional modulation of TERC by PAPD5 inhibition rescues hematopoietic development in dyskeratosis congenita","googleId":"_3mb1qCFhj0J","googleLink":"https://ashpublications.org/blood/article-abstract/133/12/1308/260474","googleCitationCount":17,"googleAuthor":"WC Fok"},{"title":"Phase 1 study of Adct-301 (camidanlumab tesirine), a novel pyrrolobenzodiazepine-based antibody drug conjugate, in relapsed/refractory classical Hodgkin …","googleId":"jO5VB86pDTQJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/928/266207","googleCitationCount":25,"googleAuthor":"M Hamadani"},{"title":"Megakaryocytes and platelets from a novel human adipose tissue–derived mesenchymal stem cell line","googleId":"VDJD6ND2m04J","googleLink":"https://ashpublications.org/blood/article-abstract/133/7/633/260573","googleCitationCount":19,"googleAuthor":"T Mori"},{"title":"Blood group genotyping","googleId":"rGQxT8MTHVYJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/17/1814/275900","googleCitationCount":21,"googleAuthor":""},{"title":"Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy","googleId":"NvL9XNhCF48J","googleLink":"https://ashpublications.org/blood/article-abstract/133/21/2348/272729","googleCitationCount":21,"googleAuthor":""},{"title":"High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT","googleId":"Z-OPRzGVdasJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/12/1345/39606","googleCitationCount":25,"googleAuthor":"DM Arnold"},{"title":"The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosis","googleId":"bYYdVUcoMiwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120319480","googleCitationCount":24,"googleAuthor":"SR Cataland","doi":"10.1182/blood-2018-02-791533","elsevierAuthor":"Masias C.","publicationName":"Blood","elsevierCoverDate":"2018-08-30","elsevierCoverDisplayDate":"30 August 2018","elsevierCitationCount":"16","altmetricAuthors":["Camila Masias","Spero R. Cataland"],"twitterCount":40,"altmetricId":45309195},{"title":"Taking a “BiTE out of ALL”: blinatumomab approval for MRD-positive ALL","googleId":"hkRnVMjTx_0J","googleLink":"https://ashpublications.org/blood/article-abstract/133/16/1715/260494","googleCitationCount":16,"googleAuthor":""},{"title":"Treatment of bleeding complications in patients on anticoagulant therapy","googleId":"lraEEgCT-t4J","googleLink":"https://ashpublications.org/blood/article-abstract/133/5/425/272782","googleCitationCount":19,"googleAuthor":"S Piran"},{"title":"Increased galactose expression and enhanced clearance in patients with low von Willebrand factor","googleId":"6qsufRNB3ZMJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/14/1585/260529","googleCitationCount":17,"googleAuthor":"S Aguila"},{"title":"Efficacy and safety of single-agent quizartinib (Q), a potent and selective FLT3 inhibitor (FLT3i), in patients (pts) with FLT3-internal tandem duplication (FLT3-ITD) …","googleId":"XV9mjEES24gJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/563/263148","googleCitationCount":22,"googleAuthor":"G Martinelli"},{"title":"Discovery of a CD10-negative B-progenitor in human fetal life identifies unique ontogeny-related developmental programs","googleId":"iBzvCyZC6EEJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/13/1059/374931","googleCitationCount":14,"googleAuthor":"S O'Byrne"},{"title":"Four-Year follow-up of the phase 3 Pollux study of Daratumumab plus lenalidomide and dexamethasone (D-Rd) versus lenalidomide and dexamethasone (RD) alone …","googleId":"uKogi8TKKvYJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/Supplement_1/1866/427677","googleCitationCount":15,"googleAuthor":"JL Kaufman"},{"title":"How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes","googleId":"m73mP-S0Xc8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/16/1657/39350","googleCitationCount":24,"googleAuthor":"DP Steensma"},{"title":"Ibrutinib plus venetoclax in relapsed/refractory CLL: results of the bloodwise TAP clarity study","googleId":"QQAMQDetDOAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/182/273012","googleCitationCount":27,"googleAuthor":"P Hillmen"},{"title":"Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study","googleId":"PVUgggStiD0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/22/2449/37071","googleCitationCount":29,"googleAuthor":"S Luminari"},{"title":"TET2 deficiency leads to stem cell factor–dependent clonal expansion of dysfunctional erythroid progenitors","googleId":"P5qgNas7zkoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/22/2406/107713","googleCitationCount":22,"googleAuthor":"X Qu"},{"title":"The α-emitter astatine-211 targeted to CD38 can eradicate multiple myeloma in a disseminated disease model","googleId":"H8RRJy-xCvAJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/15/1247/374464","googleCitationCount":12,"googleAuthor":""},{"title":"Evidence for superior efficacy and disease modification after three years of prospective randomized controlled treatment of polycythemia vera patients with …","googleId":"9GwtMS3HZXUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/579/263449","googleCitationCount":23,"googleAuthor":""},{"title":"Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry","googleId":"FdK0BGizyyEJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/24/2159/374998","googleCitationCount":25,"googleAuthor":"C Amador"},{"title":"SRC-3 is involved in maintaining hematopoietic stem cell quiescence by regulation of mitochondrial metabolism in mice","googleId":"YJxhZy-vpgwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/9/911/39423","googleCitationCount":23,"googleAuthor":""},{"title":"LEDGF/p75 is dispensable for hematopoiesis but essential for MLL-rearranged leukemogenesis","googleId":"IArPTxXwR30J","googleLink":"https://ashpublications.org/blood/article-abstract/131/1/95/107705","googleCitationCount":30,"googleAuthor":"J Schwaller"},{"title":"Low iron promotes megakaryocytic commitment of megakaryocytic-erythroid progenitors in humans and mice","googleId":"bB3Gh2U-MRUJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/18/1547/374971","googleCitationCount":15,"googleAuthor":""},{"title":"B-cell lymphomas present immunoglobulin neoantigens","googleId":"8lwpFPSg7z4J","googleLink":"https://ashpublications.org/blood/article-abstract/133/8/878/260603","googleCitationCount":19,"googleAuthor":"N Olsson"},{"title":"Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis","googleId":"7qSO3jd37M4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/21/2298/39522","googleCitationCount":20,"googleAuthor":""},{"title":"How I diagnose and treat venous thromboembolism in sickle cell disease","googleId":"qNajeWzMFLoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120606541","googleCitationCount":23,"googleAuthor":"AS Shet","doi":"10.1182/blood-2018-03-822593","elsevierAuthor":"Shet A.","publicationName":"Blood","elsevierCoverDate":"2018-10-25","elsevierCoverDisplayDate":"25 October 2018","elsevierCitationCount":"11","altmetricAuthors":["Arun S. Shet","Ted Wun"],"twitterCount":47,"altmetricId":41604831},{"title":"Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition","googleId":"WbPOCH_RU3cJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/15/1691/273299","googleCitationCount":19,"googleAuthor":"OS Eckstein"},{"title":"Selinexor, pomalidomide, and dexamethasone (SPd) in patients with relapsed or refractory multiple myeloma","googleId":"8gMdfwCp5dgJ","googleLink":"https://www.karyopharm.com/wp-content/uploads/2019/12/SPd-ASH2019-7Dec2019.pdf","googleCitationCount":17,"googleAuthor":"CI Chen"},{"title":"A phase 1/2 trial of investigational SPK-8011 in hemophilia A demonstrates durable expression and prevention of bleeds","googleId":"_5wv_m5RtkEJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/487/262202","googleCitationCount":22,"googleAuthor":""},{"title":"Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL","googleId":"M4r_Ua6S2TUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/4/405/103901","googleCitationCount":23,"googleAuthor":""},{"title":"IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemia","googleId":"HbDXEy7Zvl0J","googleLink":"https://ashpublications.org/blood/article-abstract/134/6/534/260756","googleCitationCount":15,"googleAuthor":"BMC Jebaraj"},{"title":"Wnt5a induces ROR1 to recruit DOCK2 to activate Rac1/2 in chronic lymphocytic leukemia","googleId":"IZN0p_u_0iMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/2/170/39232","googleCitationCount":24,"googleAuthor":"MK Hasan"},{"title":"Effect of donor, component, and recipient characteristics on hemoglobin increments following red blood cell transfusion","googleId":"mz1orcs3fQgJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/13/1003/374918","googleCitationCount":15,"googleAuthor":"NH Roubinian"},{"title":"Extravascular coagulation in hematopoietic stem and progenitor cell regulation","googleId":"8pbrGKQFMpwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/2/123/39213","googleCitationCount":21,"googleAuthor":""},{"title":"Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma","googleId":"hHLqttqVh7AJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/2/179/39226","googleCitationCount":26,"googleAuthor":"L Milan"},{"title":"How I treat the blast phase of Philadelphia chromosome–negative myeloproliferative neoplasms","googleId":"9zMudGvsxqsJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/22/2339/107700","googleCitationCount":18,"googleAuthor":""},{"title":"Low vs high hemoglobin trigger for transfusion in vascular surgery: a randomized clinical feasibility trial","googleId":"v72P3Mc_VVMJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/25/2639/273894","googleCitationCount":16,"googleAuthor":""},{"title":"RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1","googleId":"Vg7dblqNSXUJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/1/59/260666","googleCitationCount":26,"googleAuthor":"CP Mill"},{"title":"UCH-L1 bypasses mTOR to promote protein biosynthesis and is required for MYC-driven lymphomagenesis in mice","googleId":"ndRIy61Xj2MJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/24/2564/39547","googleCitationCount":20,"googleAuthor":"S Hussain"},{"title":"PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome","googleId":"DiiK2TfeqKIJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/3/280/261405","googleCitationCount":19,"googleAuthor":""},{"title":"Disrupting CD147-RAP2 interaction abrogates erythrocyte invasion by Plasmodium falciparum","googleId":"WrQ7ZWDmW2gJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/10/1111/36416","googleCitationCount":24,"googleAuthor":""},{"title":"Blinatumomab in combination with immune checkpoint inhibitors of PD-1 and CTLA-4 in adult patients with relapsed/refractory (R/R) CD19 positive B-cell acute …","googleId":"RlFvahsCVfcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/557/262977","googleCitationCount":22,"googleAuthor":"J Webster"},{"title":"How I treat myelofibrosis after failure of JAK inhibitors","googleId":"xLRiUcvxIWUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S000649712032022X","googleCitationCount":22,"googleAuthor":"","doi":"10.1182/blood-2018-02-785923","elsevierAuthor":"Pardanani A.","publicationName":"Blood","elsevierCoverDate":"2018-08-02","elsevierCoverDisplayDate":"2 August 2018","elsevierCitationCount":"12","altmetricAuthors":["Animesh Pardanani","Ayalew Tefferi"],"twitterCount":54,"altmetricId":43301917},{"title":"Hydroxyurea reduces cerebral metabolic stress in patients with sickle cell anemia","googleId":"T85wFJoPrwMJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/22/2436/273861","googleCitationCount":17,"googleAuthor":"D Ragan"},{"title":"Phase 1 cohort expansion of flotetuzumab, a CD123× CD3 bispecific Dart® protein in patients with relapsed/refractory acute myeloid leukemia (AML)","googleId":"VJWyYwHaFfQJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/764/266322","googleCitationCount":22,"googleAuthor":"GL Uy"},{"title":"The global clonal complexity of the murine blood system declines throughout life and after serial transplantation","googleId":"g4VMF0D1HawJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/18/1927/260470","googleCitationCount":18,"googleAuthor":"M Ganuza"},{"title":"The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosis","googleId":"TH5aYJ6EhbAJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/12/1325/260475","googleCitationCount":18,"googleAuthor":""},{"title":"Vaccine therapy in hematologic malignancies","googleId":"5VL86YpymBcJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/24/2640/37160","googleCitationCount":21,"googleAuthor":""},{"title":"Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing","googleId":"9NeUiJECPSsJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/26/2915/39188","googleCitationCount":28,"googleAuthor":"C Li"},{"title":"A phase 1 study with point-of-care manufacturing of dual targeted, tandem anti-CD19, anti-CD20 chimeric antigen receptor modified T (CAR-T) cells for relapsed …","googleId":"BwLp8lmC804J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/4193/275540","googleCitationCount":22,"googleAuthor":"NN Shah"},{"title":"How I treat type 2B von Willebrand disease","googleId":"VTMR4hCcbEIJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/12/1292/36611","googleCitationCount":24,"googleAuthor":""},{"title":"PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival","googleId":"Uyik2sm60B8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/19/2026/39485","googleCitationCount":23,"googleAuthor":"N Yusufova"},{"title":"Complete responses in relapsed/refractory acute myeloid leukemia (AML) patients on a weekly dosing schedule of XmAb14045, a CD123 x CD3 T cell-engaging …","googleId":"xObuEcVh8DMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/763/266313","googleCitationCount":21,"googleAuthor":""},{"title":"New insights into hematopoietic differentiation landscapes from single-cell RNA sequencing","googleId":"ZXZSsr3uRHkJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/13/1415/261444","googleCitationCount":17,"googleAuthor":"I Kucinski"},{"title":"Ibrutinib+ obinutuzumab versus chlorambucil+ obinutuzumab as first-line treatment in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL …","googleId":"5Mf4iQKG2koJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/691/266013","googleCitationCount":22,"googleAuthor":"C Moreno"},{"title":"Maintenance with 5-azacytidine for acute myeloid leukemia and myelodysplastic syndrome patients","googleId":"JczyQRBSej4J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/971/266187","googleCitationCount":23,"googleAuthor":"G Garcia-Manero"},{"title":"EBV microRNA-BHRF1-2-5p targets the 3′ UTR of immune checkpoint ligands PD-L1 and PD-L2","googleId":"Yh9wTm0gMzEJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/25/2261/422729","googleCitationCount":8,"googleAuthor":"AS Cristino"},{"title":"CD30-chimeric antigen receptor (CAR) T cells for therapy of Hodgkin lymphoma (HL)","googleId":"QGR6LR8KrNwJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/680/266379","googleCitationCount":20,"googleAuthor":"CA Ramos"},{"title":"PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formation","googleId":"2jUDU3OAxhMJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/14/1176/374902","googleCitationCount":13,"googleAuthor":"Z Ren"},{"title":"Reduced ADAMTS13 activity during TTP remission is associated with stroke in TTP survivors","googleId":"gqIcRpggUTEJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/13/1037/374919","googleCitationCount":14,"googleAuthor":"EM Braunstein"},{"title":"Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma","googleId":"u-5r3O-2e1cJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/7/771/39304","googleCitationCount":25,"googleAuthor":""},{"title":"Prospective isolation of nonhematopoietic cells of the niche and their differential molecular interactions with HSCs","googleId":"OBGSMjR-CeoJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/15/1214/374461","googleCitationCount":11,"googleAuthor":"N Mende"},{"title":"Lactadherin promotes microvesicle clearance to prevent coagulopathy and improves survival of severe TBI mice","googleId":"n6sfSD7GlP4J","googleLink":"https://ashpublications.org/blood/article-abstract/131/5/563/104412","googleCitationCount":24,"googleAuthor":""},{"title":"The HLA-B− 21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemia","googleId":"uxuc6QOnZU8J","googleLink":"https://ashpublications.org/blood/article-abstract/133/13/1479/261472","googleCitationCount":16,"googleAuthor":"A Hallner"},{"title":"Promising activity of nelfinavir-Bortezomib-Dexamethasone in proteasome inhibitor–refractory multiple myeloma","googleId":"MmufFIq9YDoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/19/2097/39455","googleCitationCount":19,"googleAuthor":"U Novak"},{"title":"Differentiation-based model of hematopoietic stem cell functions and lineage pathways","googleId":"mmE0xYO9EGQJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/11/1106/39354","googleCitationCount":20,"googleAuthor":"T Höfer"},{"title":"RNA-binding proteins in hematopoiesis and hematological malignancy","googleId":"tffsdWjBO34J","googleLink":"https://ashpublications.org/blood/article-abstract/133/22/2365/273860","googleCitationCount":14,"googleAuthor":"M Turner"},{"title":"Metabolites in a mouse cancer model enhance venous thrombogenicity through the aryl hydrocarbon receptor–tissue factor axis","googleId":"fpjzGa5Xb3sJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/26/2399/422726","googleCitationCount":9,"googleAuthor":""},{"title":"The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases","googleId":"QlJSv6_YlBcJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/7/754/260555","googleCitationCount":17,"googleAuthor":""},{"title":"Synergistic effects of ADAMTS13 deficiency and complement activation in pathogenesis of thrombotic microangiopathy","googleId":"_vhjLQkPPZQJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/13/1095/374920","googleCitationCount":11,"googleAuthor":"X Zheng"},{"title":"Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study","googleId":"i3F4eGeJH2gJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/5/547/39375","googleCitationCount":23,"googleAuthor":"F Paoloni"},{"title":"Hypoxia downregulates protein S expression","googleId":"zF_Q16ZlSs4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/4/452/103891","googleCitationCount":20,"googleAuthor":"VS Pilli"},{"title":"How I treat early-relapsing follicular lymphoma","googleId":"byYmm-gPr0oJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/14/1540/260517","googleCitationCount":17,"googleAuthor":"PM Barr"},{"title":"Nuclear FOXO1 promotes lymphomagenesis in germinal center B cells","googleId":"brC3XBGBzq4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/25/2670/39591","googleCitationCount":17,"googleAuthor":""},{"title":"Results of PAC203: a randomized phase 2 dose-finding study and determination of the recommended dose of pacritinib in patients with myelofibrosis","googleId":"LDLaJF6GN64J","googleLink":"https://pdfs.semanticscholar.org/e4ee/59d40d4a432d7926721d9a78b92a7700e374.pdf","googleCitationCount":13,"googleAuthor":""},{"title":"Treatment with combination of dabrafenib and trametinib in patients with recurrent/refractory BRAF V600E-mutated hairy cell leukemia (HCL)","googleId":"ZqdPa-OsnEkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/391/264975","googleCitationCount":19,"googleAuthor":"P Moreau"},{"title":"Genetic defects in hematopoietic transcription factors and predisposition to acute lymphoblastic leukemia","googleId":"XACujyCdzMYJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/10/793/260620","googleCitationCount":13,"googleAuthor":"JJ Yang"},{"title":"Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice","googleId":"M_ph8KNuPnMJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/3/193/261410","googleCitationCount":18,"googleAuthor":"MA Lopez-Ramirez"},{"title":"Ivosidenib (AG-120) induced durable remissions and transfusion independence in patients with IDH1-mutant relapsed or refractory myelodysplastic syndrome: results …","googleId":"deyXuhRZYpMJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1812/272936","googleCitationCount":20,"googleAuthor":"JM Watts"},{"title":"Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling","googleId":"Fwu4w0-G05cJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/6/674/39225","googleCitationCount":22,"googleAuthor":"E Liu"},{"title":"Donor-derived MDS/AML in families with germline GATA2 mutation","googleId":"-TwsK9OWwjoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/18/1994/39608","googleCitationCount":19,"googleAuthor":"AP Hsu"},{"title":"Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study","googleId":"79cuYeX14nQJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/10/798/260629","googleCitationCount":14,"googleAuthor":"S Luminari"},{"title":"Results of a phase 2, open-label study of idarubicin (I), cytarabine (A) and nivolumab (Nivo) in patients with newly diagnosed acute myeloid leukemia (AML) and high …","googleId":"-55YAA4vmJEJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/905/266416","googleCitationCount":19,"googleAuthor":"R Assi"},{"title":"A synthesis approach of mouse studies to identify genes and proteins in arterial thrombosis and bleeding","googleId":"6UiyL2QOQeAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/24/e35/39549","googleCitationCount":17,"googleAuthor":""},{"title":"A phase I, open-label study to evaluate the safety, pharmacokinetic, pharmacodynamic, and clinical activity of PF-06863135, a B-cell maturation antigen/CD3 …","googleId":"MvjCwiozu9sJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3229/263918","googleCitationCount":19,"googleAuthor":""},{"title":"Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease","googleId":"IytcZRQyDnQJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/1/101/39273","googleCitationCount":20,"googleAuthor":"MD Chatfield"},{"title":"Warfarin and vitamin K epoxide reductase: a molecular accounting for observed inhibition","googleId":"knvzpuNa-xIJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/6/647/39443","googleCitationCount":18,"googleAuthor":"S Wu"},{"title":"Preclinical evaluation of NUDT15-guided thiopurine therapy and its effects on toxicity and antileukemic efficacy","googleId":"Gd8jISl7FPMJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/22/2466/37086","googleCitationCount":23,"googleAuthor":"W Yang"},{"title":"Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes","googleId":"pDhun_bdzGwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/21/2309/39535","googleCitationCount":17,"googleAuthor":"S Narumi"},{"title":"Results from a phase II study of isatuximab as a single agent and in combination with dexamethasone in patients with relapsed/refractory multiple myeloma","googleId":"3rhp_nM3BoMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/155/272957","googleCitationCount":16,"googleAuthor":"MA Dimopoulos"},{"title":"Combined ibrutinib and venetoclax in patients with treatment-naïve high-risk chronic lymphocytic leukemia (CLL)","googleId":"itzQOtNNn3sJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/696/272996","googleCitationCount":20,"googleAuthor":"N Jain"},{"title":"Acute hyperviscosity: syndromes and management","googleId":"8ub3jRMRTeEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120607212","googleCitationCount":17,"googleAuthor":"","doi":"10.1182/blood-2018-06-846816","elsevierAuthor":"Gertz M.","publicationName":"Blood","elsevierCoverDate":"2018-09-27","elsevierCoverDisplayDate":"27 September 2018","elsevierCitationCount":"14","altmetricAuthors":["Morie A. Gertz"],"twitterCount":36,"altmetricId":46487402},{"title":"Three-year follow up of the phase 3 pollux study of daratumumab plus lenalidomide and dexamethasone (D-Rd) versus lenalidomide and dexamethasone (Rd) …","googleId":"wPAVL3UC_WIJ","googleLink":"http://eprints.whiterose.ac.uk/157106/2/Bahlis%20manuscript_FINAL.pdf","googleCitationCount":16,"googleAuthor":"N Bahlis"},{"title":"NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML","googleId":"4rDj8EPfizwJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/21/2305/272755","googleCitationCount":15,"googleAuthor":"D Sasca"},{"title":"GNE variants causing autosomal recessive macrothrombocytopenia without associated muscle wasting","googleId":"Jpr5iLZSbmAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/17/1851/39491","googleCitationCount":18,"googleAuthor":""},{"title":"Making HSCs in vitro: don't forget the hemogenic endothelium","googleId":"pjLkWCrH3WwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/13/1372/105718","googleCitationCount":16,"googleAuthor":""},{"title":"Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes","googleId":"O0YoltVGBo4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/5/501/39392","googleCitationCount":21,"googleAuthor":"SR Panch"},{"title":"Subclonal TP53 copy number is associated with prognosis in multiple myeloma","googleId":"JliS6aqMpy8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/23/2465/39997","googleCitationCount":17,"googleAuthor":"AL Sherborne"},{"title":"Anti-BCMA BiTE® AMG 701 potently induces specific T cell lysis of human multiple myeloma (MM) cells and immunomodulation in the bone marrow microenvironment","googleId":"freVGQqiJLMJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/592/263439","googleCitationCount":19,"googleAuthor":"L Lin"},{"title":"Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma","googleId":"toaNLCqugwMJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/16/1289/374928","googleCitationCount":12,"googleAuthor":"Y Wang"},{"title":"Fostamatinib for the treatment of chronic immune thrombocytopenia","googleId":"VafOwAkEen8J","googleLink":"https://ashpublications.org/blood/article-abstract/133/19/2027/273805","googleCitationCount":13,"googleAuthor":"NT Connell"},{"title":"Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period","googleId":"rwtz4z7KpnUJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/18/1558/374982","googleCitationCount":11,"googleAuthor":"VL Lazarevic"},{"title":"Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia","googleId":"IXFET2azDZoJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/23/2036/374975","googleCitationCount":9,"googleAuthor":"C Rizzari"},{"title":"Preliminary results from a phase I study of isatuximab (ISA) in combination with bortezomib, lenalidomide, dexamethasone (VRd), and in patients with newly …","googleId":"_Fam6pvhSz8J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/595/263465","googleCitationCount":16,"googleAuthor":"EM Ocio"},{"title":"An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma","googleId":"bVj8MZYdGKUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/14/1486/39342","googleCitationCount":21,"googleAuthor":"G Salles"},{"title":"Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients","googleId":"0o8-1YEri98J","googleLink":"https://ashpublications.org/blood/article-abstract/134/11/880/273874","googleCitationCount":9,"googleAuthor":"C Brown"},{"title":"Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations","googleId":"6HOn0MW1-sgJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/26/2989/39100","googleCitationCount":21,"googleAuthor":"SO Ciurea"},{"title":"Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib","googleId":"Mx9Fvly816MJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/21/2260/39546","googleCitationCount":21,"googleAuthor":""},{"title":"Safety, efficacy, pharmacokinetic (PK) and biomarker analyses of BCL2 inhibitor venetoclax (Ven) plus MDM2 inhibitor idasanutlin (idasa) in patients (pts) with …","googleId":"eZz5_s7yPEoJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/767/266352","googleCitationCount":17,"googleAuthor":"BA Jonas"},{"title":"EBV/LMP-specific T cells maintain remissions of T-and B-cell EBV lymphomas after allogeneic bone marrow transplantation","googleId":"Csfq3rHDPXEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/22/2351/107706","googleCitationCount":18,"googleAuthor":"S Gottschalk"},{"title":"Clinically indicated ibrutinib dose interruptions and reductions do not compromise long-term outcomes in CLL","googleId":"sz-7hqZRwvAJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/22/2452/273858","googleCitationCount":12,"googleAuthor":"IE Ahn"},{"title":"Rivaroxaban thromboprophylaxis in high-risk ambulatory cancer patients receiving systemic therapy: results of a randomized clinical trial (CASSINI)","googleId":"x7-S79ShjPYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/LBA-1/375115","googleCitationCount":19,"googleAuthor":"AA Khorana"},{"title":"Secreted mutant calreticulins as rogue cytokines trigger thrombopoietin receptor activation specifically in CALR mutated cells: perspectives for MPN therapy","googleId":"oa0c_9uTsBYJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/4/264991","googleCitationCount":19,"googleAuthor":"C Pecquet"},{"title":"How I treat Philadelphia chromosome–positive acute lymphoblastic leukemia","googleId":"AffcnkrvhYwJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/2/130/39555","googleCitationCount":16,"googleAuthor":""},{"title":"Tissue factor pathway inhibitor primes monocytes for antiphospholipid antibody-induced thrombosis","googleId":"T8VVLod4UiYJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/14/1119/374910","googleCitationCount":8,"googleAuthor":""},{"title":"Patterns of substrate affinity, competition, and degradation kinetics underlie biological activity of thalidomide analogs","googleId":"kAv_6FP8nE8J","googleLink":"https://ashpublications.org/blood/article-abstract/134/2/160/260688","googleCitationCount":9,"googleAuthor":""},{"title":"Chromatin occupancy and epigenetic analysis reveal new insights into the function of the GATA1 N terminus in erythropoiesis","googleId":"t1rKnzNPjXAJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/19/1619/374957","googleCitationCount":9,"googleAuthor":"T Ling"},{"title":"Adjuvant low-dose rituximab and plasma exchange for acquired TTP","googleId":"avh6mY43XDwJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/13/1106/374917","googleCitationCount":12,"googleAuthor":""},{"title":"Filamin A: key actor in platelet biology","googleId":"jXx3-LfqqaoJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/16/1279/374959","googleCitationCount":8,"googleAuthor":""},{"title":"Management of aggressive B-cell NHLs in the AYA population: an adult vs pediatric perspective","googleId":"Wm6nA0mgYnsJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/4/369/103906","googleCitationCount":19,"googleAuthor":""},{"title":"Ready for prime time: Role for geriatric assessment to improve quality of care in hematology practice","googleId":"BVEBaM_dlscJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/23/2005/429194","googleCitationCount":6,"googleAuthor":""},{"title":"Serum levels of TARC, MDC, IL-10, and soluble CD163 in Hodgkin lymphoma: a SWOG S0816 correlative study","googleId":"rDkdpH14IaQJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/16/1762/260493","googleCitationCount":13,"googleAuthor":"ED Hsi"},{"title":"Efficacy and safety of daratumumab, bortezomib, and dexamethasone (D-Vd) versus bortezomib and dexamethasone (Vd) in first relapse patients (pts) with multiple …","googleId":"3c-6qTGJx6cJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/Supplement_1/3192/423938","googleCitationCount":9,"googleAuthor":"MV Mateos"},{"title":"Kaposi sarcoma–associated herpesvirus/human herpesvirus 8–associated lymphoproliferative disorders","googleId":"WUfkSKoopg8J","googleLink":"https://ashpublications.org/blood/article-abstract/133/11/1186/260479","googleCitationCount":13,"googleAuthor":""},{"title":"Loxo-305, a highly selective and non-covalent next generation BTK inhibitor, inhibits diverse BTK C481 substitution mutations","googleId":"7ahFVeCARG0J","googleLink":"https://www.loxooncology.com/docs/presentations/ASH-poster-2Dec-2019-Final.pdf","googleCitationCount":8,"googleAuthor":""},{"title":"Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) for firstline treatment of patients with CLL with mutated IGHV and without TP53 aberrations","googleId":"X6AVqwAe0rMJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/695/272866","googleCitationCount":18,"googleAuthor":"N Jain"},{"title":"Glutamine via α-ketoglutarate dehydrogenase provides succinyl-CoA for heme synthesis during erythropoiesis","googleId":"ApMYf7W1lgYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/10/987/39324","googleCitationCount":19,"googleAuthor":"JE Cox"},{"title":"Cirmtuzumab blocks Wnt5a/ROR1 stimulation of NF-κB to repress autocrine STAT3 activation in chronic lymphocytic leukemia","googleId":"PMv9jWU077QJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/13/1084/374921","googleCitationCount":11,"googleAuthor":"J Yu"},{"title":"Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesis","googleId":"9hb-8F21NxEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/12/1265/39645","googleCitationCount":15,"googleAuthor":"E Pronier"},{"title":"Hippo kinase loss contributes to del (20q) hematologic malignancies through chronic innate immune activation","googleId":"aH0wPol1rckJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/20/1730/374960","googleCitationCount":7,"googleAuthor":"SA Stoner"},{"title":"Safety of axicabtagene ciloleucel CD19 CAR T-cell therapy in elderly patients with relapsed or refractory large B-cell lymphoma","googleId":"DiAx05ICdSsJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/96/266049","googleCitationCount":16,"googleAuthor":""},{"title":"Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation","googleId":"_4oyGnStLDEJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/18/2036/36738","googleCitationCount":19,"googleAuthor":"J Gunawardana"},{"title":"Excellent outcome of young patients (18-60 years) with favourable-prognosis diffuse large B-cell lymphoma (DLBCL) treated with 4 cycles CHOP plus 6 applications of …","googleId":"Cx54HLu6sbgJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/781/266032","googleCitationCount":17,"googleAuthor":""},{"title":"A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from the TACL consortium","googleId":"7W-C2C8t3zMJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/10/1145/36403","googleCitationCount":19,"googleAuthor":"T Triche"},{"title":"An etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma","googleId":"_rpIR_3MxEgJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/7/591/260723","googleCitationCount":12,"googleAuthor":"PG Murray"},{"title":"Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: evidence from a murine model","googleId":"xgtX7yOoAb8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/21/2286/39548","googleCitationCount":14,"googleAuthor":"S Altamura"},{"title":"Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome","googleId":"8D4A-Phe3XUJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/15/1227/374455","googleCitationCount":18,"googleAuthor":"AJ De Smith"},{"title":"Skin colonization by circulating neoplastic clones in cutaneous T-cell lymphoma","googleId":"U6Bh14pj098J","googleLink":"https://ashpublications.org/blood/article-abstract/134/18/1517/375109","googleCitationCount":8,"googleAuthor":"J Patterson"},{"title":"Interim analysis of phase II study of venetoclax with 10-day decitabine (DEC10-VEN) in acute myeloid leukemia and myelodysplastic syndrome","googleId":"gIKdyO00dosJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/286/263731","googleCitationCount":18,"googleAuthor":""},{"title":"Hematopoiesis and the bacterial microbiome","googleId":"8_0MceyG8FQJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/6/559/39408","googleCitationCount":18,"googleAuthor":"MT Baldridge"},{"title":"Duvelisib for CLL/SLL and follicular non-Hodgkin lymphoma","googleId":"Y_LqDtA3yrAJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/19/1573/375003","googleCitationCount":11,"googleAuthor":"K Patel"},{"title":"Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with Sézary syndrome","googleId":"5h4hqBSkcQgJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/16/1346/374964","googleCitationCount":11,"googleAuthor":"C McCormack"},{"title":"Results of the pivotal STORM study (part 2) in penta-refractory multiple myeloma (MM): deep and durable responses with oral selinexor plus low dose dexamethasone …","googleId":"yJupHEn8MBIJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/598/263468","googleCitationCount":16,"googleAuthor":"MA Dimopoulos"},{"title":"Tolerogenic properties of the Fc portion of IgG and its relevance to the treatment and management of hemophilia","googleId":"QoeWNAQgkJMJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/20/2205/6533","googleCitationCount":17,"googleAuthor":""},{"title":"The chromatin-binding protein Phf6 restricts the self-renewal of hematopoietic stem cells","googleId":"9fK71VmbwAUJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/23/2495/273845","googleCitationCount":10,"googleAuthor":"S Miyagi"},{"title":"Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia","googleId":"5HjV7R88UW8J","googleLink":"https://ashpublications.org/blood/article-abstract/134/16/1323/374974","googleCitationCount":7,"googleAuthor":"S Demeyer"},{"title":"Mouse venous thrombosis upon silencing of anticoagulants depends on tissue factor and platelets, not FXII or neutrophils","googleId":"RrGqQCk87FkJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/19/2090/273815","googleCitationCount":9,"googleAuthor":"S Salloum-Asfar"},{"title":"Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia","googleId":"ul6KO72swQEJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/8/688/260758","googleCitationCount":8,"googleAuthor":""},{"title":"Tumor-educated platelets","googleId":"xM_SWo3X8csJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120425145","googleCitationCount":10,"googleAuthor":"","doi":"10.1182/blood-2018-12-852830","elsevierAuthor":"In 'T Veld S.G.J.G.","publicationName":"Blood","elsevierCoverDate":"2019-05-30","elsevierCoverDisplayDate":"30 May 2019","elsevierCitationCount":"22","altmetricAuthors":["Sjors G. J. G. In ‘t Veld","Thomas Wurdinger"],"twitterCount":5,"altmetricId":56473131},{"title":"Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study","googleId":"p2vhau-RH4QJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120319868","googleCitationCount":17,"googleAuthor":"","doi":"10.1182/blood-2018-01-829630","elsevierAuthor":"De Latour R.P.","publicationName":"Blood","elsevierCoverDate":"2018-08-16","elsevierCoverDisplayDate":"16 August 2018","elsevierCitationCount":"21","altmetricAuthors":["Regis Peffault de Latour","Sylvie Chevret","Charlotte Jubert","Anne Sirvent","Claire Galambrun","Annalisa Ruggeri","Virginie Gandemer","Jérôme Cornillon","Fanny Rialland","Jean-Hugues Dalle","Edouard Forcade","Benedicte Bruno","Catherine Paillard","Pierre S. Rorlich","Alexandra Salmon","Sabine Fürst","Flore Sicre de Fontbrune","Marie Therese Rubio","Jacques-Olivier Bay","Mohamad Mohty","Jerome Larghero","Eliane Gluckman","Gerard Socié"],"twitterCount":32,"altmetricId":41462652},{"title":"Evaluation of sustained minimal residual disease (MRD) negativity in relapsed/refractory multiple myeloma (RRMM) patients (Pts) treated with daratumumab in …","googleId":"2NIu09rrPM8J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/3272/264829","googleCitationCount":16,"googleAuthor":"JF San-Miguel"},{"title":"Cross talk between neutrophils and the microbiota","googleId":"laToUUUmWPEJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/20/2168/273834","googleCitationCount":11,"googleAuthor":"PS Frenette"},{"title":"Balancing risk and benefit in early-stage classical Hodgkin lymphoma","googleId":"W6F4YfnpBksJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/15/1666/36825","googleCitationCount":18,"googleAuthor":""},{"title":"Standardization of 18F-FDG PET/CT according to Deauville criteria for MRD evaluation in newly diagnosed transplant eligible multiple myeloma patients: joined …","googleId":"PN0fpfYUP20J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/257/264029","googleCitationCount":16,"googleAuthor":"L Dozza"},{"title":"Patients with CD3G mutations reveal a role for human CD3γ in Treg diversity and suppressive function","googleId":"8PAPwVL-8X0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/21/2335/37150","googleCitationCount":18,"googleAuthor":"JH Rowe"},{"title":"Risk of hepatitis B virus reactivation in patients treated with ibrutinib","googleId":"ROt8KNrR17gJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/17/1987/36751","googleCitationCount":21,"googleAuthor":"K Chen"},{"title":"Bad weed: synthetic cannabinoid–associated coagulopathy","googleId":"lncN4ZB5l3kJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/9/902/260627","googleCitationCount":11,"googleAuthor":"GM Arepally"},{"title":"A phase II study of the hyper-CVAD regimen in sequential combination with blinatumomab as frontline therapy for adults with B-cell acute lymphoblastic leukemia (B …","googleId":"YmIcwypsNtcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/32/263589","googleCitationCount":17,"googleAuthor":"NJ Short"},{"title":"CD20-Tcb (RG6026), a Novel 2: 1 Format T-Cell-Engaging Bispecific Antibody, Induces Complete Remissions in Relapsed/Refractory B-Cell Non-Hodgkin's …","googleId":"0Ch-1tUN-DMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/226/261591","googleCitationCount":19,"googleAuthor":"M Hutchings"},{"title":"Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients","googleId":"3ycGxuOrkLAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/24/2608/39539","googleCitationCount":16,"googleAuthor":"R Sklavenitis-Pistofidis"},{"title":"Extracellular RNA released due to shear stress controls natural bypass growth by mediating mechanotransduction in mice","googleId":"v7wnPE0zgWMJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/17/1469/374979","googleCitationCount":7,"googleAuthor":"K Kumaraswami"},{"title":"Clinical activity of melflufen in patients with triple-class refractory multiple myeloma and poor-risk features in an updated analysis of HORIZON (OP-106), a …","googleId":"A_ESfv98auoJ","googleLink":"https://www.oncopeptides.se/en/wp-content/uploads/sites/2/2019/11/clinical-activity-of-melflufen-in-patients-with-triple-class-refractory-multiple-myeloma-horizon-op-106.pdf","googleCitationCount":10,"googleAuthor":"MV Mateos"},{"title":"Targeting PRMT1-mediated FLT3 methylation disrupts maintenance of MLL-rearranged acute lymphoblastic leukemia","googleId":"vLI0aHafEnkJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/15/1257/374459","googleCitationCount":7,"googleAuthor":"Y Zhu"},{"title":"Inhibition of C3 with APL-2 results in normalisation of markers of intravascular and extravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria …","googleId":"CivyX6QAIe8J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2314/261691","googleCitationCount":15,"googleAuthor":"P Deschatelets"},{"title":"Interim results from Fight-203, a phase 2, open-label, multicenter study evaluating the efficacy and safety of pemigatinib (INCB054828) in patients with myeloid …","googleId":"LO72d8w_aBsJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/690/266005","googleCitationCount":15,"googleAuthor":"A Rambaldi"},{"title":"The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction","googleId":"AgLmKwBExW0J","googleLink":"https://ashpublications.org/blood/article-abstract/133/4/356/272775","googleCitationCount":13,"googleAuthor":""},{"title":"Increased SLAMF7high monocytes in myelofibrosis patients harboring JAK2V617F provide a therapeutic target of elotuzumab","googleId":"V177Qi9j7gUJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/10/814/260635","googleCitationCount":9,"googleAuthor":"T Maekawa"},{"title":"The natural history of asymptomatic central venous catheter–related thrombosis in critically ill children","googleId":"WNbp7BHpZXMJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/8/857/260604","googleCitationCount":17,"googleAuthor":"P Monagle"},{"title":"14-3-3 proteins in platelet biology and glycoprotein Ib-IX signaling","googleId":"6yNnbHXs6IEJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/22/2436/37082","googleCitationCount":16,"googleAuthor":"Y Chen"},{"title":"L-selectin shedding affects bacterial clearance in the lung: a new regulatory pathway for integrin outside-in signaling","googleId":"qn1RBTf7FGwJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/17/1445/374926","googleCitationCount":8,"googleAuthor":""},{"title":"Multicenter prospective phase II study of venetoclax in patients with previously treated Waldenstrom macroglobulinemia","googleId":"RafapmwfW_QJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2888/263549","googleCitationCount":15,"googleAuthor":"JJ Castillo"},{"title":"Polatuzumab vedotin (Pola) plus bendamustine (B) with rituximab (R) or obinutuzumab (G) in Relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) …","googleId":"brWxstncHM0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1683/272963","googleCitationCount":18,"googleAuthor":"AF Herrera"},{"title":"Neutrophils as regulators of the hematopoietic niche","googleId":"wPteT7srpHgJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/20/2140/273832","googleCitationCount":10,"googleAuthor":"A Hidalgo"},{"title":"Sequential combination of low-intensity chemotherapy (mini-hyper-CVD) plus inotuzumab ozogamicin with or without blinatumomab in patients with relapsed …","googleId":"znUqApkxJukJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/553/263018","googleCitationCount":16,"googleAuthor":"K Sasaki"},{"title":"Natural history and cell of origin of TCF3-ZNF384 and PTPN11 mutations in monozygotic twins with concordant BCP-ALL","googleId":"lYiD3AeOO90J","googleLink":"https://ashpublications.org/blood/article-abstract/134/11/900/273872","googleCitationCount":9,"googleAuthor":"C Bueno"},{"title":"Acalabrutinib in treatment-naive (TN) chronic lymphocytic leukemia (CLL): updated results from the phase 1/2 ACE-CL-001 study","googleId":"qDM7bvia93wJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/692/266024","googleCitationCount":14,"googleAuthor":"JC Byrd"},{"title":"Nilotinib (Tasigna®) and low intensity chemotherapy for first-line treatment of elderly patients with BCR-ABL1-positive acute lymphoblastic leukemia: final results of a …","googleId":"zqT4CvBa0AYJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/31/263951","googleCitationCount":15,"googleAuthor":""},{"title":"The believe trial: results of a phase 3, randomized, double-blind, placebo-controlled study of luspatercept in adult beta-thalassemia patients who require regular red …","googleId":"Cl4HHHQJ5b4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/163/272861","googleCitationCount":18,"googleAuthor":"MD Cappellini"},{"title":"Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab","googleId":"-0K9slmf0tYJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/5/494/272785","googleCitationCount":16,"googleAuthor":""},{"title":"Insight into origins, mechanisms, and utility of DNA methylation in B-cell malignancies","googleId":"3jTCTFopp8oJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/10/999/39303","googleCitationCount":14,"googleAuthor":"CC Oakes"},{"title":"Plasmin-mediated fibrinolysis enables macrophage migration in a murine model of inflammation","googleId":"jf0z-bRPA1AJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/3/291/260724","googleCitationCount":10,"googleAuthor":"LM Silva"},{"title":"Long-term follow-up of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma","googleId":"r7CkeVtsvSEJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2876/263920","googleCitationCount":18,"googleAuthor":"M Wang"},{"title":"B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation","googleId":"uxtpRKWn6TEJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/26/2967/39148","googleCitationCount":17,"googleAuthor":""},{"title":"LCL161, an oral Smac mimetic/IAP antagonist for patients with myelofibrosis (MF): novel translational findings among long-term responders in a phase 2 clinical trial","googleId":"v0rmMtvrEmAJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/687/265961","googleCitationCount":14,"googleAuthor":""},{"title":"Potency and selectivity of BTK inhibitors in clinical development for B-cell malignancies","googleId":"rSzJx5pw0acJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1871/273136","googleCitationCount":16,"googleAuthor":""},{"title":"REGN5458, a bispecific BCMAxCD3 T cell engaging antibody, demonstrates robust in vitro and in vivo anti-tumor efficacy in multiple myeloma models, comparable to …","googleId":"A3r635WvPgwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1944/261532","googleCitationCount":13,"googleAuthor":""},{"title":"Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia","googleId":"dtlTYA_8BK4J","googleLink":"https://ashpublications.org/blood/article-abstract/134/8/713/260747","googleCitationCount":10,"googleAuthor":""},{"title":"Salmonella-induced thrombi in mice develop asynchronously in the spleen and liver and are not effective bacterial traps","googleId":"WFeistPg2_IJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/6/600/260558","googleCitationCount":13,"googleAuthor":"N Beristain-Covarrubias"},{"title":"Transplant strategies in relapsed/refractory Hodgkin lymphoma","googleId":"hInpw9IGJhQJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/15/1689/36839","googleCitationCount":16,"googleAuthor":"GL Shah"},{"title":"Carfilzomib vs bortezomib in patients with multiple myeloma and renal failure: a subgroup analysis of ENDEAVOR","googleId":"Nsg4J5JcmfkJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/2/147/39567","googleCitationCount":14,"googleAuthor":"M Dimopoulos"},{"title":"Optimizing therapy in advanced-stage Hodgkin lymphoma","googleId":"qV_qrNM-HqEJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/15/1679/36837","googleCitationCount":16,"googleAuthor":"PWM Johnson"},{"title":"Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis","googleId":"_mQmIzU5C6cJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/19/2088/39466","googleCitationCount":14,"googleAuthor":"A Worth"},{"title":"Incidence of differentiation syndrome with ivosidenib (IVO) and enasidenib (ENA) for treatment of patients with relapsed or refractory (R/R) isocitrate dehydrogenase …","googleId":"Ox4IN6QpWdMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/288/263959","googleCitationCount":18,"googleAuthor":""},{"title":"Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome","googleId":"XtCxpQ9FlxwJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/19/2173/36901","googleCitationCount":18,"googleAuthor":""},{"title":"Ruxopeg, a multi-center Bayesian phase 1/2 adaptive randomized trial of the combination of ruxolitinib and pegylated interferon alpha 2a in patients with …","googleId":"n3gvQXDZuxcJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/581/263204","googleCitationCount":15,"googleAuthor":""},{"title":"Familial predisposition to TP53/complex karyotype MDS and leukemia in DNA repair-deficient xeroderma pigmentosum","googleId":"Tfee5hyVgD0J","googleLink":"https://ashpublications.org/blood/article-abstract/133/25/2718/273880","googleCitationCount":11,"googleAuthor":""},{"title":"Treatment strategies for adolescent and young adult patients with acute myeloid leukemia","googleId":"WU1OlMhS9F4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/4/362/103887","googleCitationCount":17,"googleAuthor":""},{"title":"A universal solution for eliminating false positives in myeloma due to therapeutic monoclonal antibody interference","googleId":"h7f_JjLAfKMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/6/670/39417","googleCitationCount":16,"googleAuthor":"MAV Willrich"},{"title":"Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia","googleId":"gCvo4hQ6Qf8J","googleLink":"https://ashpublications.org/blood/article-abstract/133/22/2427/273875","googleCitationCount":10,"googleAuthor":"Y Zhou"},{"title":"Combination of enasidenib and venetoclax shows superior anti-leukemic activity against IDH2 mutated AML in patient-derived xenograft models","googleId":"daFVuIHxVgwJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/562/263035","googleCitationCount":13,"googleAuthor":"D Sharon"},{"title":"CAR T cell viability release testing and clinical outcomes: is there a lower limit?","googleId":"0bvq57vLJB4J","googleLink":"https://ashpublications.org/blood/article-abstract/134/21/1873/374995","googleCitationCount":6,"googleAuthor":"BL Levine"},{"title":"Low-dose rituximab in autoimmune hemolytic anemia: 10 years after","googleId":"m6g0cilPAuIJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/9/996/260622","googleCitationCount":12,"googleAuthor":"B Fattizzo"},{"title":"miR-125a and miR-34a expression predicts Richter syndrome in chronic lymphocytic leukemia patients","googleId":"mm93Z6AFK50J","googleLink":"https://ashpublications.org/blood/article-abstract/132/20/2179/39502","googleCitationCount":16,"googleAuthor":"V Balatti"},{"title":"Combining brentuximab vedotin with DHAP as salvage treatment in relapsed/refractory Hodgkin lymphoma: the phase II HOVON/LLPC transplant BRaVE study","googleId":"PT8007jpvigJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2923/263955","googleCitationCount":13,"googleAuthor":"JM Zijlstra"},{"title":"Resveratrol trimer enhances gene delivery to hematopoietic stem cells by reducing antiviral restriction at endosomes","googleId":"1yI1rR2sHgMJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/16/1298/374955","googleCitationCount":7,"googleAuthor":""},{"title":"Assessment of longer-term efficacy and safety in the phase 3, randomized, double-blind, placebo-controlled medalist trial of luspatercept to treat anemia in …","googleId":"cGbTkPzos-sJ","googleLink":"https://acceleronpharma.com/wp-content/uploads/2019/12/ASH-2019-MEDALIST-long-term-analysis-Fenaux-oral-7-Dec-2019V2.pdf","googleCitationCount":11,"googleAuthor":"GJ Mufti"},{"title":"BIVV001: the first investigational factor VIII therapy to break through the VWF ceiling in hemophilia A, with potential for extended protection for one week or longer","googleId":"tUeyQ6jDXsUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/636/266400","googleCitationCount":14,"googleAuthor":"A Shapiro"},{"title":"Uncoupling ITIM receptor G6b-B from tyrosine phosphatases Shp1 and Shp2 disrupts murine platelet homeostasis","googleId":"xi4Nul3sAMEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/13/1413/105721","googleCitationCount":15,"googleAuthor":"P Gopalasingam"},{"title":"Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma","googleId":"Pqbh4aqZEeEJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/10/1130/272741","googleCitationCount":10,"googleAuthor":""},{"title":"A phase 2 study of ruxolitinib with chemotherapy in children with Philadelphia chromosome-like acute lymphoblastic leukemia (INCB18424-269/AALL1521): dose …","googleId":"YYjfG3Icdm0J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/555/263236","googleCitationCount":13,"googleAuthor":"SK Tasian"},{"title":"MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice","googleId":"pRQIW9KXb9YJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/17/1974/36765","googleCitationCount":16,"googleAuthor":""},{"title":"Antithrombotic therapy in abdominal aortic aneurysm: beneficial or detrimental?","googleId":"zYcgVd99zsIJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/25/2619/39564","googleCitationCount":13,"googleAuthor":"SJ Cameron"},{"title":"Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial","googleId":"nTKsMZn8jkEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/13/1452/105712","googleCitationCount":17,"googleAuthor":"N Russell"},{"title":"Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53","googleId":"4gbFcKOklIoJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/21/1821/374989","googleCitationCount":7,"googleAuthor":""},{"title":"Olutasidenib (FT-2102) induces rapid remissions in patients with IDH1-mutant myelodysplastic syndrome: results of phase 1/2 single agent treatment and combination …","googleId":"vqhO7QyI2x8J","googleLink":"https://ashpublications.org/blood/article-abstract/134/Supplement_1/674/426552","googleCitationCount":8,"googleAuthor":"JM Watts"},{"title":"Atezolizumab in combination with daratumumab with or without lenalidomide or pomalidomide: a phase Ib study in patients with multiple myeloma","googleId":"CLEDhu4VQXIJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/597/263467","googleCitationCount":12,"googleAuthor":"R Vij"},{"title":"GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia","googleId":"LFexzC_2wkEJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/12/935/374904","googleCitationCount":30,"googleAuthor":"A Venditti"},{"title":"Fertility preservation in patients with hematologic malignancies and recipients of hematopoietic cell transplants","googleId":"KQR1Rn7kEagJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/9/746/260765","googleCitationCount":7,"googleAuthor":""},{"title":"Lobe specificity of iron binding to transferrin modulates murine erythropoiesis and iron homeostasis","googleId":"5KNGWhmXwPcJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/17/1373/374958","googleCitationCount":8,"googleAuthor":"A Guerra"},{"title":"Asrij/OCIAD1 suppresses CSN5-mediated p53 degradation and maintains mouse hematopoietic stem cell quiescence","googleId":"TZJ8ZSNZXu0J","googleLink":"https://ashpublications.org/blood/article-abstract/133/22/2385/273888","googleCitationCount":7,"googleAuthor":"S Sinha"},{"title":"Safety, efficacy, and biomarkers of response to azacitidine (AZA) with nivolumab (Nivo) and AZA with nivo and ipilimumab (Ipi) in relapsed/refractory acute myeloid …","googleId":"NUQSgWrYtJkJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/906/266423","googleCitationCount":13,"googleAuthor":"G Garcia-Manero"},{"title":"The management of Hodgkin lymphoma in adolescents and young adults: burden of disease or burden of choice?","googleId":"owciG3ZdawAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/4/376/103907","googleCitationCount":14,"googleAuthor":"ML Metzger"},{"title":"TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma","googleId":"mucfRRYM7AUJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/25/2789/37161","googleCitationCount":16,"googleAuthor":"M Słabicki"},{"title":"Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade?","googleId":"k7oXXKEJ1fQJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/1/17/39265","googleCitationCount":14,"googleAuthor":"A Carbone"},{"title":"Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma","googleId":"PS4DC4dQGDsJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/26/2744/39690","googleCitationCount":11,"googleAuthor":"L Thurner"},{"title":"The combination of duvelisib, a PI3K-δ, γ inhibitor, and romidepsin is highly active in relapsed/refractory peripheral T-cell lymphoma with low rates of transaminitis …","googleId":"cinRKp0T6tkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/683/266410","googleCitationCount":12,"googleAuthor":"SM Horwitz"},{"title":"GO-8: preliminary results of a phase I/II dose escalation trial of gene therapy for haemophilia a using a novel human factor VIII variant","googleId":"_8Bx7vZhE50J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/489/262419","googleCitationCount":14,"googleAuthor":"E Tuddenham"},{"title":"Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy","googleId":"nKu94ivMqE4J","googleLink":"https://ashpublications.org/blood/article-abstract/134/24/2218/375149","googleCitationCount":14,"googleAuthor":"L Sanoja-Flores"},{"title":"Phase 2 trial of ixazomib, lenalidomide, dexamethasone and daratumumab in patients with newly diagnosed multiple myeloma","googleId":"QUaentiAaFsJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/304/263787","googleCitationCount":12,"googleAuthor":"E Muchtar"},{"title":"Acalabrutinib for mantle cell lymphoma","googleId":"gNityb56cyUJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/24/2570/261455","googleCitationCount":9,"googleAuthor":"TE Witzig"},{"title":"Human NOTCH4 is a key target of RUNX1 in megakaryocytic differentiation","googleId":"v0rS3llUdZMJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/2/191/37024","googleCitationCount":18,"googleAuthor":"H Bai"},{"title":"Perioperative anticoagulant use for surgery evaluation (PAUSE) study: a perioperative management plan for patients with atrial fibrillation who are receiving a direct …","googleId":"OksSQFUvy5cJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/LBA-5/375113","googleCitationCount":13,"googleAuthor":"J Douketis"},{"title":"Bone marrow CX3CR1+ mononuclear cells relay a systemic microbiota signal to control hematopoietic progenitors in mice","googleId":"x8CJf4k0pnEJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/16/1312/374933","googleCitationCount":11,"googleAuthor":""},{"title":"AML-specific cytotoxic antibodies in patients with durable graft-versus-leukemia responses","googleId":"PJsPl7KKMYQJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/1/131/107701","googleCitationCount":15,"googleAuthor":""},{"title":"Phase II trial of the combination of ixazomib, lenalidomide, and dexamethasone in high-risk smoldering multiple myeloma","googleId":"10JkLZC9TSAJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/804/266281","googleCitationCount":14,"googleAuthor":"M Bustoros"},{"title":"CK1α and IRF4 are essential and independent effectors of immunomodulatory drugs in primary effusion lymphoma","googleId":"RBJR55rBLl0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/6/577/39433","googleCitationCount":15,"googleAuthor":"A Patil"},{"title":"A personalized prediction model to risk stratify patients with myelodysplastic syndromes","googleId":"FGPgsPlLeLkJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/793/266156","googleCitationCount":15,"googleAuthor":"A Nazha"},{"title":"Two-year follow-up of keynote-087 study: pembrolizumab monotherapy in relapsed/refractory classic hodgkin lymphoma","googleId":"7Io1FAdfiM4J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2900/263697","googleCitationCount":13,"googleAuthor":"PL Zinzani"},{"title":"A phase I/Ib study of nivolumab for relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation (alloHCT)","googleId":"C_uDzMCqSssJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/705/266170","googleCitationCount":12,"googleAuthor":"HT Kim"},{"title":"How I treat the older adult with sickle cell disease","googleId":"yRYxtAzZ4T0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/17/1750/39513","googleCitationCount":14,"googleAuthor":""},{"title":"Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria","googleId":"p_X2MDMSbGkJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/3/304/260710","googleCitationCount":14,"googleAuthor":""},{"title":"Platelet lamellipodium formation is not required for thrombus formation and stability","googleId":"mvSxoIHMpAsJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/25/2318/381163","googleCitationCount":9,"googleAuthor":""},{"title":"Small-molecule BCL6 inhibitor effectively treats mice with nonsclerodermatous chronic graft-versus-host disease","googleId":"KRYTqQgnFqYJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/1/94/6618","googleCitationCount":11,"googleAuthor":"J Du"},{"title":"Trib1 regulates eosinophil lineage commitment and identity by restraining the neutrophil program","googleId":"nQ9Y3b5pEOsJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/22/2413/273881","googleCitationCount":8,"googleAuthor":"GB Wertheim"},{"title":"Rapid MRD-negative responses in patients with relapsed/refractory CLL treated with Liso-Cel, a CD19-directed CAR T-cell product: preliminary results from transcend …","googleId":"6vGQKnKuMnYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/300/263833","googleCitationCount":14,"googleAuthor":""},{"title":"A single intravenous infusion of FLT180a results in factor IX activity levels of more than 40% and has the potential to provide a functional cure for patients with …","googleId":"94bgMk5b6PUJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/631/266354","googleCitationCount":13,"googleAuthor":""},{"title":"Inhibition of C3 with APL-2 results in normalisation of markers of intravascular and extravascular hemolysis in patients with autoimmune hemolytic anemia (AIHA)","googleId":"mpAG1zrcRBQJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3623/264815","googleCitationCount":12,"googleAuthor":""},{"title":"Carfilzomib, pomalidomide and dexamethasone (KPd) in patients with multiple myeloma refractory to bortezomib and lenalidomide. the EMN011 trial","googleId":"mU7cN3GAjtYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/801/266248","googleCitationCount":11,"googleAuthor":"M Cavo"},{"title":"ERCC6L2 defines a novel entity within inherited acute myeloid leukemia","googleId":"9q_yzJR58lEJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/25/2724/273882","googleCitationCount":9,"googleAuthor":""},{"title":"Nrf2 regulates CD4+ T cell–induced acute graft-versus-host disease in mice","googleId":"ZTvhVQW5_1UJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/26/2763/39706","googleCitationCount":9,"googleAuthor":"JJ Tsai"},{"title":"MURANO trial establishes feasibility of time-limited venetoclax-rituximab (VenR) combination therapy in relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL)","googleId":"a99hjAGxnDQJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/184/273230","googleCitationCount":12,"googleAuthor":"TJ Kipps"},{"title":"PET-guided treatment of early-stage favorable Hodgkin lymphoma: final results of the international, randomized phase 3 trial HD16 by the German Hodgkin Study …","googleId":"FDiotPHI7DwJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/925/266183","googleCitationCount":12,"googleAuthor":"C Baues"},{"title":"Current results of lentiglobin gene therapy in patients with severe sickle cell disease treated under a refined protocol in the phase 1 Hgb-206 study","googleId":"QBFcVIfFXyoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1026/262786","googleCitationCount":17,"googleAuthor":"MY Mapara"},{"title":"Notch signaling mediated by Delta-like ligands 1 and 4 controls the pathogenesis of chronic GVHD in mice","googleId":"lK7LC6s6JM8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/20/2188/39514","googleCitationCount":11,"googleAuthor":"V Radojcic"},{"title":"Understanding cell fate control by continuous single-cell quantification","googleId":"lgxqp--p9tAJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/13/1406/261464","googleCitationCount":10,"googleAuthor":"D Loeffler"},{"title":"Early detection and evolution of preleukemic clones in therapy-related myeloid neoplasms following autologous SCT","googleId":"TpqvARLzxKcJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/16/1846/36850","googleCitationCount":17,"googleAuthor":""},{"title":"Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis","googleId":"LPD9fDnan4MJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/23/2541/36947","googleCitationCount":15,"googleAuthor":"G Kleinstern"},{"title":"NKG2D-CAR transduced primary natural killer cells efficiently target multiple myeloma cells","googleId":"jDhXCG6zXfwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/590/263209","googleCitationCount":11,"googleAuthor":"A Leivas"},{"title":"The BRISC deubiquitinating enzyme complex limits hematopoietic stem cell expansion by regulating JAK2 K63-ubiquitination","googleId":"LVJkZMwAXKYJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/14/1560/260526","googleCitationCount":8,"googleAuthor":"Q Jiang"},{"title":"Efficacy and toxicity of JCAR014 in combination with durvalumab for the treatment of patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma","googleId":"JFaUGZniZT8J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1680/272925","googleCitationCount":11,"googleAuthor":"J Gauthier"},{"title":"Enhancer dysfunction in leukemia","googleId":"51ZzqdKmHQQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120322965","googleCitationCount":14,"googleAuthor":"AS Bhagwat","doi":"10.1182/blood-2017-11-737379","elsevierAuthor":"Bhagwat A.","publicationName":"Blood","elsevierCoverDate":"2018-04-19","elsevierCoverDisplayDate":"19 April 2018","elsevierCitationCount":"10","altmetricAuthors":["Anand S. Bhagwat","Bin Lu","Christopher R. Vakoc"],"twitterCount":16,"altmetricId":32989664},{"title":"Every 2 weeks or every 4 weeks subcutaneous injection of emicizumab in pediatric patients with severe hemophilia a without inhibitors: a multi-center, open-label …","googleId":"VEE02vNsHhAJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1186/262605","googleCitationCount":11,"googleAuthor":""},{"title":"HDP101, a novel B-cell maturation antigen (BCMA)-targeted antibody conjugated to α-Amanitin, is active against myeloma with preferential efficacy against pre …","googleId":"oPId81kBba8J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/593/263463","googleCitationCount":11,"googleAuthor":"RK Singh"},{"title":"Efficacy and tolerability of ixazomib, daratumumab and low dose dexamethasone (IDd) in unfit and frail newly diagnosed multiple myeloma (NDMM) patients; first …","googleId":"mwOxW1aYTeAJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/596/263466","googleCitationCount":12,"googleAuthor":"MD Levin"},{"title":"Long-term efficacy and safety of recombinant interferon alpha-2 vs. hydroxyurea in polycythemia vera: preliminary results from the three-year analysis of the daliah trial …","googleId":"MZu9Z18lXn0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/580/263094","googleCitationCount":11,"googleAuthor":"DL Hansen"},{"title":"Murine pre–B-cell ALL induces T-cell dysfunction not fully reversed by introduction of a chimeric antigen receptor","googleId":"ah8S6RV1IlwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/18/1899/39617","googleCitationCount":11,"googleAuthor":"H Qin"},{"title":"Maintaining perioperative hemostasis in patients with severe hemophilia A and inhibitors receiving emicizumab prophylaxis","googleId":"WH4E2FUxSJYJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/635/266393","googleCitationCount":11,"googleAuthor":""},{"title":"Molecular patterns of response and outcome in the chemotherapy and venetoclax in elderly AML trial (CAVEAT study)","googleId":"fPaBmYjO4A0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/333/264495","googleCitationCount":13,"googleAuthor":"AH Wei"},{"title":"Haploidentical hematopoietic cell and kidney transplantation for hematological malignancies and end-stage renal failure","googleId":"sugU42LdTH8J","googleLink":"https://ashpublications.org/blood/article-abstract/134/2/211/260684","googleCitationCount":7,"googleAuthor":"YB Chen"},{"title":"Clinical responses to CAR. CD30-T cells in patients with CD30+ lymphomas relapsed after multiple treatments including brentuximab vedotin","googleId":"tXv_yMc7RBkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/681/266391","googleCitationCount":13,"googleAuthor":"SI Park"},{"title":"B-cell–specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion","googleId":"HK5I8wMkNY0J","googleLink":"https://ashpublications.org/blood/article-abstract/134/20/1717/374993","googleCitationCount":5,"googleAuthor":""},{"title":"Phase 1 study of the IDH1m inhibitor FT-2102 as a single agent in patients with IDH1m acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)","googleId":"W6xLTTwqKL8J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1453/272864","googleCitationCount":12,"googleAuthor":"J Watts"},{"title":"RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature","googleId":"QAq67cSz3a0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/20/2154/39511","googleCitationCount":10,"googleAuthor":""},{"title":"OP-106 Horizon—melflufen therapy for RRMM patients refractory to daratumumab and/or pomalidomide; updated results and first report on PFS","googleId":"BswtMgWUK-AJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/600/266001","googleCitationCount":11,"googleAuthor":"E Ocio"},{"title":"Targeted therapy for fusion-driven high-risk acute leukemia","googleId":"ve2U1XlBe3QJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/12/1241/39602","googleCitationCount":10,"googleAuthor":""},{"title":"A mutation of the human EPHB2 gene leads to a major platelet functional defect","googleId":"N2xWvsFF7sMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/19/2067/39483","googleCitationCount":11,"googleAuthor":""},{"title":"Updated safety and activity of the investigational bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) in patients with mantle cell lymphoma","googleId":"4zW3Ot9NmZsJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1592/272930","googleCitationCount":10,"googleAuthor":"CS Tam"},{"title":"Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group","googleId":"mlGOjHSD5_oJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/14/1519/39338","googleCitationCount":12,"googleAuthor":""},{"title":"Venous thromboembolism in cancer patients receiving immunotherapy","googleId":"tfyh3eeMgrEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2510/264382","googleCitationCount":10,"googleAuthor":"AS Kim"},{"title":"The search for new antithrombotic mechanisms and therapies that may spare hemostasis","googleId":"Xa468UTcwKYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120322746","googleCitationCount":13,"googleAuthor":"Y Wang","doi":"10.1182/blood-2017-10-784074","elsevierAuthor":"Plow E.F.","publicationName":"Blood","elsevierCoverDate":"2018-04-26","elsevierCoverDisplayDate":"26 April 2018","elsevierCitationCount":"11","altmetricAuthors":["Edward F. Plow","Yunmei Wang","Daniel I. Simon"],"twitterCount":12,"altmetricId":39381469},{"title":"Adct-301 (camidanlumab tesirine), a novel pyrrolobenzodiazepine-based CD25-targeting antibody drug conjugate, in a phase 1 study of relapsed/refractory non …","googleId":"G-DOMMLlJDUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1658/273195","googleCitationCount":13,"googleAuthor":"GP Collins"},{"title":"Results from REACH1, a single-arm phase 2 study of ruxolitinib in combination with corticosteroids for the treatment of steroid-refractory acute graft-vs-host disease","googleId":"0TlOLJPsrbMJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/601/266011","googleCitationCount":10,"googleAuthor":"NN Shah"},{"title":"The preleukemic TCF3-PBX1 gene fusion can be generated in utero and is present in≈ 0.6% of healthy newborns","googleId":"zuX8RZHSZEoJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/16/1355/374972","googleCitationCount":7,"googleAuthor":"K Dreisig"},{"title":"Identification of novel recurrent STAT3-RARA fusions in acute promyelocytic leukemia lacking t (15; 17)(q22; q12)/PML-RARA","googleId":"y1oXBTRqL1EJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/8/935/104414","googleCitationCount":13,"googleAuthor":""},{"title":"Phase 1 dose escalation and expansion study to determine safety, tolerability, pharmacokinetics, and pharmacodynamics of the BET inhibitor FT-1101 as a …","googleId":"QDsCm9GRcygJ","googleLink":"https://forma.mbicreative.com/wp-content/uploads/2019/12/FORMA-Poster-ASH-2019_FT-1101-Final.pdf","googleCitationCount":6,"googleAuthor":"G Garcia-Manero"},{"title":"Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death","googleId":"XiwPyarFsWkJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/26/2354/422541","googleCitationCount":6,"googleAuthor":"SF Fustolo-Gunnink"},{"title":"RNA-based FLT3-ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AML","googleId":"gwLZ6apD-osJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/22/2485/37075","googleCitationCount":11,"googleAuthor":"DGJ Cucchi"},{"title":"Mutant JAK3 signaling is increased by loss of wild-type JAK3 or by acquisition of secondary JAK3 mutations in T-ALL","googleId":"ODa-XKRFbsYJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/4/421/38492","googleCitationCount":13,"googleAuthor":"E Leroy"},{"title":"Successful donor engraftment and repair of the blood-brain barrier in cerebral adrenoleukodystrophy","googleId":"B1DnFlw0RuEJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/12/1378/260467","googleCitationCount":8,"googleAuthor":"PJ Orchard"},{"title":"Avapritinib, a potent and selective inhibitor of KIT D816V, improves symptoms of advanced systemic mastocytosis (AdvSM): analyses of patient reported outcomes …","googleId":"a7rYALnXA9QJ","googleLink":"https://ashpublications.org/blood/article/132/Suppl_1/351/264522","googleCitationCount":11,"googleAuthor":""},{"title":"Treatment-naive CLL: lessons from phase 2 and phase 3 clinical trials","googleId":"rJAcVOnF-9IJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/21/1796/428772","googleCitationCount":5,"googleAuthor":""},{"title":"Neutrophils, NETs, and immunothrombosis","googleId":"gQWrQE0ji3sJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/13/1360/105710","googleCitationCount":10,"googleAuthor":"SP Grover"},{"title":"Single-cell MYD88 sequencing of isolated B cells from vitreous biopsies aids vitreoretinal lymphoma diagnosis","googleId":"zsuG1pQ_J_YJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/8/709/260749","googleCitationCount":6,"googleAuthor":"MM Wang"},{"title":"HAP1 loss confers l-asparaginase resistance in ALL by downregulating the calpain-1-Bid-caspase-3/12 pathway","googleId":"wHNY0EnS_R4J","googleLink":"https://ashpublications.org/blood/article-abstract/133/20/2222/273854","googleCitationCount":10,"googleAuthor":"JK Lee"},{"title":"Venous stasis-induced fibrinolysis prevents thrombosis in mice: role of α2-antiplasmin","googleId":"m65YUaVJGFYJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/12/970/374905","googleCitationCount":4,"googleAuthor":"S Singh"},{"title":"AUGMENT: A phase III randomized study of lenalidomide plus rituximab (R2) vs rituximab/placebo in patients with relapsed/refractory indolent non-Hodgkin …","googleId":"741PclHY6gYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/445/275452","googleCitationCount":12,"googleAuthor":""},{"title":"Normal plasma IgG inhibits HIT antibody–mediated platelet activation: implications for therapeutic plasma exchange","googleId":"nbimHebxNb0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/6/703/39216","googleCitationCount":12,"googleAuthor":"CG Jones"},{"title":"Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations","googleId":"UnQEvsc6ftEJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/16/1766/260514","googleCitationCount":7,"googleAuthor":""},{"title":"Integrated analysis of randomized controlled trials evaluating bortezomib+ lenalidomide+ dexamethasone or bortezomib+ thalidomide+ dexamethasone induction in …","googleId":"RXI4Tp3D0uUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3245/264523","googleCitationCount":11,"googleAuthor":"A Oriol"},{"title":"BTK Leu528Trp-a potential secondary resistance mechanism specific for patients with chronic lymphocytic leukemia treated with the next generation BTK …","googleId":"j7eN1M7sddoJ","googleLink":"https://www.beigenemedical.com/CongressDocuments/Handunnetti%20Resistance%20Study%20ASH%20Presentation%202019.pdf","googleCitationCount":5,"googleAuthor":"CPS Tang"},{"title":"BTK Leu528Trp-a potential secondary resistance mechanism specific for patients with chronic lymphocytic leukemia treated with the next generation BTK …","googleId":"j7eN1M7sddoJ","googleLink":"https://www.beigenemedical.com/CongressDocuments/Handunnetti%20Resistance%20Study%20ASH%20Presentation%202019.pdf","googleCitationCount":5,"googleAuthor":"CPS Tang"},{"title":"Improvement in global longitudinal strain (GLS) correlates with NT-Probnp response in patients with cardiac amyloidosis treated on a Phase 1b study of anti-amyloid …","googleId":"J4_y0D1zHwMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/958/266030","googleCitationCount":10,"googleAuthor":"MS Maurer"},{"title":"Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development","googleId":"4LA84_E6yS0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/12/1279/39659","googleCitationCount":8,"googleAuthor":"Q Wang"},{"title":"Epo receptor marks the spot","googleId":"bxAKGGoIPloJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/5/413/273895","googleCitationCount":5,"googleAuthor":""},{"title":"Nivolumab for relapsed or refractory classical Hodgkin lymphoma (cHL) after autologous hematopoietic cell transplantation (auto-HCT): extended follow-up of the …","googleId":"PFtnjbORk6cJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2897/263642","googleCitationCount":11,"googleAuthor":""},{"title":"Flipping the switch: initial results of genetic targeting of the fetal to adult globin switch in sickle cell patients","googleId":"RlmiBO8I6SYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1023/262755","googleCitationCount":12,"googleAuthor":"C Brendel"},{"title":"Ivosidenib (AG-120) in patients with IDH1-mutant relapsed/refractory myelodysplastic syndrome: Updated enrollment of a phase 1 dose escalation and …","googleId":"h6xRmwA8HZ0J","googleLink":"https://investor.agios.com/static-files/d991564f-e91e-4d41-9973-2f7c4e821eab","googleCitationCount":4,"googleAuthor":"JM Watts"},{"title":"DNA methylation age is associated with an altered hemostatic profile in a multiethnic meta-analysis","googleId":"3aaUsNH9HSUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/17/1842/39486","googleCitationCount":10,"googleAuthor":"CK Ward-Caviness"},{"title":"Combination treatment with 5F9 and azacitidine enhances phagocytic elimination of acute myeloid leukemia","googleId":"lxwK1I_N8r8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2729/264326","googleCitationCount":10,"googleAuthor":""},{"title":"Aged CAR T cells exhibit enhanced cytotoxicity and effector function but shorter persistence and less memory-like phenotypes","googleId":"CnW_ETMm29oJ","googleLink":"https://isoplexis.com/wp-content/uploads/2019/01/ASH-2018-Moffitt-Poster.pdf","googleCitationCount":9,"googleAuthor":"G Li"},{"title":"CAR T cell therapy targeting G protein-coupled receptor class c group 5 member D (GPRC5D), a novel target for the immunotherapy of multiple myeloma","googleId":"qUkitJ__fBYJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/589/263087","googleCitationCount":9,"googleAuthor":"M Staehr"},{"title":"A phase I study with an expansion cohort of the combinations of ipilimumab, nivolumab and brentuximab vedotin in patients with relapsed/refractory Hodgkin …","googleId":"69CJ-Uli9e8J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/679/266357","googleCitationCount":17,"googleAuthor":"F Hong"},{"title":"Design and characterization of α1-antitrypsin variants for treatment of contact system–driven thromboinflammation","googleId":"hkF6BQqZz94J","googleLink":"https://ashpublications.org/blood/article-abstract/134/19/1658/374925","googleCitationCount":4,"googleAuthor":"S De Maat"},{"title":"Hematopoietic stem cell response to acute thrombocytopenia requires signaling through distinct receptor tyrosine kinases","googleId":"jaekKg_8ZkEJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/13/1046/374937","googleCitationCount":5,"googleAuthor":"A Sinha"},{"title":"Tislelizumab (BGB-A317) for relapsed/refractory classical Hodgkin lymphoma: preliminary efficacy and safety results from a phase 2 study","googleId":"hQk0ihAuAPkJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/682/266402","googleCitationCount":11,"googleAuthor":""},{"title":"Interim analysis of a Phase II study of the glutaminase inhibitor telaglenastat (CB-839) in combination with azacitidine in advanced myelodysplastic syndrome …","googleId":"Te_0mJEhjNMJ","googleLink":"https://www.calithera.com/wp-content/uploads/2020/05/ASH-presentation-Veronica-Guerra11-27-19_Calithera-comments.pdf","googleCitationCount":5,"googleAuthor":"VA Guerra"},{"title":"LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis","googleId":"kczcbgln-agJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/14/1159/374906","googleCitationCount":5,"googleAuthor":""},{"title":"Pembrolizumab: living up to expectations","googleId":"KP9AahinSs8J","googleLink":"https://ashpublications.org/blood/article-abstract/134/14/1114/374894","googleCitationCount":4,"googleAuthor":""},{"title":"Remissions in relapse/refractory acute myeloid leukemia patients following treatment with NKG2D CAR-T therapy without a prior preconditioning chemotherapy","googleId":"qo6OmL0cHbYJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/902/266381","googleCitationCount":9,"googleAuthor":"X Poire"},{"title":"Prediction of CAR T-related toxicities in R/R DLBCL patients treated with axicabtagene ciloleucel using point of care cytokine measurements","googleId":"sY_yD3XOBeQJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/95/266432","googleCitationCount":10,"googleAuthor":"FL Locke"},{"title":"Lentiglobin gene therapy for patients with transfusion-dependent β-thalassemia (TDT): results from the phase 3 Northstar-2 and Northstar-3 studies","googleId":"ktsQmXV7sIUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1025/262776","googleCitationCount":15,"googleAuthor":""},{"title":"PD-L1 blockade with atezolizumab in higher-risk myelodysplastic syndrome: an initial safety and efficacy analysis","googleId":"lqgTw1N9dY4J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/466/262333","googleCitationCount":10,"googleAuthor":""},{"title":"Lyra: a phase 2 study of daratumumab (Dara) plus cyclophosphamide, bortezomib, and dexamethasone (Cybord) in newly diagnosed and relapsed patients (Pts) with …","googleId":"nu7_nycvyOYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/152/273100","googleCitationCount":11,"googleAuthor":""},{"title":"Low levels of neurologic toxicity with retained anti-lymphoma activity in a phase I clinical trial of T cells expressing a novel anti-CD19 CAR","googleId":"nHnMtK7iKK4J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/697/266071","googleCitationCount":9,"googleAuthor":""},{"title":"Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease","googleId":"i3r-5XOzJ30J","googleLink":"https://ashpublications.org/blood/article-abstract/131/18/2074/36730","googleCitationCount":11,"googleAuthor":"S Takahashi"},{"title":"Obinutuzumab-based immunochemotherapy prolongs progression-free survival and time to next anti-lymphoma treatment in patients with previously untreated …","googleId":"EdD7MRTxN6YJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1597/272983","googleCitationCount":12,"googleAuthor":"D Cunningham"},{"title":"Early response data for pediatric patients with non-Hodgkin lymphoma treated with CD19 chimeric antigen receptor (CAR) T-cells","googleId":"x_log1i6cKgJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2957/263812","googleCitationCount":11,"googleAuthor":""},{"title":"The case for CAR T-cell therapy in follicular lymphomas","googleId":"CqTxNKrx7KEJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/7/577/260714","googleCitationCount":6,"googleAuthor":""},{"title":"Targeted inhibition of CD47-SIRPα requires Fc-FcγR interactions to maximize activity in T-cell lymphomas","googleId":"r5SoinlOBcwJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/17/1430/374929","googleCitationCount":13,"googleAuthor":"S Jain"},{"title":"How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism","googleId":"H6mwlmQCrZYJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/21/2269/272731","googleCitationCount":6,"googleAuthor":"NC Chan"},{"title":"Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma","googleId":"9iX4W2h852oJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/19/2040/39473","googleCitationCount":13,"googleAuthor":"A Sud"},{"title":"A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology","googleId":"LXUVBB6eoqoJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/9/967/260636","googleCitationCount":7,"googleAuthor":"PS De Vries"},{"title":"PRDM16s transforms megakaryocyte-erythroid progenitors into myeloid leukemia–initiating cells","googleId":"yqHXKpp7pdAJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/7/614/260739","googleCitationCount":4,"googleAuthor":"MC Hill"},{"title":"PTPN11 mutations confer unique metabolic properties and increase resistance to venetoclax and azacitidine in acute myelogenous leukemia","googleId":"YAgfKAm1z_gJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/909/265985","googleCitationCount":9,"googleAuthor":""},{"title":"Phase 1/1b study of the stapled peptide ALRN-6924, a dual inhibitor of MDMX and MDM2, as monotherapy or in combination with cytarabine for the treatment of …","googleId":"zKJl4T6mf8IJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/4066/265250","googleCitationCount":10,"googleAuthor":""},{"title":"FT-2102, an IDH1m inhibitor, in combination with azacitidine in patients with acute myeloid leukemia (AML) or myelodysplastic ayndrome (MDS): results from a phase …","googleId":"llMwJKjYD98J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1452/272851","googleCitationCount":11,"googleAuthor":"J Watts"},{"title":"Target antigen downregulation and other mechanisms of failure after axicabtagene ciloleucel (CAR19) therapy","googleId":"AcfX9_BTc3wJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/4656/262290","googleCitationCount":8,"googleAuthor":"B Sahaf"},{"title":"Carfilzomib-lenalidomide-dexamethasone versus bortezomib-lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma: results from the …","googleId":"r0BciICOgG8J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%A01/799/266209","googleCitationCount":9,"googleAuthor":"DS Siegel"},{"title":"Initial report of the beat AML umbrella study for previously untreated AML: evidence of feasibility and early success in molecularly driven phase 1 and 2 studies","googleId":"y4DV5_yKI5oJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/559/263190","googleCitationCount":10,"googleAuthor":"AS Mims"},{"title":"Consensus grading of cytokine release syndrome (CRS) in adult patients with relapsed or refractory diffuse large B-cell lymphoma (r/r DLBCL) treated with …","googleId":"uW0hmU_dkrAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/4190/275507","googleCitationCount":10,"googleAuthor":""},{"title":"Uproleselan (GMI-1271), an e-selectin antagonist, improves the efficacy and safety of chemotherapy in relapsed/refractory (r/r) and newly diagnosed older patients …","googleId":"HvbDJXnOwKUJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/331/264778","googleCitationCount":9,"googleAuthor":"BA Jonas"},{"title":"Adaptive immune gene signatures correlate with response to flotetuzumab, a CD123× CD3 bispecific DART® molecule, in patients with relapsed/refractory acute …","googleId":"0lep1rK61hcJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/444/275837","googleCitationCount":9,"googleAuthor":"S Rutella"},{"title":"Steady-state and regenerative hematopoiesis occurs normally in mice in the absence of GDF11","googleId":"hcHKp78g-6EJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/20/1712/374990","googleCitationCount":4,"googleAuthor":""},{"title":"Phase 1 first-in-human trial of AMV564, a bivalent bispecific (2: 2) CD33/CD3 T-cell engager, in patients with relapsed/refractory acute myeloid leukemia (AML)","googleId":"Uolx1rD5Kx8J","googleLink":"http://amphivena.com/wp-content/uploads/AMV564-ASH-2019-Presentation-Final-2019-12-04.pdf","googleCitationCount":7,"googleAuthor":""},{"title":"Older patients (pts) with previously untreated classical Hodgkin lymphoma (cHL): a detailed analysis from the phase 3 ECHELON-1 study","googleId":"5F7jRYWqd54J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1618/273225","googleCitationCount":10,"googleAuthor":"AM Evens"},{"title":"Extracellular galectins as controllers of cytokines in hematological cancer","googleId":"0LTsz10Tic8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/5/484/39380","googleCitationCount":8,"googleAuthor":"M Gordon-Alonso"},{"title":"Hif-1α and Hif-2α regulate hemogenic endothelium and hematopoietic stem cell formation in zebrafish","googleId":"mncXKe6gsxEJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/9/963/39200","googleCitationCount":10,"googleAuthor":"C Gerri"},{"title":"Minimal residual disease response at end of induction and during maintenance correlates with updated outcome in the phase III GALLIUM study of obinutuzumab-or …","googleId":"PWcRRarpvWcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/396/265038","googleCitationCount":10,"googleAuthor":"C Pott"},{"title":"Imetelstat treatment leads to durable transfusion independence (TI) in RBC transfusion-dependent (TD), non-del (5q) lower risk MDS relapsed/refractory to …","googleId":"Ms6LHzfU3JsJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/463/261993","googleCitationCount":8,"googleAuthor":"DP Steensma"},{"title":"Targeting protease nexin-1, a natural anticoagulant serpin, to control bleeding and improve hemostasis in hemophilia","googleId":"w42aFET7KvkJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/19/1632/374924","googleCitationCount":5,"googleAuthor":""},{"title":"Outcome of patients with myelofibrosis after ruxolitinib failure: role of disease status and treatment strategies in 214 patients","googleId":"BhQVIvhs2boJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/4277/275515","googleCitationCount":8,"googleAuthor":"EM Elli"},{"title":"ALLO-715, an allogeneic BCMA CAR T therapy possessing an off-switch for the treatment of multiple myeloma","googleId":"3-BR2I8PqvgJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/591/263328","googleCitationCount":8,"googleAuthor":""},{"title":"Pembrolizumab in patients with relapsed or refractory primary mediastinal large B-cell lymphoma (PMBCL): data from the Keynote-013 and Keynote-170 studies","googleId":"5obI6J35-eMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/228/261811","googleCitationCount":11,"googleAuthor":"SJ Rodig"},{"title":"Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia","googleId":"NMaiKSuy7R4J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1298/262849","googleCitationCount":7,"googleAuthor":"A Contejean"},{"title":"Phase 1 first-in-human trial of AMV564, a bivalent bispecific (2x2) CD33/CD3 T-cell Engager, in patients with relapsed/refractory acute myeloid leukemia (AML)","googleId":"yIs_-YSAF7UJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1455/272888","googleCitationCount":9,"googleAuthor":""},{"title":"Phase I-IIa clinical trial to assess safety and efficacy of MLM-CAR44. 1, a CD44v6 directed CAR-T in relapsed/refractory acute myeloid leukemia (AML) and multiple …","googleId":"XpjjCNfR7BcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/5790/262976","googleCitationCount":8,"googleAuthor":""},{"title":"Efficacy and safety of ibrutinib (IBR) after venetoclax (VEN) treatment in IBR-naïve patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL): follow …","googleId":"hm7fjr35BGgJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/5548/263219","googleCitationCount":10,"googleAuthor":"R Greil"},{"title":"Efficacy and safety of daratumumab, bortezomib, and dexamethasone (D-Vd) versus bortezomib and dexamethasone (Vd) in first relapse patients: two-year update of …","googleId":"qV3J0WDioFcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3270/264807","googleCitationCount":10,"googleAuthor":"MV Mateos"},{"title":"A retrospective review of tocilizumab for the management of blinatumomab (a bispecific T cell engager)-induced cytokine release syndrome (CRS)","googleId":"JSDs6kdF42UJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/5211/265497","googleCitationCount":8,"googleAuthor":""},{"title":"Correcting Rare Blood Disorders Using Coagulation Factors Produced In Vivo By Shielded Living TherapeuticsTM Products","googleId":"djGwKLXXCAEJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/Supplement_1/2065/427914","googleCitationCount":4,"googleAuthor":""},{"title":"A retrospective review of tocilizumab for the management of blinatumomab (a bispecific T cell engager)-induced cytokine release syndrome (CRS)","googleId":"JSDs6kdF42UJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/5211/265497","googleCitationCount":8,"googleAuthor":""},{"title":"Correcting Rare Blood Disorders Using Coagulation Factors Produced In Vivo By Shielded Living TherapeuticsTM Products","googleId":"djGwKLXXCAEJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/Supplement_1/2065/427914","googleCitationCount":4,"googleAuthor":""},{"title":"Manufacture of an allogeneic CAR-T stem cell memory product candidate for multiple myeloma, P-Bcma-ALLO1, is robust, reproducible and highly scalable","googleId":"1yCgfOocSFEJ","googleLink":"https://poseida.com/wp-content/uploads/2020/03/191128-P-BCMA-ALLO1-Poster-ASH-2019.pdf","googleCitationCount":4,"googleAuthor":""},{"title":"MHC class II cell-autonomously regulates self-renewal and differentiation of normal and malignant B cells","googleId":"sWzH3GmBegYJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/10/1108/272752","googleCitationCount":6,"googleAuthor":"J Attig"},{"title":"Regulation of globin-heme balance in Diamond-Blackfan anemia by HSP70/GATA1","googleId":"nqi_fhhbhn0J","googleLink":"https://ashpublications.org/blood/article-abstract/133/12/1358/260480","googleCitationCount":7,"googleAuthor":"M Gastou"},{"title":"Nivolumab treatment beyond investigator-assessed progression: extended follow-up in patients with relapsed/refractory classical Hodgkin lymphoma from the phase 2 …","googleId":"-AC7NDB2lIgJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2932/263562","googleCitationCount":8,"googleAuthor":""},{"title":"Anti-CD123 targeted therapy with Talacotuzumab in advanced MDS and AML after failing hypomethylating agents-final results of the Samba trial","googleId":"NKbL6lhlFxYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/4045/265010","googleCitationCount":9,"googleAuthor":"AS Kubasch"},{"title":"VLS-101 is a novel therapeutic antibody-drug conjugate (ADC) targeting receptor tyrosine kinase-like orphan receptor 1 (ROR1) in Richter's syndrome (RS)","googleId":"qJMUzQkg9QEJ","googleLink":"https://www.adcreview.com/wp-content/uploads/2020/11/VelosBio_ASH2019_Poster_FINAL_20191125_reduced.pdf","googleCitationCount":5,"googleAuthor":"T Vaisitti"},{"title":"B-CAP (brentuximab vedotin, cyclophosphamide, doxorubicin and predniso (lo) Ne) in older patients with advanced-stage Hodgkin lymphoma: results of a phase II …","googleId":"srCcdOogSJkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/926/266188","googleCitationCount":9,"googleAuthor":"A Fosså"},{"title":"Blinatumomab for minimal residual disease (MRD) in adults with B-cell precursor acute lymphoblastic leukemia (BCP-ALL): median overall survival (OS) is not …","googleId":"DC71xGP8Q3oJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/554/263122","googleCitationCount":11,"googleAuthor":""},{"title":"Updated results of a phase II study of lenalidomide-elotuzumab as maintenance therapy post-autologous stem cell transplant (AuSCT) in patients (Pts) with multiple …","googleId":"r_C1IDoI-IoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1982/261951","googleCitationCount":9,"googleAuthor":""},{"title":"Clinical utility of targeted next-generation sequencing–based screening of peripheral blood in the evaluation of cytopenias","googleId":"gWfqwKMJjjgJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/24/2222/375127","googleCitationCount":4,"googleAuthor":"V Shanmugam"},{"title":"A phase 2 study of the safety and efficacy of INCB050465, a selective PI3Kδ inhibitor, in combination with ruxolitinib in patients with myelofibrosis","googleId":"PkqJeEGJol4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/353/264722","googleCitationCount":11,"googleAuthor":""},{"title":"A phase IIa, open‑label, multicenter study of single‑agent tafasitamab (MOR208), an Fc‑optimized anti‑CD19 antibody, in patients with relapsed or refractory B …","googleId":"wmwNYIZ_0acJ","googleLink":"https://www.morphosys.com/sites/default/files/downloads/nhl-a_phase_iia_open-label_multicenter_study_of_single-agent_tafasitama.pdf","googleCitationCount":5,"googleAuthor":"PL Zinzani"},{"title":"New approaches to molecular monitoring in CML (and other diseases)","googleId":"fzI-8ibgVPUJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/19/1578/374986","googleCitationCount":3,"googleAuthor":"J Radich"},{"title":"Addition of crenolanib to induction chemotherapy overcomes the poor prognostic impact of co-occurring driver mutations in patients with newly diagnosed FLT3 …","googleId":"lBiqiewRKFwJ","googleLink":"https://arogpharma.com/wp-content/uploads/2020/05/4.-Addition-of-Crenolanib-to-Induction-Chemotherapy-Overcomes-the-Poor-Prognostic-Impact-of-Co-Occurring-Driver-Mutations-in-Patients-with-Newly-Diagnosed-FLT3-Mutated-AML.pdf","googleCitationCount":10,"googleAuthor":"AD Goldberg"},{"title":"Deep and durable responses with selinexor, daratumumab, and dexamethasome (SDd) in patients with multiple myeloma (MM) previously exposed to proteasome …","googleId":"61i_3CuFYrkJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/599/265968","googleCitationCount":8,"googleAuthor":""},{"title":"ANCHOR (OP-104): updated efficacy and safety from a phase 1/2 study of melflufen and dexamethasone plus bortezomib or daratumumab in patients with …","googleId":"DZwbeLeoypEJ","googleLink":"https://www.oncopeptides.se/en/wp-content/uploads/sites/2/2019/11/anchor-op-104-updated-efficacy-and-safety-from-a-phase-1-and-2-study.pdf","googleCitationCount":12,"googleAuthor":"EM Ocio"},{"title":"How I treat primary cutaneous CD30+ lymphoproliferative disorders","googleId":"3SVX-UZi9TIJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/6/515/260744","googleCitationCount":4,"googleAuthor":""},{"title":"Validation of clinical prognostic models and integration of genetic biomarkers of drug resistance in CLL patients treated with ibrutinib","googleId":"SkWta7wv4hIJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/186/266059","googleCitationCount":9,"googleAuthor":"IE Ahn"},{"title":"Venetoclax and obinutuzumab for frontline treatment of chronic lymphocytic leukemia","googleId":"18zM2giaW3QJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/20/1691/374969","googleCitationCount":5,"googleAuthor":""},{"title":"Maintenance therapy with the oral proteasome inhibitor (PI) Ixazomib significantly prolongs progression-free survival (PFS) following autologous stem cell …","googleId":"G8QjtImBvNkJ","googleLink":"https://cms.cws.net/content/beta.myelomasociety.org/files/2018ash/Dimopoulos%20ixazomib%20MM3_ASH_21NOV2018.pdf","googleCitationCount":9,"googleAuthor":"MA Dimopoulos"},{"title":"Beat pediatric ALL MRD: CD28 CAR T and transplant","googleId":"Kbzj6XX63gsJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/26/2333/429975","googleCitationCount":3,"googleAuthor":"M Ruella"},{"title":"A randomized Phase II study of azacitidine (AZA) alone or with lenalidomide (LEN), valproic acid (VPA) or idarubicin (IDA) in higher-risk MDS: Gfm's' pick a winner'trial","googleId":"hOLQ7MI4GkUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/467/262450","googleCitationCount":8,"googleAuthor":""},{"title":"KD025-208: a phase 2a study of KD025 for patients with chronic graft versus host disease (cGVHD)—pharmacodynamics and updated results","googleId":"SlxCObhdyD4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/602/266021","googleCitationCount":8,"googleAuthor":""},{"title":"JAK inhibitors and risk of B-cell lymphomas","googleId":"FFSKonCFLx0J","googleLink":"https://ashpublications.org/blood/article-abstract/133/21/2251/272737","googleCitationCount":6,"googleAuthor":""},{"title":"Long-term efficacy and safety from the copanlisib CHRONOS-1 study in patients with relapsed or refractory indolent B-cell lymphoma","googleId":"QjTjLz6qe44J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1595/272961","googleCitationCount":9,"googleAuthor":"M Dreyling"},{"title":"The transmembrane protein disulfide isomerase TMX1 negatively regulates platelet responses","googleId":"dEdKrwBEhoEJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/3/246/261416","googleCitationCount":7,"googleAuthor":"Y Wu"},{"title":"The novel SYK/JAK inhibitor cerdulatinib demonstrates good tolerability and clinical response in a phase 2a study in relapsed/refractory peripheral T-cell lymphoma …","googleId":"On93ylD8tiUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1001/262522","googleCitationCount":9,"googleAuthor":"SM Horwitz"},{"title":"Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT","googleId":"sppcqj3HTqwJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/9/978/260665","googleCitationCount":6,"googleAuthor":"K Krauel"},{"title":"Prognostic and long-term survival of immune thrombotic thrombocytopenic purpura in older patients","googleId":"v9YV1zZet8QJ","googleLink":"https://ashpublications.org/blood/article-pdf/doi/10.1182/blood.2019000748/1547391/blood.2019000748.pdf","googleCitationCount":3,"googleAuthor":"M Jamme","doi":"10.1182/blood.2019000748/1547391/blood.2019000748.pdf","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Myelofibrosis osteoclasts are clonal and functionally impaired","googleId":"A3mRiSjOn-oJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/21/2320/272744","googleCitationCount":8,"googleAuthor":"I Veletic"},{"title":"A novel RAG1 mutation reveals a critical in vivo role for HMGB1/2 during V (D) J recombination","googleId":"pEFs5EXq42kJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/8/820/260613","googleCitationCount":7,"googleAuthor":"D Lawless"},{"title":"Outcomes for initial patient cohorts with up to 33 months of follow-up in the Hgb-206 phase 1 trial","googleId":"Rkt_1_Wwy0QJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1080/262893","googleCitationCount":8,"googleAuthor":""},{"title":"LYMRIT 37-01: a phase I/II study of 177Lu-lilotomab satetraxetan (Betalutin®) antibody-radionuclide-conjugate (ARC) for the treatment of relapsed non-Hodgkin's …","googleId":"S0JNWfndX9IJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2879/263950","googleCitationCount":8,"googleAuthor":"A Kolstad"},{"title":"The curious incident of TdT-mediated mutations in AML","googleId":"bgpPG6PrUCUJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/25/2229/429657","googleCitationCount":3,"googleAuthor":"GS Vassiliou"},{"title":"Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL","googleId":"mg5rQz-LAw4J","googleLink":"https://ashpublications.org/blood/article-abstract/133/5/498/272843","googleCitationCount":9,"googleAuthor":""},{"title":"Bone marrow–specific loss of ABI1 induces myeloproliferative neoplasm with features resembling human myelofibrosis","googleId":"2VPJ6F3pvAAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/19/2053/39484","googleCitationCount":8,"googleAuthor":"N Ahsan"},{"title":"Bone and joint health markers in persons with hemophilia A (PwHA) treated with emicizumab in HAVEN 3","googleId":"b3xvwgq-rdoJ","googleLink":"https://www.emicizumabinfo.global/content/dam/hemlibra/global/en/congresses/ash-2019/ASH%202019_Oral_Kiialainen_HAVEN3%20Bone%20Joint%20Biomark.pdf","googleCitationCount":3,"googleAuthor":""},{"title":"MGUS, lymphoplasmacytic malignancies, and Gaucher disease: the significance of the clinical association","googleId":"tARFuLxHn80J","googleLink":"https://ashpublications.org/blood/article-abstract/131/22/2500/37073","googleCitationCount":9,"googleAuthor":"PK Mistry"},{"title":"Bone and joint health markers in persons with hemophilia A (PwHA) treated with emicizumab in HAVEN 3","googleId":"b3xvwgq-rdoJ","googleLink":"https://www.emicizumabinfo.global/content/dam/hemlibra/global/en/congresses/ash-2019/ASH%202019_Oral_Kiialainen_HAVEN3%20Bone%20Joint%20Biomark.pdf","googleCitationCount":3,"googleAuthor":""},{"title":"MGUS, lymphoplasmacytic malignancies, and Gaucher disease: the significance of the clinical association","googleId":"tARFuLxHn80J","googleLink":"https://ashpublications.org/blood/article-abstract/131/22/2500/37073","googleCitationCount":9,"googleAuthor":"PK Mistry"},{"title":"Tumor-educated platelets","googleId":"z4KaQ1l-CPQJ","googleLink":"https://www.narcis.nl/publication/RecordID/oai:pure.atira.dk:publications%2Fe7fc8031-ac42-4785-bfd5-3bd6b994088b","googleCitationCount":11,"googleAuthor":"","doi":"10.1182/blood-2018-12-852830","elsevierAuthor":"In 'T Veld S.G.J.G.","publicationName":"Blood","elsevierCoverDate":"2019-05-30","elsevierCoverDisplayDate":"30 May 2019","elsevierCitationCount":"22","altmetricAuthors":["Sjors G. J. G. In ‘t Veld","Thomas Wurdinger"],"twitterCount":5,"altmetricId":56473131},{"title":"Management of relapsed/refractory classical Hodgkin lymphoma in transplant-ineligible patients","googleId":"GWHY0GIbKb0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/15/1698/36823","googleCitationCount":8,"googleAuthor":""},{"title":"How I treat patients with hereditary antithrombin deficiency","googleId":"y06mwrKWoOYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120731149","googleCitationCount":4,"googleAuthor":"I Pabinger","doi":"10.1182/blood.2019002927","elsevierAuthor":"Pabinger I.","publicationName":"Blood","elsevierCoverDate":"2019-12-26","elsevierCoverDisplayDate":"26 December 2019","elsevierCitationCount":"2","altmetricAuthors":["Ingrid Pabinger","Johannes Thaler"],"twitterCount":1,"altmetricId":70086298},{"title":"Temporal autoregulation during human PU. 1 locus SubTAD formation","googleId":"biaJ8HjTmfEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/25/2643/39578","googleCitationCount":6,"googleAuthor":""},{"title":"Immune mediated mechanisms of resistance to daratumumab","googleId":"bHJfCt5Bl7UJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3201/263617","googleCitationCount":8,"googleAuthor":"A Dona"},{"title":"A stemness screen reveals C3orf54/INKA1 as a promoter of human leukemia stem cell latency","googleId":"ex4M5cWoVrkJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/20/2198/273856","googleCitationCount":9,"googleAuthor":"KB Kaufmann"},{"title":"Dasatinib versus imatinib in patients (Pts) with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of …","googleId":"LOtXQUSc-VAJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/788/266093","googleCitationCount":10,"googleAuthor":""},{"title":"Emicizumab for the treatment of acquired hemophilia_A: lessons learned from 4 very different cases","googleId":"-85moJq74ZcJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2476/263968","googleCitationCount":9,"googleAuthor":"P Schellongowski"},{"title":"Patient-reported and neurocognitive outcomes in patients treated with axicabtagene ciloleucel","googleId":"O9J5r5ufHMoJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2289/261910","googleCitationCount":7,"googleAuthor":"HSL Jim"},{"title":"Interim results from the first-in-human clinical trial of Adct-402 (Loncastuximab Tesirine), a novel pyrrolobenzodiazepine-based antibody drug conjugate, in relapsed …","googleId":"4K3GTsEu6XYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/398/265272","googleCitationCount":9,"googleAuthor":"J Radford"},{"title":"Successful treatment of MYC rearrangement positive large B cell lymphoma patients with R-CHOP21 plus lenalidomide: results of a multicenter phase II HOVON trial","googleId":"pm5f8EPRJYMJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/786/266075","googleCitationCount":8,"googleAuthor":"MED Chamuleau"},{"title":"Phase-1 study of PF-114 mesylate in CML failing prior tyrosine kinase-inhibitor therapy","googleId":"9sTKEBws17sJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/790/266127","googleCitationCount":8,"googleAuthor":""},{"title":"Shared roles for Scl and Lyl1 in murine platelet production and function","googleId":"YoaVi_ufKhgJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/10/826/260642","googleCitationCount":4,"googleAuthor":"S Ellis"},{"title":"Ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: pharmacokinetics and pharmacodynamics observed in two phase …","googleId":"t-u4yyg-UsUJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/626/266288","googleCitationCount":7,"googleAuthor":"RA Brodsky"},{"title":"Cost-effectiveness of a 12-month fixed duration of venetoclax in combination with obinutuzumab in first-line chronic lymphocytic Leukemia in the United States","googleId":"-tRRm4LLPO8J","googleLink":"https://medically.roche.com/content/dam/pdmahub/non-restricted/haematology/ash-2019/ASH-2019-poster-davids-cost-effectiveness-of-a-12-month-fixed-duration-of-venetoclax-in-combination-with-obinutuzumab.pdf","googleCitationCount":4,"googleAuthor":""},{"title":"Prospective multicenter phase 3 study comparing 5-azacytidine (5-aza) induction followed by allogeneic stem cell transplantation versus continuous 5-aza according …","googleId":"NpX-XwPMlDsJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/208/261557","googleCitationCount":7,"googleAuthor":"N Kroeger"},{"title":"Acalabrutinib in patients with relapsed/refractory (R/R) and high-risk, treatment-naive (TN) chronic lymphocytic leukemia (CLL)","googleId":"orNny3nfdL4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/4424/275670","googleCitationCount":8,"googleAuthor":"IE Ahn"},{"title":"Subsequent treatment outcomes of multiple myeloma refractory to CD38-monoclonal antibody therapy","googleId":"tM3OdXRptWMJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2015/261845","googleCitationCount":7,"googleAuthor":"A Lakshman"},{"title":"Open-label, phase 2 study of blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma","googleId":"tBiH6jOF2KoJ","googleLink":"http://eprints.whiterose.ac.uk/143614/1/Open-Label%2C%20Phase%202%20Study%20of%20Bli...Aggressive%20B-Cell%20Non-Hodgkin%20Lymphoma.pdf","googleCitationCount":8,"googleAuthor":"A Rambaldi"},{"title":"Updated phase 1 results of Zuma-3: Kte-C19, an anti-CD19 chimeric antigen receptor T cell therapy, in adult patients with relapsed/refractory acute lymphoblastic …","googleId":"iqHVE5EAodcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/897/266310","googleCitationCount":7,"googleAuthor":""},{"title":"Safety and efficacy data for combined checkpoint inhibition with ipilimumab (Ipi) and nivolumab (Nivo) as consolidation following autologous stem cell transplantation …","googleId":"QPJMsAQBVOkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/256/264413","googleCitationCount":8,"googleAuthor":"R Korngold"},{"title":"Factor VIII Use in the Treatment of Breakthrough Bleeds in Hemophilia A Patients without Inhibitors on Emicizumab Prophylaxis: The Phase 3 HAVEN 3 Study …","googleId":"kknceuCG-xoJ","googleLink":"https://www.emicizumabinfo.global/content/dam/hemlibra/global/en/congresses/ash-2019/ASH%202019_Poster_Callaghan_HAVEN%203%20FVIII%20Use%20For%20BTB.pdf","googleCitationCount":3,"googleAuthor":"M Callaghan"},{"title":"Safety and efficacy of Adct-402 (Loncastuximab Tesirine), a novel antibody drug conjugate, in relapsed/refractory follicular lymphoma and mantle cell lymphoma …","googleId":"LLCPAPTpZDEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2874/263899","googleCitationCount":8,"googleAuthor":"P Caimi"},{"title":"A randomized, double-blind, placebo-controlled phase 1 study of the pharmacokinetics and pharmacodynamics of REGN3918, a human antibody against complement …","googleId":"274ZQq446eIJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1039/262930","googleCitationCount":7,"googleAuthor":""},{"title":"Durable responses observed with JAK inhibition in T-cell lymphomas","googleId":"UZjtDdiN3_MJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2922/263945","googleCitationCount":7,"googleAuthor":"JH Schatz"},{"title":"Comprehensive viromewide antibody responses by systematic epitope scanning after hematopoietic cell transplantation","googleId":"gSb4jTNS5VgJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/6/503/260751","googleCitationCount":4,"googleAuthor":"RA Bender Ignacio"},{"title":"Study of AUTO3, the first bicistronic chimeric antigen receptor (CAR) targeting CD19 and CD22, followed by anti-PD1 consolidation in patients with relapsed/refractory …","googleId":"sPlf185ZpDkJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1679/272906","googleCitationCount":7,"googleAuthor":"M Al-Hajj"},{"title":"Preference for emicizumab over prior factor treatments: results from the HAVEN 3 and HAVEN 4 studies","googleId":"MasJUbiiWuMJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1187/262613","googleCitationCount":6,"googleAuthor":"I Paz-Priel"},{"title":"Disparities in survival by insurance status in follicular lymphoma","googleId":"LV-T6381k84J","googleLink":"https://ashpublications.org/blood/article-abstract/132/11/1159/39365","googleCitationCount":8,"googleAuthor":"X Han"},{"title":"HLH: genomics illuminates pathophysiological diversity","googleId":"TTCWnf1fqM0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/1/5/39284","googleCitationCount":8,"googleAuthor":"B Tesi"},{"title":"Frequency of PAR4 Ala120Thr variant associated with platelet reactivity significantly varies across sub-Saharan African populations","googleId":"8fd-4b1p6y0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/19/2103/39471","googleCitationCount":6,"googleAuthor":"TL Lindahl"},{"title":"Daratumumab monotherapy for patients with relapsed or refractory (R/R) natural killer/T-cell lymphoma (NKTCL), nasal type: an open-label, single-arm, multicenter …","googleId":"Sbkom2KEnXYJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1617/273215","googleCitationCount":7,"googleAuthor":"WS Kim"},{"title":"Radiotherapy priming chimeric antigen receptor T cell therapy is a safe and promising approach in relapsed/refractory diffuse large B cell lymphoma patients with high …","googleId":"Uwal8ZcL48oJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2961/263859","googleCitationCount":7,"googleAuthor":""},{"title":"FLT3mutation Assay Laboratory Cross Validation: Results from the CALGB 10603/Ratify Trial in Patients with Newly Diagnosed FLT3-Mutated Acute Myeloid …","googleId":"QniLgfHhB_gJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2800/263578","googleCitationCount":6,"googleAuthor":"C Thiede"},{"title":"Ring1A and Ring1B inhibit expression of Glis2 to maintain murine MOZ-TIF2 AML stem cells","googleId":"TuJdbbgCvd4J","googleLink":"https://ashpublications.org/blood/article-abstract/131/16/1833/36846","googleCitationCount":8,"googleAuthor":""},{"title":"Treatment of IgM-associated immunoglobulin light-chain amyloidosis with rituximab-bendamustine","googleId":"CX287NdligEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/7/761/39436","googleCitationCount":9,"googleAuthor":""},{"title":"Tolerability and efficacy of crenolanib and cytarabine/anthracycline chemotherapy in older patients (aged 61 to 75) with newly diagnosed FLT3-mutated acute …","googleId":"rdhhwpiKrIoJ","googleLink":"https://jibiotech.com/wp-content/uploads/2020/05/0.2.-Wang-ASH-2019-Poster-Tolerability-and-Efficacy-of-Crenolanib-and-73-in-older-patients-ARO-006.pdf","googleCitationCount":4,"googleAuthor":""},{"title":"Ibrutinib and fungus: an invasive concern","googleId":"ltz8st7pXK8J","googleLink":"https://ashpublications.org/blood/article-abstract/131/17/1882/36762","googleCitationCount":8,"googleAuthor":""},{"title":"Mutation-enhanced international prognostic systems for essential thrombocythemia (MIPSS-ET) and polycythemia vera (MIPSS-PV)","googleId":"3vQRfNjEX2sJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/578/263344","googleCitationCount":7,"googleAuthor":"P Guglielmelli"},{"title":"Long-term follow-up of SWOG S0816: Response-adapted therapy for stage III/IV Hodgkin Lymphoma demonstrates limitations of PET-adapted approach","googleId":"xXWsaoGtQAAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/929/266214","googleCitationCount":8,"googleAuthor":""},{"title":"Pre-clinical evaluation of B7-H3-specific chimeric antigen receptor T-cells for the treatment of acute myeloid leukemia","googleId":"3NGo4HmN-tMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/701/266136","googleCitationCount":5,"googleAuthor":""},{"title":"A single autologous stem cell transplant (ASCT) followed by two years of post-transplant therapy in recently diagnosed elderly multiple myeloma (MM) patients. Safety …","googleId":"HcUsG23K6DkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2153/261875","googleCitationCount":6,"googleAuthor":"K Nadiminti"},{"title":"No added benefit of eight versus six cycles of CHOP when combined with rituximab in previously untreated diffuse large B-cell lymphoma patients: results from the …","googleId":"aPmnI7URzNUJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/783/266048","googleCitationCount":6,"googleAuthor":"DJ Culligan"},{"title":"Plateletpheresis-associated lymphopenia in frequent platelet donors","googleId":"LHJ5SqlqYPgJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/6/605/260561","googleCitationCount":5,"googleAuthor":"M Rahmani"},{"title":"Efficacy of daratumumab in combination with standard of care regimens in lenalidomide-exposed or-refractory patients with relapsed/refractory multiple myeloma …","googleId":"1cYbZZ0NqqMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3288/264510","googleCitationCount":9,"googleAuthor":"SZ Usmani"},{"title":"Spirit 2: final 5 year analysis of the UK national cancer research institute randomized study comparing imatinib with dasatinib in patients with newly diagnosed chronic …","googleId":"99KJ2TaCDakJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/457/275807","googleCitationCount":8,"googleAuthor":""},{"title":"The SMART Anti-hC5 antibody (SKY59/RO7112689) shows good safety and efficacy in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)","googleId":"BsSDoMlrBKQJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/535/265551","googleCitationCount":6,"googleAuthor":"Z Nagy"},{"title":"Gemtuzumab ozogamicin in NPM1-mutated acute myeloid leukemia (AML): results from the prospective randomized AMLSG 09-09 phase-iii study","googleId":"5JBhlT2CT5MJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/81/266344","googleCitationCount":6,"googleAuthor":"RF Schlenk"},{"title":"Efficacy and safety following dose reduction of bosutinib or imatinib in patients with newly diagnosed chronic myeloid leukemia: analysis of the phase 3 BFORE trial","googleId":"Ih52cHgR0-cJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3005/263897","googleCitationCount":7,"googleAuthor":""},{"title":"Challenging the concept of immunothrombosis","googleId":"WI47CVuIaB0J","googleLink":"https://ashpublications.org/blood/article-abstract/133/6/508/260553","googleCitationCount":6,"googleAuthor":"R Palankar"},{"title":"Benefits and limitations of long-term eculizumab treatment for paroxysmal nocturnal hemoglobinuria (PNH): Real-world data from large cohort study in Russia","googleId":"yBMN0evgOYsJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2589/264219","googleCitationCount":6,"googleAuthor":""},{"title":"High Prevalence of BTK Mutations on ibrutinib therapy after 3 years of treatment in a real-life cohort of CLL patients: a study from the French Innovative Leukemia …","googleId":"26o8Jb3a8ZQJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/584/263038","googleCitationCount":8,"googleAuthor":"LM Fornecker"},{"title":"Durability of responses on continuous therapy and following drug cessation in deep responders with venetoclax and rituximab","googleId":"e1zblRtM4c0J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/183/273119","googleCitationCount":7,"googleAuthor":""},{"title":"Emerging clinical activity of REGN1979, an anti-CD20 x anti-CD3 bispecific antibody, in patients with relapsed/refractory follicular lymphoma (FL), diffuse large B-cell …","googleId":"4KokDyuEXBQJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1690/273046","googleCitationCount":7,"googleAuthor":""},{"title":"A phase 1 dose escalation study of ARQ 531 in selected patients with relapsed or refractory hematologic malignancies","googleId":"42dLdmS7PcIJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/3136/263890","googleCitationCount":7,"googleAuthor":"FT Awan"},{"title":"Sequential CD19-and CD22-CART cell therapies for relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation","googleId":"PAdc6C84TD8J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2126/261582","googleCitationCount":7,"googleAuthor":""},{"title":"Primary analysis of anti-CD19 tafasitamab (MOR208) treatment in combination with idelalisib or venetoclax in R/R CLL patients who failed prior BTK inhibitor …","googleId":"EovWA_yQdeQJ","googleLink":"https://www.morphosys.com/sites/default/files/downloads/cosmos-primary_analysis_of_anti-cd19_tafasitamab_mor208_treatment_in_combination_with_idelalisib_or_venetoclax_in_rr_cll_patients_who_failed_prior_btk_inhibitor_therapy.pdf","googleCitationCount":4,"googleAuthor":"PB Staber"},{"title":"Long-term efficacy and safety (5 years) in RESPONSE, a phase 3 study comparing ruxolitinib (rux) with best available therapy (BAT) in hydroxyurea (HU)-resistant …","googleId":"9cmEa1moZmYJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1753/273242","googleCitationCount":7,"googleAuthor":"F Pane"},{"title":"Response-adapted therapy with nivolumab and brentuximab vedotin (BV), followed by BV and bendamustine for suboptimal response, in children, adolescents, and …","googleId":"r57u0OxTWMEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/927/266199","googleCitationCount":7,"googleAuthor":""},{"title":"Chronic lymphocytic leukemia international prognostic index: a systematic review and meta-analysis","googleId":"lD1s2lZ8OJwJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/3/365/38296","googleCitationCount":13,"googleAuthor":"D Giannarelli"},{"title":"A novel point-of-care whole blood coagulation assay to monitor emicizumab therapy in patients with hemophilia","googleId":"FVeepYAuUm0J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2475/264456","googleCitationCount":6,"googleAuthor":"MA Suster"},{"title":"Double blind randomized control trial of postoperative low molecular weight heparin bridging therapy for patients who are at high risk for arterial thromboembolism …","googleId":"4lvNyMp2cGEJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/424/275575","googleCitationCount":7,"googleAuthor":"M Rodger"},{"title":"Hypertension is a modifiable risk factor for osteonecrosis in acute lymphoblastic leukemia","googleId":"8ygdD8HtkycJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/12/983/374901","googleCitationCount":3,"googleAuthor":"SL Van Driest"},{"title":"Baseline suvmax did not predict histological transformation from follicular lymphoma to aggressive lymphoma in the phase III GALLIUM study","googleId":"oV24HwMwyyYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/4160/275688","googleCitationCount":9,"googleAuthor":"SF Barrington"},{"title":"Hematopoietic stem cell gene therapy for IFNγR1 deficiency protects mice from mycobacterial infections","googleId":"_bPIQ-_kgi8J","googleLink":"https://ashpublications.org/blood/article-abstract/131/5/533/104434","googleCitationCount":10,"googleAuthor":""},{"title":"Preliminary safety and efficacy results with an intermittent schedule of the PI3kδ inhibitor ME-401 alone or in combination with rituximab for B-cell malignancies","googleId":"34gyRQpMub8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2893/263605","googleCitationCount":7,"googleAuthor":""},{"title":"Effect of ropeginterferon alfa-2b in prefibrotic primary myelofibrosis","googleId":"Ent2ZbVJmb8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3029/263666","googleCitationCount":6,"googleAuthor":"M Schalling"},{"title":"Affimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot, and reduce bleeding complications","googleId":"b7xGhmitoHQJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/11/1233/260504","googleCitationCount":4,"googleAuthor":"KJ Kearney"},{"title":"Mass cytometry of Hodgkin lymphoma reveals a CD4 (+) exhausted T-effector and T-regulatory cell rich microenvironment","googleId":"Kw4xxlM5mpMJ","googleLink":"http://shipplab.dfci.harvard.edu/wp-content/uploads/2018/06/Blood-2018-04-843714-full.pdf","googleCitationCount":8,"googleAuthor":"X Hu"},{"title":"Anti-CD30 chimeric antigen receptor T cell therapy for CD30+ relapsed/refractory Hodgkin lymphoma and anaplastic large cell lymphoma patients","googleId":"eEDHX4Z4RYYJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1660/273228","googleCitationCount":7,"googleAuthor":"L Huang"},{"title":"Starting T cell and cell product phenotype are associated with durable remission of leukemia following CD19 CAR-T cell immunotherapy","googleId":"Y9cWbhftBuAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/4022/265257","googleCitationCount":7,"googleAuthor":"R Gardner"},{"title":"Proteomic evidence of specific IGKV1-8 association with cystic lung light chain deposition disease","googleId":"HpIRBiNRtIMJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/26/2741/272763","googleCitationCount":7,"googleAuthor":""},{"title":"Defining success with cellular therapeutics: the current landscape for clinical end point and toxicity analysis","googleId":"bDsXM36jB7AJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120321583","googleCitationCount":6,"googleAuthor":"LS Kean","doi":"10.1182/blood-2018-02-785881","elsevierAuthor":"Kean L.S.","publicationName":"Blood","elsevierCoverDate":"2018-06-14","elsevierCoverDisplayDate":"14 June 2018","elsevierCitationCount":"3","altmetricAuthors":["Leslie S. Kean"],"twitterCount":6,"altmetricId":43752647},{"title":"Minimal residual disease status with venetoclax monotherapy is associated with progression-free survival in chronic lymphocytic Leukemia","googleId":"KByUWev1icMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3134/263873","googleCitationCount":7,"googleAuthor":"AW Roberts"},{"title":"PTENα promotes neutrophil chemotaxis through regulation of cell deformability","googleId":"OzkVtIE229YJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/19/2079/273821","googleCitationCount":5,"googleAuthor":""},{"title":"AGILE: A phase 3, multicenter, double-blind, randomized, placebo-controlled study of ivosidenib in combination with azacitidine in adult patients with previously …","googleId":"onPD2nHZY7IJ","googleLink":"https://investor.agios.com/static-files/50d41d4e-6d04-4218-9c7b-0fe553128f4a","googleCitationCount":3,"googleAuthor":"C Recher"},{"title":"Pembrolizumab for the treatment of disease relapse following allogeneic hematopoietic cell transplantation","googleId":"sZAcj2U8mnkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3415/264928","googleCitationCount":6,"googleAuthor":"J Kline"},{"title":"Efficacy of combined ruxolitinib and decitabine in patients with accelerated and blast-phase myeloproliferative neoplasms: results of a phase II study (MPN-RC 109 …","googleId":"ARTEhEtwY78J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3027/263644","googleCitationCount":6,"googleAuthor":""},{"title":"Dysfunctional endogenous FIX impairs prophylaxis in a mouse hemophilia B model","googleId":"N-QvVglUhwoJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/22/2445/273873","googleCitationCount":2,"googleAuthor":"FC Lin"},{"title":"Alemtuzumab added to CHOP for treatment of peripheral T-cell lymphoma (PTCL) in previously untreated young and elderly patients: pooled analysis of the …","googleId":"e32KUFN9tPMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1622/273276","googleCitationCount":7,"googleAuthor":""},{"title":"AVID200, a potent trap for TGF-β ligands inhibits TGF-β1 signaling in human myelofibrosis","googleId":"uHOIiTqKEh4J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1791/273182","googleCitationCount":7,"googleAuthor":""},{"title":"Multidimensional single cell analysis shows increased T/NK cell subsets in both blood and bone marrow of Iberdomide (CC-220) treated relapsed/refractory …","googleId":"teTnznku0wUJ","googleLink":"https://www.researchgate.net/profile/Oliver_Van_Oekelen/publication/337246969_Multidimensional_Single_Cell_Analysis_Shows_Increased_TNK_Cell_Subsets_in_Both_Blood_and_Bone_Marrow_of_Iberdomide_CC-220_Treated_RelapsedRefractory_Multiple_Myeloma_Patients/links/5f3fee24a6fdcccc43e11a33/Multidimensional-Single-Cell-Analysis-Shows-Increased-T-NK-Cell-Subsets-in-Both-Blood-and-Bone-Marrow-of-Iberdomide-CC-220-Treated-Relapsed-Refractory-Multiple-Myeloma-Patients.pdf","googleCitationCount":4,"googleAuthor":"O Van Oekelen"},{"title":"Outcomes of ibrutinib therapy given after prior venetoclax therapy in ibrutinib-naïve patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL)","googleId":"s-y9zHZapk0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/5556/263295","googleCitationCount":6,"googleAuthor":""},{"title":"Hepcidin suppression by momelotinib is associated with increased iron availability and erythropoiesis in transfusion-dependent myelofibrosis patients","googleId":"bQYBIbdelTYJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/4282/275580","googleCitationCount":6,"googleAuthor":"V Gupta"},{"title":"Mechanisms of adaptation to ibrutinib in high risk chronic lymphocytic leukemia","googleId":"7heNOPR9CY0J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/585/263142","googleCitationCount":7,"googleAuthor":"V Spina"},{"title":"Assessment of emicizumab-driven clot stability in hemophilia A model","googleId":"9dayJvP4pa8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2478/263997","googleCitationCount":6,"googleAuthor":""},{"title":"Phase 1 Study of MDR1 inhibitor plus brentuximab vedotin in relapsed/refractory Hodgkin lymphoma","googleId":"PgMIUUoBLCIJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1636/272939","googleCitationCount":6,"googleAuthor":"AF Herrera"},{"title":"Phase I/II, open-label, adaptive study of oral bruton tyrosine kinase inhibitor PRN1008 in patients with relapsed/refractory primary or secondary immune …","googleId":"XsXaGDJeyDAJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/Supplement_1/87/424448","googleCitationCount":4,"googleAuthor":""},{"title":"Randomized, open-label, non-inferiority, phase 3 study of subcutaneous (Sc) versus intravenous (IV) Daratumumab (DarA) administration in patients with relapsed or …","googleId":"552zF621rFsJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/Supplement_1/1865/427658","googleCitationCount":7,"googleAuthor":"SZ Usmani"},{"title":"Clonal suppression of TP53 mutant MDS and oligoblastic AML with hypomethylating agent therapy improves overall survival","googleId":"OSCRVD2BtTUJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1817/272984","googleCitationCount":5,"googleAuthor":"S Yun"},{"title":"The Impact of lenalidomide, bortezomib, and dexamethasone treatment on health-related quality of life in transplant-eligible patients with newly-diagnosed …","googleId":"loeAR-hfL8sJ","googleLink":"http://cms.cws.net/content/beta.myelomasociety.org/files/2018ash/murielle%20roussel%20-%20rousselifm2009hrqolfinalmr.pdf","googleCitationCount":5,"googleAuthor":"A Perrot"},{"title":"How I treat hypoxia in adults with hemoglobinopathies and hemolytic disorders","googleId":"vcuxwx-2nCkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/17/1770/39495","googleCitationCount":5,"googleAuthor":""},{"title":"A clinical study of tomaralimab (OPN-305), a toll-like receptor 2 (TLR-2) antibody, in heavily pre-treated transfusion dependent patients with lower risk myelodysplastic …","googleId":"F5nnXusTLdkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/798/266200","googleCitationCount":7,"googleAuthor":"G Garcia-Manero"},{"title":"Phase II clinical trial of alisertib, an Aurora A kinase inhibitor, in combination with induction chemotherapy in high-risk, untreated patients with acute myeloid leukemia","googleId":"VtuUS5FfYWIJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/766/266342","googleCitationCount":6,"googleAuthor":"AM Brunner"},{"title":"Pegasus causes inherited thrombocytopenia","googleId":"aj8i_Esd9FYJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/23/2000/429199","googleCitationCount":3,"googleAuthor":""},{"title":"Duffy antigen phenotyping is a useful and clinically available test for benign ethnic neutropenia","googleId":"4HPOTjuXO-8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2546/264262","googleCitationCount":5,"googleAuthor":"M Rahmani"},{"title":"Cardiovascular adverse events of ibrutinib","googleId":"tEFPfxe0TVkJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/22/1881/428845","googleCitationCount":2,"googleAuthor":"IE Ahn"},{"title":"The role of clonal hematopoiesis of indeterminate potential (CHIP) in multiple myeloma: Immunomodulator maintenance post autologous stem cell transplant (ASCT) …","googleId":"1k0NJwErHvMJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/749/266162","googleCitationCount":5,"googleAuthor":"TH Mouhieddine"},{"title":"CD19-CAR therapy using naive/memory or central memory T cells integrated into the autologous stem cell transplant regimen for patients with B-NHL","googleId":"KKtvTPmcAJgJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/610/266114","googleCitationCount":5,"googleAuthor":""},{"title":"Development and evaluation of CART targeting Bcma with humanized alpaca-derived single-domain antibody as antigen recognition domain","googleId":"tN7Xwhiu4a8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1976/261883","googleCitationCount":6,"googleAuthor":""},{"title":"Imatinib Suspension and Validation (ISAV) study: final results at 79 months","googleId":"fJZ5nY1KeBoJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/461/262254","googleCitationCount":6,"googleAuthor":"P le Coutre"},{"title":"Closing the loop on cohesin in hematopoiesis","googleId":"yXCONJglAQAJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/24/2123/429570","googleCitationCount":2,"googleAuthor":"S Rao"},{"title":"Venetoclax and navitoclax in patients with relapsed or refractory acute lymphoblastic leukemia and lymphoblastic lymphoma","googleId":"EU11hezwlAcJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/3966/265101","googleCitationCount":5,"googleAuthor":""},{"title":"Variable BCL2/BCL2L1 ratio in multiple myeloma with t (11; 14)","googleId":"XwPgtT174F8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/26/2778/39677","googleCitationCount":6,"googleAuthor":"A Perrot"},{"title":"Iberdomide (CC-220) has synergistic anti-tumor and immunostimulatory activity against multiple myeloma in combination with both bortezomib and dexamethasone …","googleId":"odUDjsIWJnAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1935/261933","googleCitationCount":6,"googleAuthor":""},{"title":"ET190L1-ArtemisTM T Cell Therapy Results in Durable Disease Remissions with No Cytokine Release Syndrome or Neurotoxicity in Patients with Relapsed and …","googleId":"NxNV5mZD-bwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1689/273023","googleCitationCount":5,"googleAuthor":""},{"title":"Progression-free survival subset analysis-denosumab vs zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double …","googleId":"Oh0lUX125-EJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1969/261797","googleCitationCount":7,"googleAuthor":"E Terpos"},{"title":"Blocking Vascular Niche E-Selectin Dampens AML Stem Cell Regeneration/Survival Potential In Vivo By Inhibiting MAPK/ERK and PI3K/AKT Signalling …","googleId":"ZbTY_WPGwe8J","googleLink":"http://glycomimetics.com/wp-content/uploads/2020/02/ASH-2019-poster-Winkler.pdf","googleCitationCount":2,"googleAuthor":"J Tay"},{"title":"ET190L1-ArtemisTM T Cell Therapy Results in Durable Disease Remissions with No Cytokine Release Syndrome or Neurotoxicity in Patients with Relapsed and …","googleId":"NxNV5mZD-bwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1689/273023","googleCitationCount":5,"googleAuthor":""},{"title":"Progression-free survival subset analysis-denosumab vs zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double …","googleId":"Oh0lUX125-EJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1969/261797","googleCitationCount":7,"googleAuthor":"E Terpos"},{"title":"Blocking Vascular Niche E-Selectin Dampens AML Stem Cell Regeneration/Survival Potential In Vivo By Inhibiting MAPK/ERK and PI3K/AKT Signalling …","googleId":"ZbTY_WPGwe8J","googleLink":"http://glycomimetics.com/wp-content/uploads/2020/02/ASH-2019-poster-Winkler.pdf","googleCitationCount":2,"googleAuthor":"J Tay"},{"title":"A method for noninvasive prenatal diagnosis of monogenic autosomal recessive disorders","googleId":"Y2m7cwwPL1sJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/14/1190/374893","googleCitationCount":5,"googleAuthor":"DV Vavoulis"},{"title":"The Evaluation of Residual Disease By Digital PCR, and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after for Stopping Imatinib First-Line in …","googleId":"nbr9N5O4z80J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/462/262360","googleCitationCount":5,"googleAuthor":""},{"title":"Daratumumab in combination with vincristine or nelarabine as effective salvage therapy for patients with acute lymphoblastic leukemia at high risk of relapse","googleId":"FmXFa6GxNyMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/5206/265933","googleCitationCount":6,"googleAuthor":"Y Ofran"},{"title":"Genomics reveal potential biomarkers of response to pembrolizumab after high dose cytarabine in an ongoing phase II trial in relapsed/refractory AML","googleId":"z46w-4qgEh8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/4054/265118","googleCitationCount":6,"googleAuthor":"JF Zeidner"},{"title":"Alisertib (MLN8237), an oral selective inhibitor of aurora kinase A, has clinical activity and restores GATA1 expression in patients with myelofibrosis","googleId":"xfxanOVRSasJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/688/265971","googleCitationCount":6,"googleAuthor":"C Marinaccio"},{"title":"Adult patients with ALL treated with CD62L+ T Naïve/memory-enriched T cells expressing a CD19-CAR mediate potent antitumor activity with a low toxicity profile","googleId":"E4TXNH6qdV4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/4016/265191","googleCitationCount":6,"googleAuthor":""},{"title":"Platelet hyperreactivity: a new twist in old mice","googleId":"e096OVofi6sJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/9/723/260757","googleCitationCount":2,"googleAuthor":""},{"title":"Responsiveness and the minimal clinically important difference for HM-PRO in patients with hematological malignancies","googleId":"xj7DmeQdOUcJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2294/261487","googleCitationCount":5,"googleAuthor":"EN Oliva"},{"title":"A Phase II StudyÂ of Sequential Pembrolizumab (PEM) Â FollowedÂ By AVD for Frontline TreatmentÂ of Classical Hodgkin Lymphoma (CHL): Quantifying Response …","googleId":"i8efRLsf8jwJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1651/273122","googleCitationCount":5,"googleAuthor":"AM Evens"},{"title":"Activating MAPK pathway mutations mediate primary resistance to PI3K inhibitors in chronic lymphocytic leukemia (CLL)","googleId":"i9FJbJ_xjAMJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/587/263369","googleCitationCount":6,"googleAuthor":""},{"title":"Safety and feasibility of outpatient liposomal daunorubicin and cytarabine (Vyxeos) induction and management in patients with secondary AML","googleId":"0n9h1JR6ntQJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3559/264587","googleCitationCount":8,"googleAuthor":""},{"title":"Efficacy and safety of venetoclax (Ven)+ rituximab (R) or Ven+ bendamustine (B)+ R randomized versus B+ R in patients (pts) with relapsed/refractory (R/R) follicular …","googleId":"24Cvpm3-knUJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1614/273181","googleCitationCount":5,"googleAuthor":"PL Zinzani"},{"title":"The earlier the better: timely mitigation of CRS","googleId":"p50_5RoF7UQJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/24/2119/429571","googleCitationCount":2,"googleAuthor":""},{"title":"Loss-of-function mutations in Dnmt3a and Tet2 lead to accelerated atherosclerosis and convergent macrophage phenotypes in mice","googleId":"e9gU5IcudMoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/745/266118","googleCitationCount":6,"googleAuthor":"PJ Rauch"},{"title":"Asciminib, a specific allosteric BCR-ABL1 inhibitor, in patients with chronic myeloid leukemia carrying the T315I mutation in a phase 1 trial","googleId":"9TDUZ-ijIBQJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/792/266146","googleCitationCount":5,"googleAuthor":"DW Kim"},{"title":"Activation of hedgehog signaling associates with early disease progression in chronic lymphocytic leukemia","googleId":"Wpah3x43lx0J","googleLink":"https://ashpublications.org/blood/article-abstract/133/25/2651/273898","googleCitationCount":3,"googleAuthor":"EM Ghia"},{"title":"Aggressive genomic features in clinically indolent primary HHV8-negative effusion-based lymphoma","googleId":"VmSw0annPWsJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/4/377/272771","googleCitationCount":4,"googleAuthor":"MGM Roemer"},{"title":"Ravulizumab: a complementary option for PNH","googleId":"YQzVvI7Cn0wJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/6/503/260564","googleCitationCount":5,"googleAuthor":"NT Connell"},{"title":"Radiation therapy as a bridging strategy for refractory diffuse large B cell lymphoma patients awaiting CAR T manufacturing of axicabtagene ciloleucel","googleId":"NhH8c2BMZXoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/4220/275841","googleCitationCount":8,"googleAuthor":""},{"title":"Cannibalistic acute myeloid leukemia with ZMYND11-MBTD1 fusion","googleId":"_Q6gSercQegJ","googleLink":"https://www.researchgate.net/profile/Adriana_Plesa2/publication/332517722_Cannibalistic_acute_myeloid_leukemia_with_ZMYND11-MBTD1_fusion/links/5cb99173a6fdcc1d499f607c/Cannibalistic-acute-myeloid-leukemia-with-ZMYND11-MBTD1-fusion.pdf","googleCitationCount":5,"googleAuthor":"P Sujobert"},{"title":"Measurable residual disease monitoring in acute myeloid leukemia with t (8; 21)(q22; q22. 1): results from the AML Study Group","googleId":"S6VMrXelXusJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/19/1608/374999","googleCitationCount":24,"googleAuthor":"M Agrawal"},{"title":"NCAM1 supports therapy resistance and LSC function in AML","googleId":"439_tVeF6jYJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/21/2247/272736","googleCitationCount":3,"googleAuthor":"SM Sykes"},{"title":"The real-world incidence of relapse in Acute Myeloid Leukemia (AML): a Systematic Literature Review (SLR)","googleId":"lcRfQ4g8GJwJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/5188/265727","googleCitationCount":4,"googleAuthor":"EN Oliva"},{"title":"Hematologic malignancies arising in patients with germ cell tumors: secondary somatic differentiation of hematopoietic malignancies from germ cell precursors","googleId":"EXR6H1ei-xUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/87/266025","googleCitationCount":4,"googleAuthor":"J Taylor"},{"title":"Make time for gait speed: vital to staging the aging","googleId":"MN21zYlZCs4J","googleLink":"https://ashpublications.org/blood/article-abstract/134/4/334/260682","googleCitationCount":3,"googleAuthor":"TM Wildes"},{"title":"Survival improvement of patients with chronic lymphocytic leukemia (CLL) in routine care 1995-2017","googleId":"mkh9K8muxkEJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/4823/262172","googleCitationCount":5,"googleAuthor":""},{"title":"Nivolumab for relapsed or residual haematological malignancies after allogeneic haematopoietic stem cell transplantation (NIVALLO)","googleId":"hRh-rJs2BBoJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/4633/262036","googleCitationCount":5,"googleAuthor":""},{"title":"Compound BCR-ABL1 kinase domain mutants: prevalence, spectrum and correlation with tyrosine kinase inhibitor resistance in a prospective series of Philadelphia …","googleId":"JdlwbyYb4vAJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/789/266103","googleCitationCount":5,"googleAuthor":"L Bavaro"},{"title":"Assessment of Ototoxicity and Nephrotoxicity in patients receiving weekly Cisplatin Chemotherapy: A Prospective Observational Study","googleId":"QkDSYhUMetoJ","googleLink":"https://rjptonline.org/HTML_Papers/Research%20Journal%20of%20Pharmacy%20and%20Technology__PID__2019-12-4-77.html","googleCitationCount":3,"googleAuthor":""},{"title":"Efficacy and safety of romiplostim in patients with acquired aplastic anemia ineligible or refractory to immunosuppressive therapy: interim analysis of phase 2/3 clinical …","googleId":"JganbGeOgLQJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1306/262960","googleCitationCount":5,"googleAuthor":"Y Tomiyama"},{"title":"Randomized phase 3 study of carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible, NDMM patients","googleId":"6ETsMm1-tAAJ","googleLink":"https://www.legeforeningen.no/contentassets/a19f9a10f52a4365a68bb4578320f0fd/car-vs-borte-i-komb-m-mp.pdf","googleCitationCount":4,"googleAuthor":"P Moreau"},{"title":"Phase I-II study of crenolanib combined with standard salvage chemotherapy and crenolanib combined with 5-azacitidine in acute myeloid leukemia patients with …","googleId":"4DrJlJc0WUsJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2715/264176","googleCitationCount":5,"googleAuthor":""},{"title":"Ixazomib-thalidomide-low dose dexamethasone (ITd) induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma …","googleId":"Q1W_asOS29sJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/800/266242","googleCitationCount":7,"googleAuthor":"MD Levin"},{"title":"Acute myeloid leukemia with plasmacytoid dendritic cell differentiation: predominantly secondary AML, enriched for RUNX1 mutations, frequent cross-lineage antigen …","googleId":"FaxYqqCFqCkJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2789/264461","googleCitationCount":4,"googleAuthor":"W Xiao"},{"title":"PET-adapted treatment of Hodgkin lymphoma","googleId":"S8fMuQW68I0J","googleLink":"https://ashpublications.org/blood/article-abstract/134/15/1200/374444","googleCitationCount":2,"googleAuthor":"M Hutchings"},{"title":"Primitive macrophages are dispensable for HSPC mobilization and definitive hematopoiesis","googleId":"cRMq1G2aSh4J","googleLink":"https://ashpublications.org/blood/article-abstract/134/9/782/260764","googleCitationCount":2,"googleAuthor":""},{"title":"A gain of function mutation in the NSD2 histone methyltransferase drives glucocorticoid resistance of acute lymphoblastic leukemia","googleId":"JXw29Rkah0EJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/653/266082","googleCitationCount":5,"googleAuthor":"J Li"},{"title":"Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemia","googleId":"kc18yJmMaB4J","googleLink":"https://ashpublications.org/blood/article-abstract/131/26/2943/39174","googleCitationCount":6,"googleAuthor":"SK Noothi"},{"title":"Carfilzomib Weekly 20/56mg/m², Lenalidomide and Dexamethasone for Early Relapsed Refractory Multiple Myeloma","googleId":"hQEumcE5aZYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3276/264868","googleCitationCount":7,"googleAuthor":""},{"title":"Phosphatidylinositol transfer proteins regulate megakaryocyte TGF-β1 secretion and hematopoiesis in mice","googleId":"SSsB-cBXuIwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/10/1027/39311","googleCitationCount":5,"googleAuthor":""},{"title":"Ruxolitinib and steroid refractory/dependent bronchiolitis obliterans after hematopoietic cell transplantation: a steroid sparing agent that also resulted in improved lung …","googleId":"JUCq6LJ1UN4J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/3407/264853","googleCitationCount":5,"googleAuthor":""},{"title":"Disruption of TET2 dioxygenase enhances antitumor efficiency in CD8+ tumor infiltrating lymphocytes","googleId":"ZhyKrhpvWccJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/860/266445","googleCitationCount":4,"googleAuthor":"M Lee"},{"title":"Sustained disease control for adult patients with relapsed or refractory diffuse large B-cell lymphoma: an updated analysis of Juliet, a global pivotal phase 2 trial of …","googleId":"vPw42Z-XU0MJ","googleLink":"https://kups.ub.uni-koeln.de/16514/","googleCitationCount":37,"googleAuthor":"C Tam"},{"title":"Results of pivotal phase 2 clinical trial of tagraxofusp (SL-401) in patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN)","googleId":"E-1_75C9NuwJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/765/266332","googleCitationCount":6,"googleAuthor":"AA Lane"},{"title":"Pharmacokinetics (PK) of subcutaneous daratumumab in patients with relapsed or refractory (RR) multiple myeloma (MM): primary clinical pharmacology analysis of …","googleId":"tK83etwqnKgJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2006/261747","googleCitationCount":4,"googleAuthor":"S Xu"},{"title":"Effects of Luspatercept on Iron Overload and Impact on Responders to Luspatercept: Results from the BELIEVE Trial","googleId":"3H-_tIwQag8J","googleLink":"https://www.postersessiononline.eu/173580348_eu/congresos/BSH2020/aula/-PO_143_BSH2020.pdf","googleCitationCount":3,"googleAuthor":"T Coates"},{"title":"Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia","googleId":"yC03Etrx99gJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/12/951/374903","googleCitationCount":9,"googleAuthor":""},{"title":"Nilotinib vs nilotinib plus pegylated interferon-alpha2b induction and nilotinib or pegylated interferon-alpha2b maintenance therapy for newly diagnosed BCR-ABL+ …","googleId":"c2xnKSB2LwMJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/460/262146","googleCitationCount":5,"googleAuthor":""},{"title":"ASPIRE final results confirm established safety and sustained efficacy for up to 4 years of treatment with rFVIIIFc in previously treated subjects with severe hemophilia …","googleId":"5F6ZvaKXOs8J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1192/262676","googleCitationCount":5,"googleAuthor":""},{"title":"MOR202 with low-dose dexamethasone (dex) or pomalidomide/dex or lenalidomide/dex in relapsed or refractory multiple myeloma (rrmm): primary analysis of a …","googleId":"-Tsorrn12gIJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/153/273212","googleCitationCount":10,"googleAuthor":""},{"title":"Phase 1/2 study of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory classic Hodgkin lymphoma: part 3 (concurrent dosing) …","googleId":"4CdLRJPn2AIJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1635/272928","googleCitationCount":5,"googleAuthor":""},{"title":"Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia","googleId":"yC03Etrx99gJ","googleLink":"https://ashpublications.org/blood/article-abstract/134/12/951/374903","googleCitationCount":9,"googleAuthor":""},{"title":"Nilotinib vs nilotinib plus pegylated interferon-alpha2b induction and nilotinib or pegylated interferon-alpha2b maintenance therapy for newly diagnosed BCR-ABL+ …","googleId":"c2xnKSB2LwMJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/460/262146","googleCitationCount":5,"googleAuthor":""},{"title":"ASPIRE final results confirm established safety and sustained efficacy for up to 4 years of treatment with rFVIIIFc in previously treated subjects with severe hemophilia …","googleId":"5F6ZvaKXOs8J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1192/262676","googleCitationCount":5,"googleAuthor":""},{"title":"MOR202 with low-dose dexamethasone (dex) or pomalidomide/dex or lenalidomide/dex in relapsed or refractory multiple myeloma (rrmm): primary analysis of a …","googleId":"-Tsorrn12gIJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/153/273212","googleCitationCount":10,"googleAuthor":""},{"title":"Phase 1/2 study of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory classic Hodgkin lymphoma: part 3 (concurrent dosing) …","googleId":"4CdLRJPn2AIJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1635/272928","googleCitationCount":5,"googleAuthor":""},{"title":"Deep incremental statistical closeness factor-based algorithm DIS-CFBA; to assess diabetes mellitus","googleId":"X4BfmYpf3NsJ","googleLink":"https://www.researchgate.net/profile/Rahul_Joshi19/publication/331327748_Deep_Incremental_Statistical_Closeness_Factor_Based_Algorithm_DIS-CFBA_to_assess_Diabetes_Mellitus/links/5c74071e299bf1268d259192/Deep-Incremental-Statistical-Closeness-Factor-Based-Algorithm-DIS-CFBA-to-assess-Diabetes-Mellitus.pdf","googleCitationCount":5,"googleAuthor":"RR Joshi"},{"title":"Preliminary results from a phase II study of the combination of azacitidine and pembrolizumab in patients with higher-risk myelodysplastic syndrome","googleId":"xTY5LSgUTuoJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/464/262113","googleCitationCount":6,"googleAuthor":""},{"title":"Survival outcomes following idelalisib interruption in the treatment of relapsed or refractory indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia","googleId":"-C4YzXhQ_McJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/3149/263528","googleCitationCount":4,"googleAuthor":""},{"title":"Post-transplant sorafenib improves overall survival in FLT3 mutated AML: a report from the EBMT acute leukemia working party","googleId":"X7uf825KcXoJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/708/266203","googleCitationCount":5,"googleAuthor":"A Bazarbachi"},{"title":"First evidence of restoration of T and NK cell compartment after venetoclax treatment","googleId":"aR-82R0din4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1860/273008","googleCitationCount":5,"googleAuthor":"J Dubois"},{"title":"Curativestategy (GEM-CESAR) for high-risk smoldering myeloma (SMM): carfilzomib, Lenalidomide and dexamethasone (KRd) as induction followed by HDT-ASCT …","googleId":"X3gBDoDzbioJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2142/261761","googleCitationCount":5,"googleAuthor":"MV Mateos"},{"title":"Patients with immune thrombocytopenia (ITP) frequently experience severe fatigue but is it under-recognized by physicians: results from the ITP World Impact Survey (I …","googleId":"H4ahvzBHXQcJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2273/261742","googleCitationCount":4,"googleAuthor":"N Cooper"},{"title":"Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study","googleId":"I3y-je9ZkroJ","googleLink":"https://ashpublications.org/blood/article-abstract/133/6/576/260565","googleCitationCount":28,"googleAuthor":""},{"title":"The BCL-2-selective inhibitor venetoclax spares activated T-cells during anti-tumor immunity","googleId":"GEuQrLsqfrsJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/3704/265133","googleCitationCount":4,"googleAuthor":"R Mathew"},{"title":"Intralesional administration of the CD47 antagonist TTI-621 (SIRPαFc) induces responses in both injected and non-injected lesions in patients with relapsed/refractory …","googleId":"ivqCPHzxjZAJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1653/273141","googleCitationCount":5,"googleAuthor":""},{"title":"Final analysis of the front-line phase III randomized ACT-1 trial in younger patients with systemic peripheral T-cell lymphoma treated with CHOP …","googleId":"3BwPDdcUjWQJ","googleLink":"https://portal.findresearcher.sdu.dk/en/publications/final-analysis-of-the-front-line-phase-iii-randomized-act-1-trial","googleCitationCount":12,"googleAuthor":"","doi":"10.1182/blood-2018-99-110429","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Salvage autologous transplant and lenalidomide maintenance versus continuous lenalidomide/dexamethasone for relapsed multiple myeloma: results of the …","googleId":"QMtm3iHGIlkJ","googleLink":"http://kups.ub.uni-koeln.de/id/eprint/16505","googleCitationCount":11,"googleAuthor":""},{"title":"Long-term outcomes with ibrutinib versus the prior regimen: a pooled analysis in relapsed/refractory (R/R) Mantle Cell Lymphoma (MCL) with up to 7.5 years of …","googleId":"zT32mjXHPkAJ","googleLink":"https://fr.janssenmedicalcloud.be/sites/fr.janssenmedicalcloud.be/files/EN_BE_imbruvica_be_poster_rule_mcl_ash_2019.pdf","googleCitationCount":3,"googleAuthor":"MH Dreyling"}]